<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="result">
            <roleset id="result.01" name="" wordnet="2">
                <roles>
                    <role n="0" descr="Theme, prior condition &#x0A;" />
                    <role n="1" descr="Goal, end condition&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>CdNA II DNA expression of isoform II in COS7 cells cells is eventually able to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>CdNA II DNA expression of isoform II in COS7 cells has resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>CdNA II DNA expression of isoform II in COS7 cells is shown to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>CdNA II DNA expression of isoform II in COS7 cells may eventually result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>CdNA II DNA expression of isoform II in COS7 cells may have resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>CdNA II DNA expression of isoform II in COS7 cells may ultimately result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>CdNA II DNA expression of isoform II in COS7 cells resulted in a marked increase in the acetylhydrase activity of PAF .</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>CdNA II DNA expression of isoform II in COS7 cells will eventually result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>CdNA II DNA expression of isoform II in COS7 cells will result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>CdNA II DNA expression of isoform II in COS7 cells, as predicted, will result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 cells resulting in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 results in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 results in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells resulting in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Change can cause heat instability and affect Expression of the cD DNA of isoform II in COS7 cells resulting in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>Change can cause heat instability and affect Expression of the cdNA II DNA from isoform II in COS7 resulting in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>Change can cause heat instability and affect a new mutation in codon 210 resulting in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>Change can cause heat instability and affect a new mutation to codon 210 resulting in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>Change can cause heat instability and affect a new mutation to codon 210 results in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>Change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start results in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>Change can cause heat instability and affect alternative spacer of a single transcription resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>Change can cause heat instability and affect alternative spacer of a single transcription results in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>Change can cause heat instability and affect differential spacing results in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>Change can cause heat instability and affect differential spasms resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>Change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 results in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>Change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 results in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>Change can cause heat instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells results in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>Change can cause heat instability and affect fluctuation in ras-dependent signaling resulting in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>Change can cause heat instability and affect fluctuation in ras-dependent signaling results in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>Change can cause heat instability and affect fluctuation in ras-dependent signaling results in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>Change can cause heat instability and affect fluctuation in signaling depending on ras resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>Change can cause heat instability and affect fluctuation in signaling depending on the ras resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>Change can cause heat instability and affect fluctuation in signaling depending on the ras resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>Change can cause heat instability and affect fluctuation in signaling depending on the ras resulting in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>Change can cause heat instability and affect glow in signalling depending on the ras resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>Change can cause heat instability and affect glow in signalling depending on the ras results in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>Change can cause heat instability and affect glow-dependent signaling fluctuation results in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>Change can cause heat instability and affect liquid charge of varying subunits resulting in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>Change can cause heat instability and affect liquid charge of varying subunits results in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>Change can cause heat instability and affect liquid load of variant subunit results in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>Change can cause heat instability and affect multiple alternative subdomains resulting in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>Change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 results in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>Change can cause heat instability and affect some alternative subdomains results in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>Change can cause heat instability and affect the net charge of the variant subunit resulting in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>Change can cause heat instability and affect the net charge of the variant subunit resulting in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>Change can cause heat instability and affect the net charge of the variant subunit results in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>Change can cause heat instability and affect the net load of the variant subunit resulting in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>DNA II expression of Isoform II DNA in COS7 can eventually result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>DNA II expression of Isoform II DNA in COS7 can ultimately resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>DNA II expression of Isoform II DNA in COS7 cells is eventually able to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>DNA II expression of Isoform II DNA in COS7 cells may have resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>DNA II expression of Isoform II DNA in COS7 eventually resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>DNA II expression of Isoform II DNA in COS7 may eventually result in a marked increase in the activity of PAF acetylhydase</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>DNA II expression of Isoform II DNA in COS7 may eventually result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>DNA II expression of Isoform II DNA in COS7 may result in a marked increase in the activity of PAF acetylhydase .</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>DNA II expression of Isoform II DNA in COS7 resulted in a marked increase in the activity of PAF acetylhydase .</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>DNA II expression of Isoform II DNA in COS7, as predicted, may have resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>DNA II expression of Isoform II DNA in COS7, as predicted, resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>DNA II expression of Isoform II DNA in COS7, as we have predicted, has the ability to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>DNA II expression of Isoform II DNA in COS7, as we have predicted, may result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>DNA II expression of Isoform II DNA in COS7, as we have result, is able to give rise to a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Exon 13 jumping in s1031 animals cells has resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>Exon 13 jumping in s1031 animals finally resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>Exon 13 jumping in s1031 animals may eventually result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>Exon 13 jumping in s1031 animals may result in a product of 543 bp .</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>Exon 13 jumping in s1031 animals may result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>Exon 13 jumping in s1031 animals, as predicted, may have resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>Exon 13 jumping in s1031 animals, as predicted, resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>Exon 13 jumping in s1031 animals, as predicted, will result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>Exon 13 jumping in s1031 animals, as we have result, is able to give rise to a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>Expression of cDNA isoform II DNA in COS7 cells can ultimately resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>Expression of cDNA isoform II DNA in COS7 cells cells eventually resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>Expression of cDNA isoform II DNA in COS7 cells has the ability to eventually result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>Expression of cDNA isoform II DNA in COS7 cells has the ability to ultimately result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>Expression of cDNA isoform II DNA in COS7 cells may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>Expression of cDNA isoform II DNA in COS7 cells may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>Expression of cDNA isoform II DNA in COS7 cells may result in a marked increase in the activity of PAF acetylhydrolase .</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>Expression of cDNA isoform II DNA in COS7 cells resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>Expression of cDNA isoform II DNA in COS7 cells will finally result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>Expression of cDNA isoform II DNA in COS7 cells will result in a marked increase in the activity of PAF acetylhydrolase .</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>Expression of cDNA isoform II DNA in COS7 cells will result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>Expression of cDNA isoform II DNA in COS7 cells, as predicted, resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>Expression of cDNA isoform II DNA in COS7 cells, as we have predicted, may resulting in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>Expression of cDNA isoform II DNA in COS7 has resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>Expression of cDNA isoform II DNA in COS7 has the ability to eventually result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>Expression of cDNA isoform II DNA in COS7 has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>Expression of cDNA isoform II DNA in COS7 is able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>Expression of cDNA isoform II DNA in COS7 is capable of result rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>Expression of cDNA isoform II DNA in COS7 is shown to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>Expression of cDNA isoform II DNA in COS7 may eventually result in a marked increase in acetylhydrolase activity PAF</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>Expression of cDNA isoform II DNA in COS7 may result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>Expression of cDNA isoform II DNA in COS7 may ultimately result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>Expression of cDNA isoform II DNA in COS7 resulted in a marked increase in acetylhydrolase activity PAF .</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>Expression of cDNA isoform II DNA in COS7 will finally result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>Expression of cDNA isoform II DNA in COS7 will result in a marked increase in acetylhydrolase activity PAF .</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>Expression of cDNA isoform II DNA in COS7 will result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>Expression of cDNA isoform II DNA in COS7, as predicted, can result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>Expression of cDNA isoform II DNA in COS7, as predicted, resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, is able to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, is likely to resulting in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, may resulting in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>Expression of cDNA isoform II DNA in COS7, as we have predicted, will result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells can result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells cells has the ability to ultimately result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells cells may have resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells has finally resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells has resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells has resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells has the ability to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells has the ability to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells is shown to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells is shown to ultimately result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells is shown to ultimately result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells may eventually result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells may have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells may ultimately result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells will result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as predicted, will result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, has the ability to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, is able to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, may result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, may resulting in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have predicted, will result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>Expression of cdNA II DNA of isoform II in COS7 cells, as we have result, is able to give rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>Expression of isoform II cDNA in COS7 cells cells can result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>Expression of isoform II cDNA in COS7 cells cells eventually resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>Expression of isoform II cDNA in COS7 cells cells may have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>Expression of isoform II cDNA in COS7 cells is able to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>Expression of isoform II cDNA in COS7 cells is capable of result rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>Expression of isoform II cDNA in COS7 cells is likely to resulting in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>Expression of isoform II cDNA in COS7 cells is shown to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>Expression of isoform II cDNA in COS7 cells may have finally resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>Expression of isoform II cDNA in COS7 cells resulted in a marked increase in the activity of acetylhydralase of PAF .</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>Expression of isoform II cDNA in COS7 cells will eventually result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>Expression of isoform II cDNA in COS7 cells, as predicted, may have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>Expression of isoform II cDNA in COS7 cells, as we have predicted, is able to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>Expression of isoform II cDNA in COS7 cells, as we have predicted, may result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>Expression of isoform II cDNA in COS7 cells, as we have predicted, may resulting in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>Expression of the cD DNA of isoform II in COS7 cells can result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>Expression of the cD DNA of isoform II in COS7 cells cells has resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>Expression of the cD DNA of isoform II in COS7 cells may result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>Expression of the cD DNA of isoform II in COS7 cells resulted in a marked increase in the activity of acetylhydrolase PAF .</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>Expression of the cD DNA of isoform II in COS7 cells will finally result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>Expression of the cD DNA of isoform II in COS7 cells will result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>Expression of the cD DNA of isoform II in COS7 cells, as predicted, can result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>Expression of the cD DNA of isoform II in COS7 cells, as we have predicted, is likely to resulting in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>Expression of the cD DNA of isoform II in COS7 cells, as we have predicted, may have resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>Expression of the cD DNA of isoform II in COS7 cells, as we have predicted, may result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>Expression of the cD DNA of isoform II in COS7 cells, as we have predicted, resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>Expression of the cD DNA of isoform II in COS7 cells, as we have result, is able to give rise to a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 finally resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 has the ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 is shown to ultimately result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 may eventually result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 may have finally resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>Expression of the cdNA II DNA from isoform II in COS7 will eventually result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>Expression of the cdNA II DNA from isoform II in COS7, as we have result, is able to give rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that Expression of isoform II cDNA in COS7 cells had the ability to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a new mutation in codon 210 had the ability to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a new mutation to codon 210 had the ability to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a new mutation to codon 210 had the ability to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that alternative exon coupling 139 nt had the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that differential slicing had the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that differentiated xis had the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that exon 13 jump in s1031 animals had the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that expression of cDNA ISOform II DNA in COS7 had the ability to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that fluctuation in ras-dependent signaling had the ability to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that fluctuation in signaling depending on the ras had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that glow in signaling depending on the ras had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that grid-dependent fluctuation in signaling had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that liquid load of the variable subunit had the ability to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that not to use the normal donor site of the intron 12 ear had the ability to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that reduction of signaling as a function of ras had the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>It has also been reported that a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity resulted from float in ras-dependent signaling.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>It has also been reported that a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity resulted from glow in signaling depending on the ras.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>It has also been reported that a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity resulted from glow-dependent signaling fluctuation.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>It has also been reported that a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity resulted from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>It has also been reported that a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1 resulted from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>It has also been reported that a marked increase in acetylhydrolase activity PAF resulted from Expression of cDNA isoform II DNA in COS7.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>It has also been reported that a marked increase in acetylhydrolase activity PAF resulted from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>It has also been reported that a marked increase in the activity of PAF acetylhydase resulted from DNA II expression of Isoform II DNA in COS7.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>It has also been reported that a marked increase in the activity of PAF acetylhydrolase resulted from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>It has also been reported that a marked increase in the activity of PAF acetylhydrolase resulted from Expression of the cdNA II DNA from isoform II in COS7.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>It has also been reported that a marked increase in the activity of acetylhydrolase PAF resulted from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>It has also been reported that a marked increase in the activity of acetylhydroxylase PAF resulted from expression of the DNA-cDNA ISOform II DNA in COS7 cells.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>It has also been reported that a variant resulted from not to use the normal donor site of the intron 12 ear.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>It has also been reported that an electrophoretic subunit LDH-B resulted from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>It has also been reported that an electrophoretic subunit fast type LDH-B resulted from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>It has also been reported that replacement of isoleucine with valine resulted from a new mutation to codon 210.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>It has also been reported that super-repetitor resulted from alternative mixed subdomains.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>It has also been reported that superrepetitor resulted from multiple alternative subdomains.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>Mutations that can resulted in simultaneous derepression of both genes can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>Mutations that have the ability to result in simultaneous derepression of both genes can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>Mutations that have the ability to result in symultaneous derepression of both genes may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">symultaneous derepression of both genes</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>Mutations that result in symultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">symultaneous derepression of both genes</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>Mutations that resulted in symultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">symultaneous derepression of both genes</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>The CdNA II DNA expression of isoform II in COS7 cells may have resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>The CdNA II DNA expression of isoform II in COS7 cells, as predicted, has resulted in the a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>The DNA II expression of Isoform II DNA in COS7 resulted in the a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>The DNA II expression of Isoform II DNA in COS7 will result in the a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>The Exon 13 jumping in s1031 animals may have resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>The Exon 13 jumping in s1031 animals, as predicted, has the ability to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>The Expression of cDNA isoform II DNA in COS7 cells and alternative transcriptional initiation, as result in our study, are capable of giving rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>The Expression of cDNA isoform II DNA in COS7 cells has the ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>The Expression of cDNA isoform II DNA in COS7 has resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>The Expression of cDNA isoform II DNA in COS7 is capable of result rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>The Expression of cDNA isoform II DNA in COS7 resulted in the a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>The Expression of cDNA isoform II DNA in COS7, as predicted, has the ability to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>The Expression of cdNA II DNA of isoform II in COS7 cells has the ability to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>The Expression of cdNA II DNA of isoform II in COS7 cells resulted in the a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>The Expression of isoform II cDNA in COS7 cells is capable of result rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>The Expression of isoform II cDNA in COS7 cells will result in the a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>The Expression of the cD DNA of isoform II in COS7 cells, as predicted, has resulted in the a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>The Expression of the cdNA II DNA from isoform II in COS7 and alternative transcriptional initiation, as result in our study, are capable of giving rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>The Expression of the cdNA II DNA from isoform II in COS7 is capable of result rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>The Expression of the cdNA II DNA from isoform II in COS7, as predicted, has resulted in the a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>The a new mutation in codon 210 and alternative transcriptional initiation, as result in our study, are capable of giving rise to replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>The a new mutation in codon 210 has the ability to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>The a new mutation in codon 210 has the ability to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>The a new mutation in codon 210 may have resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>The a new mutation in codon 210 may have resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>The a new mutation in codon 210 may have resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>The a new mutation in codon 210 resulted in the replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>The a new mutation in codon 210 will result in the replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>The a new mutation in codon 210 will result in the replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>The a new mutation in codon 210, as predicted, has resulted in the replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>The a new mutation in codon 210, as predicted, has resulted in the replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>The a new mutation in codon 210, as predicted, has resulted in the replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>The a new mutation in codon 210, as predicted, has resulted in the substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>The a new mutation in codon 210, as predicted, has the ability to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>The a new mutation in codon 210, as predicted, has the ability to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>The a new mutation to codon 210 has the ability to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>The a new mutation to codon 210 has the ability to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>The a new mutation to codon 210 is capable of result rise to replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>The a new mutation to codon 210 may have resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>The a new mutation to codon 210 will result in the replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>The a new mutation to codon 210, as predicted, has resulted in the replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>The a new mutation to codon 210, as predicted, has the ability to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>The alteration can cause thermal instability and affect DNA II expression of Isoform II DNA in COS7 after having resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>The alteration can cause thermal instability and affect DNA II expression of Isoform II DNA in COS7 being observed to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>The alteration can cause thermal instability and affect DNA II expression of Isoform II DNA in COS7 which is observed to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>The alteration can cause thermal instability and affect Exon 13 jumping in s1031 animals which has proven to result finally in a product of 543 bp .</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 because it is able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 being observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells after having resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells because it is able to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells being observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells which is observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells, which can result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 that may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>The alteration can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 which is observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>The alteration can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells after having resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>The alteration can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells because it is able to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>The alteration can cause thermal instability and affect Expression of isoform II cDNA in COS7 cells because it is able to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>The alteration can cause thermal instability and affect Expression of isoform II cDNA in COS7 cells that may have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>The alteration can cause thermal instability and affect Expression of isoform II cDNA in COS7 cells which is shown to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>The alteration can cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells because it is able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>The alteration can cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells which is able to finally result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>The alteration can cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells which is observed to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>The alteration can cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells, which ended up resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>The alteration can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 being observed to finally result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>The alteration can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 being observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>The alteration can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 which has proven to result finally in a marked increase in the activity of PAF acetylhydrolase .</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>The alteration can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 which is able to finally result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>The alteration can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7, which can result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 after having resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 because it is able to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 being observed to finally result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 that may have resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 that may have resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 that may have resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which has proven to result finally in replacement of isoleucine with valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which has proven to result finally in replacing isoleukin with valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which has proven to result finally in substitution of isoleucine to valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is able to finally result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is able to finally result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is observed to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is observed to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is observed to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is shown to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210 which is shown to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210, which can result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>The alteration can cause thermal instability and affect a new mutation in codon 210, which ended up resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 after having resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 being observed to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 which has proven to result finally in replacement of isoleucine with valine .</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 which is observed to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210 which is observed to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>The alteration can cause thermal instability and affect a new mutation to codon 210, which ended up resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation being observed to finally result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation, which can result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation, which ended up resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start because it is able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which has proven to result finally in mRNA species with 5 different UTRs .</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which is observed to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which is shown to result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>The alteration can cause thermal instability and affect alternative exon coupling 139 nt because it is able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>The alteration can cause thermal instability and affect alternative exon coupling 139 nt being observed to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>The alteration can cause thermal instability and affect alternative exon coupling 139 nt which has proven to result finally in mRNA species with 5 different UTRs .</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>The alteration can cause thermal instability and affect alternative exon coupling 139 nt which is shown to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>The alteration can cause thermal instability and affect alternative exon coupling 139 nt, which ended up resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>The alteration can cause thermal instability and affect alternative mixed subdomains after having resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>The alteration can cause thermal instability and affect alternative mixed subdomains after having resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>The alteration can cause thermal instability and affect alternative mixed subdomains being observed to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>The alteration can cause thermal instability and affect alternative mixed subdomains which is able to finally result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>The alteration can cause thermal instability and affect alternative mixed subdomains which is shown to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>The alteration can cause thermal instability and affect alternative spacer of a single transcription which has proven to result finally in difference in the 28 C-terminal amino acids between beta(1) and beta(2) .</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>The alteration can cause thermal instability and affect alternative spacer of a single transcription which is able to finally result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>The alteration can cause thermal instability and affect differential slicing being observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>The alteration can cause thermal instability and affect differential spacing being observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>The alteration can cause thermal instability and affect differential spacing, which ended up resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>The alteration can cause thermal instability and affect differential spasms being observed to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>The alteration can cause thermal instability and affect differential spasms which is observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>The alteration can cause thermal instability and affect differential spasms, which can result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>The alteration can cause thermal instability and affect differentiated xis which is shown to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>The alteration can cause thermal instability and affect differentiated xis, which can result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>The alteration can cause thermal instability and affect differentiated xis, which ended up resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>The alteration can cause thermal instability and affect exon 13 juar in s1031 animals being observed to finally result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>The alteration can cause thermal instability and affect exon 13 juar in s1031 animals being observed to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>The alteration can cause thermal instability and affect exon 13 juar in s1031 animals, which ended up resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals because it is able to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals being observed to result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals being observed to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals that may have resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals that may have resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals which is able to finally result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals which is able to finally result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals which is shown to result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals, which can result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>The alteration can cause thermal instability and affect exon 13 jump in s1031 animals, which ended up resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>The alteration can cause thermal instability and affect exon 13 jumping in animals s1031 which has proven to result finally in a product of 543 bp .</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 after having resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 because it is able to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 because it is able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 being observed to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which has proven to result finally in a marked increase in acetylhydrolase PAF activity .</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which has proven to result finally in a marked increase in the activity of acetylhydrolase PAF .</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which is able to finally result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which is observed to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>The alteration can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which is shown to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells because it is able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II in COS7 cells because it is able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II in COS7 cells being observed to finally result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II in COS7 cells being observed to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>The alteration can cause thermal instability and affect expression of the DNA-cDNA ISOform II in COS7 cells which is shown to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>The alteration can cause thermal instability and affect failure to use the normal donor site of the intron 12 ear which is able to finally result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>The alteration can cause thermal instability and affect float in ras-dependent signaling after having resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>The alteration can cause thermal instability and affect float in ras-dependent signaling being observed to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling after having resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling after having resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling because it is able to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling being observed to finally result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling being observed to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling that may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which has proven to result finally in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1 .</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which is observed to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which is observed to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which is shown to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling which is shown to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>The alteration can cause thermal instability and affect fluctuation in ras-dependent signaling, which ended up resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on ras after having resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on ras which is able to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on ras, which can result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on the ras being observed to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on the ras being observed to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on the ras which is able to finally result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on the ras, which ended up resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>The alteration can cause thermal instability and affect fluctuation in signaling depending on the ras, which ended up resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>The alteration can cause thermal instability and affect glow in signaling depending on the ras, which can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>The alteration can cause thermal instability and affect glow in signaling depending on the ras, which ended up resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>The alteration can cause thermal instability and affect glow in signalling depending on the ras which is shown to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>The alteration can cause thermal instability and affect glow-dependent signaling fluctuation being observed to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>The alteration can cause thermal instability and affect grid-dependent fluctuation in signaling which is able to finally result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>The alteration can cause thermal instability and affect grid-dependent fluctuation in signaling, which ended up resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits after having resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits being observed to finally result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits being observed to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits which is able to finally result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits which is observed to result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>The alteration can cause thermal instability and affect liquid load of the variable subunit being observed to finally result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>The alteration can cause thermal instability and affect liquid load of the variable subunit that may have resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>The alteration can cause thermal instability and affect liquid load of the variant subunit because it is able to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>The alteration can cause thermal instability and affect liquid load of variant subunit because it is able to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>The alteration can cause thermal instability and affect liquid load of variant subunit, which ended up resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>The alteration can cause thermal instability and affect missing to use the normal donor site of the ear 12 intron because it is able to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>The alteration can cause thermal instability and affect missing to use the normal donor site of the ear 12 intron which has proven to result finally in a variant .</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>The alteration can cause thermal instability and affect multiple alternate subdomains after having resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>The alteration can cause thermal instability and affect multiple alternate subdomains being observed to finally result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>The alteration can cause thermal instability and affect multiple alternate subdomains which is able to finally result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>The alteration can cause thermal instability and affect multiple alternate subdomains, which can result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>The alteration can cause thermal instability and affect multiple alternate subdomains, which ended up resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains because it is able to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains that may have resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains that may have resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains which has proven to result finally in super-repetitor .</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the coupling of intron 12 being observed to finally result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the coupling of intron 12, which can result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the intron 12 ear being observed to finally result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the intron 12 ear being observed to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>The alteration can cause thermal instability and affect not to use the normal donor site of the intron 12 ear which is observed to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras being observed to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras being observed to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras which is able to finally result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>The alteration can cause thermal instability and affect reduction of signaling as a function of ras which is shown to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains because it is able to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains being observed to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains that may have resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains which is able to finally result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains which is observed to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains which is shown to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit because it is able to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit being observed to finally result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit being observed to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit being observed to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit that may have resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit that may have resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit which has proven to result finally in an electrophoretic subunit LDH-B .</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit which has proven to result finally in an electrophoretic subunit fast type LDH-B .</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit which is able to finally result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit which is observed to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit which is shown to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>The alteration can cause thermal instability and affect the net charge of the variant subunit, which can result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>The alteration can cause thermal instability and affect the net charge of the varying subunit because it is able to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>The alteration can cause thermal instability and affect the net charge of the varying subunit, which ended up resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit after having resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit which has proven to result finally in a variant electrophoretic subunit LDH-B fast type .</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>The alteration can cause thermal instability and affect the net load of the variant subunit, which can result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>The alteration can result thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells which is capable of giving rise to a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>The alteration can result thermal instability and affect Exon 13 jumping in s1031 animals which has finally been shown to be a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>The alteration can result thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells which is capable of giving rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>The alteration can result thermal instability and affect Expression of cDNA isoform II DNA in COS7 which is capable of giving rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>The alteration can result thermal instability and affect Expression of cDNA isoform II DNA in COS7 which is capable of giving rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>The alteration can result thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which is capable of giving rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>The alteration can result thermal instability and affect Expression of isoform II cDNA in COS7 cells which has finally been shown to be a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>The alteration can result thermal instability and affect a new mutation in codon 210 which has finally been shown to be replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>The alteration can result thermal instability and affect a new mutation in codon 210 which is capable of giving rise to replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>The alteration can result thermal instability and affect a new mutation to codon 210 which has finally been shown to be replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>The alteration can result thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which has finally been shown to be mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>The alteration can result thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which is capable of giving rise to mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>The alteration can result thermal instability and affect alternative exon coupling 139 nt which is capable of giving rise to mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>The alteration can result thermal instability and affect alternative mixed subdomains which has finally been shown to be super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>The alteration can result thermal instability and affect alternative mixed subdomains which is capable of giving rise to superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>The alteration can result thermal instability and affect differential slicing which has finally been shown to be existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>The alteration can result thermal instability and affect differential spacing which is capable of giving rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>The alteration can result thermal instability and affect differential spasms which is capable of giving rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>The alteration can result thermal instability and affect exon 13 juar in s1031 animals which has finally been shown to be a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>The alteration can result thermal instability and affect exon 13 juar in s1031 animals which is capable of giving rise to a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>The alteration can result thermal instability and affect exon 13 jump in s1031 animals which has finally been shown to be a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>The alteration can result thermal instability and affect expression of cADNA DNA isoform II in COS7 cells which is capable of giving rise to a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>The alteration can result thermal instability and affect failure to use the normal donor site of the intron 12 ear which has finally been shown to be a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>The alteration can result thermal instability and affect fluctuation in ras-dependent signaling which has finally been shown to be a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>The alteration can result thermal instability and affect fluctuation in ras-dependent signaling which has finally been shown to be a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>The alteration can result thermal instability and affect fluctuation in ras-dependent signaling which has finally been shown to be a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>The alteration can result thermal instability and affect fluctuation in ras-dependent signaling which is capable of giving rise to a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>The alteration can result thermal instability and affect fluctuation in signaling depending on ras which has finally been shown to be a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>The alteration can result thermal instability and affect fluctuation in signaling depending on the ras which is capable of giving rise to a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>The alteration can result thermal instability and affect glow in signaling depending on the ras which is capable of giving rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>The alteration can result thermal instability and affect glow in signalling depending on the ras which has finally been shown to be a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>The alteration can result thermal instability and affect grid-dependent fluctuation in signaling which has finally been shown to be a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>The alteration can result thermal instability and affect liquid load of the variant subunit which is capable of giving rise to fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>The alteration can result thermal instability and affect liquid load of variant subunit which is capable of giving rise to a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>The alteration can result thermal instability and affect multiple alternate subdomains which has finally been shown to be superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>The alteration can result thermal instability and affect multiple alternative subdomains which is capable of giving rise to superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>The alteration can result thermal instability and affect not to use the normal donor site of the coupling of intron 12 which is capable of giving rise to a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>The alteration can result thermal instability and affect not to use the normal donor site of the intron 12 ear which has finally been shown to be a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>The alteration can result thermal instability and affect reduction of signaling as a function of ras which has finally been shown to be a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>The alteration can result thermal instability and affect some alternative subdomains which has finally been shown to be superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>The alteration can result thermal instability and affect some alternative subdomains which is capable of giving rise to superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>The alteration can result thermal instability and affect the net charge of the variant subunit which has finally been shown to be an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>The alteration can result thermal instability and affect the net charge of the variant subunit which has finally been shown to be an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>The alteration can result thermal instability and affect the net charge of the variant subunit which is capable of giving rise to a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>The alteration can result thermal instability and affect the net charge of the variant subunit which is capable of giving rise to an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>The alteration can result thermal instability and affect the net load of the variant subunit which has finally been shown to be a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>The alteration can result thermal instability and affect the net load of the variant subunit which is capable of giving rise to a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>The alteration may cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells which finally resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>The alteration may cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells which is observed to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>The alteration may cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells, which may eventually result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>The alteration may cause thermal instability and affect Exon 13 jumping in s1031 animals which has been demonstrated to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 being demonstrated to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells being demonstrated to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells which has been demonstrated to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells, which may eventually result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 which has been demonstrated to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>The alteration may cause thermal instability and affect Expression of cDNA isoform II DNA in COS7, which may eventually result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>The alteration may cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which finally resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>The alteration may cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which has been demonstrated to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>The alteration may cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which may result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>The alteration may cause thermal instability and affect Expression of isoform II cDNA in COS7 cells which is observed to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>The alteration may cause thermal instability and affect Expression of isoform II cDNA in COS7 cells which may result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>The alteration may cause thermal instability and affect Expression of isoform II cDNA in COS7 cells, which may ultimately resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>The alteration may cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells which has been demonstrated to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>The alteration may cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells which resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>The alteration may cause thermal instability and affect Expression of the cD DNA of isoform II in COS7 cells, which may eventually result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>The alteration may cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 which has been demonstrated to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>The alteration may cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 which is observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>The alteration may cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 which resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>The alteration may cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7, which may ultimately resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 being demonstrated to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 being demonstrated to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 being demonstrated to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which has been demonstrated to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which is observed to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>The alteration may cause thermal instability and affect a new mutation in codon 210 which resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>The alteration may cause thermal instability and affect a new mutation to codon 210 which resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which has been demonstrated to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which may result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which finally resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, which may eventually result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>The alteration may cause thermal instability and affect alternative exon coupling 139 nt which may result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>The alteration may cause thermal instability and affect alternative mixed subdomains which has been demonstrated to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>The alteration may cause thermal instability and affect alternative mixed subdomains which is observed to result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>The alteration may cause thermal instability and affect alternative mixed subdomains, which may ultimately resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>The alteration may cause thermal instability and affect alternative spacer of a single transcription being demonstrated to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>The alteration may cause thermal instability and affect differential slicing which finally resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>The alteration may cause thermal instability and affect differential slicing, which may ultimately resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>The alteration may cause thermal instability and affect differential spacing being demonstrated to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>The alteration may cause thermal instability and affect differential spasms, which may eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>The alteration may cause thermal instability and affect exon 13 juar in s1031 animals which resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>The alteration may cause thermal instability and affect exon 13 juar in s1031 animals, which may eventually result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>The alteration may cause thermal instability and affect exon 13 jump in s1031 animals which is observed to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>The alteration may cause thermal instability and affect exon 13 jump in s1031 animals, which may ultimately resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>The alteration may cause thermal instability and affect exon 13 jumping in animals s1031, which may ultimately resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>The alteration may cause thermal instability and affect expression of cADNA DNA isoform II in COS7 cells which has been demonstrated to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>The alteration may cause thermal instability and affect expression of cADNA DNA isoform II in COS7 cells which resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 being demonstrated to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 being demonstrated to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 which may result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>The alteration may cause thermal instability and affect expression of cDNA ISOform II DNA in COS7, which may eventually result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>The alteration may cause thermal instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells which resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>The alteration may cause thermal instability and affect failure to use the normal donor site of the intron 12 ear being demonstrated to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>The alteration may cause thermal instability and affect failure to use the normal donor site of the intron 12 ear which is observed to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>The alteration may cause thermal instability and affect float in ras-dependent signaling, which may eventually result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling being demonstrated to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling being demonstrated to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling which finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling which has been demonstrated to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling which has been demonstrated to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling which has been demonstrated to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling which is observed to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling which may result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling which resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling, which may eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling, which may ultimately resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>The alteration may cause thermal instability and affect fluctuation in ras-dependent signaling, which may ultimately resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on ras being demonstrated to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on ras which finally resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on ras which has been demonstrated to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on ras which is observed to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on ras which may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on ras which may result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras being demonstrated to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras which finally resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras which is observed to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras which may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras which resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras, which may eventually result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras, which may ultimately resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>The alteration may cause thermal instability and affect fluctuation in signaling depending on the ras, which may ultimately resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>The alteration may cause thermal instability and affect glow in signaling depending on the ras which may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>The alteration may cause thermal instability and affect glow in signaling depending on the ras which resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>The alteration may cause thermal instability and affect glow in signalling depending on the ras which may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>The alteration may cause thermal instability and affect glow in signalling depending on the ras, which may ultimately resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>The alteration may cause thermal instability and affect glow-dependent signaling fluctuation being demonstrated to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>The alteration may cause thermal instability and affect glow-dependent signaling fluctuation which resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>The alteration may cause thermal instability and affect grid-dependent fluctuation in signaling which may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>The alteration may cause thermal instability and affect grid-dependent fluctuation in signaling, which may ultimately resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits which finally resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits which has been demonstrated to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits which may result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>The alteration may cause thermal instability and affect liquid charge of varying subunits, which may eventually result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>The alteration may cause thermal instability and affect liquid load of the variable subunit being demonstrated to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>The alteration may cause thermal instability and affect liquid load of the variable subunit which may result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>The alteration may cause thermal instability and affect liquid load of the variable subunit which resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>The alteration may cause thermal instability and affect liquid load of the variant subunit which has been demonstrated to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>The alteration may cause thermal instability and affect liquid load of variant subunit which is observed to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>The alteration may cause thermal instability and affect missing to use the normal donor site of the ear 12 intron being demonstrated to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>The alteration may cause thermal instability and affect missing to use the normal donor site of the ear 12 intron which finally resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>The alteration may cause thermal instability and affect missing to use the normal donor site of the ear 12 intron, which may ultimately resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>The alteration may cause thermal instability and affect multiple alternate subdomains which finally resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains being demonstrated to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains being demonstrated to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains which finally resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains which has been demonstrated to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains which is observed to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains which resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains, which may eventually result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains, which may eventually result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>The alteration may cause thermal instability and affect not to use the normal donor site of the coupling of intron 12 which resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>The alteration may cause thermal instability and affect not to use the normal donor site of the coupling of intron 12, which may ultimately resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>The alteration may cause thermal instability and affect not to use the normal donor site of the intron 12 ear which finally resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>The alteration may cause thermal instability and affect not to use the normal donor site of the intron 12 ear which may result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>The alteration may cause thermal instability and affect reduction of signaling as a function of ras which has been demonstrated to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>The alteration may cause thermal instability and affect reduction of signaling as a function of ras which resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>The alteration may cause thermal instability and affect some alternative subdomains, which may eventually result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit being demonstrated to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which finally resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which has been demonstrated to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which may result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>The alteration may cause thermal instability and affect the net charge of the variant subunit which resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>The alteration may cause thermal instability and affect the net load of the variant subunit being demonstrated to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>The alteration may cause thermal instability and affect the net load of the variant subunit, which may eventually result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>The alteration may cause thermal instability and affect the net load of the variant subunit, which may ultimately resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>The alternative exon 2 cutting (139 nt) and alternative transcriptional initiation has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>The alternative exon 2 cutting (139 nt) and alternative transcriptional initiation, as predicted, has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>The alternative exon 2 cutting (139 nt) and alternative transcriptional start has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>The alternative exon 2 cutting (139 nt) and alternative transcriptional start is capable of result rise to mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>The alternative exon 2 exhaustion (139 nt) and alternative transcriptional start and alternative transcriptional initiation, as result in our study, are capable of giving rise to mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>The alternative exon coupling 139 nt resulted in the mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>The alternative exon coupling 139 nt, as predicted, has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>The alternative mixed subdomains may have resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>The alternative mixed subdomains resulted in the super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>The alternative mixed subdomains will result in the super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>The alternative mixed subdomains, as predicted, has the ability to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>The alternative spacer of a single transcription has the ability to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>The change can cause heat instability and affect CdNA II DNA expression of isoform II in COS7 cells which can eventually result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>The change can cause heat instability and affect CdNA II DNA expression of isoform II in COS7 cells which has resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>The change can cause heat instability and affect CdNA II DNA expression of isoform II in COS7 cells which resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 which can eventually result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 which has been shown to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 which has finally resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 which may eventually have resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 which resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>The change can cause heat instability and affect DNA II expression of Isoform II DNA in COS7 which will eventually result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals by being able to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals that may have resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals which eventually resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>The change can cause heat instability and affect Exon 13 jumping in s1031 animals which will eventually result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 after it has resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 by being able to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 cells by being able to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 cells that may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 cells which can eventually result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 that may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 that may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which can eventually result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which can eventually result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which can result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which has finally resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which has resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which may eventually have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>The change can cause heat instability and affect Expression of cDNA isoform II DNA in COS7 which resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells by being able to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells by finally being able to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which eventually resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which may eventually have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>The change can cause heat instability and affect Expression of cdNA II DNA of isoform II in COS7 cells which resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells after it has resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which can eventually result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which can result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which eventually resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which has been shown to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which has finally resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which may eventually have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>The change can cause heat instability and affect Expression of isoform II cDNA in COS7 cells which will eventually result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>The change can cause heat instability and affect Expression of the cD DNA of isoform II in COS7 cells by finally being able to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>The change can cause heat instability and affect Expression of the cD DNA of isoform II in COS7 cells which has been shown to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>The change can cause heat instability and affect Expression of the cD DNA of isoform II in COS7 cells which has resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>The change can cause heat instability and affect Expression of the cdNA II DNA from isoform II in COS7 which can eventually result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>The change can cause heat instability and affect Expression of the cdNA II DNA from isoform II in COS7 which can result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>The change can cause heat instability and affect Expression of the cdNA II DNA from isoform II in COS7 which eventually resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>The change can cause heat instability and affect Expression of the cdNA II DNA from isoform II in COS7 which may eventually have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 after it has resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 by being able to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 by being able to result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 that may have resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 that may have resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which can eventually result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which can eventually result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which can result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which has finally resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which has finally resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which has resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which may eventually have resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which may eventually have resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>The change can cause heat instability and affect a new mutation in codon 210 which resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>The change can cause heat instability and affect a new mutation to codon 210 which can result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>The change can cause heat instability and affect a new mutation to codon 210 which has resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>The change can cause heat instability and affect a new mutation to codon 210 which has resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which can result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which eventually resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional initiation which has finally resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start by finally being able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which can eventually result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which can result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which has been shown to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which has finally resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>The change can cause heat instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start which resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>The change can cause heat instability and affect alternative exon coupling 139 nt after it has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>The change can cause heat instability and affect alternative exon coupling 139 nt by finally being able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>The change can cause heat instability and affect alternative exon coupling 139 nt which may eventually have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>The change can cause heat instability and affect alternative mixed subdomains by being able to result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>The change can cause heat instability and affect alternative mixed subdomains by finally being able to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>The change can cause heat instability and affect alternative mixed subdomains that may have resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>The change can cause heat instability and affect alternative mixed subdomains that may have resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>The change can cause heat instability and affect alternative mixed subdomains which can eventually result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>The change can cause heat instability and affect alternative mixed subdomains which may eventually have resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>The change can cause heat instability and affect alternative mixed subdomains which resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>The change can cause heat instability and affect alternative spacer of a single transcription which has finally resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>The change can cause heat instability and affect alternative spacer of a single transcription which has resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>The change can cause heat instability and affect differential slicing which may eventually have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>The change can cause heat instability and affect differential spacing by finally being able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>The change can cause heat instability and affect differential spacing which can result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>The change can cause heat instability and affect differential spasms which has been shown to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>The change can cause heat instability and affect differential spasms which has finally resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>The change can cause heat instability and affect differential spasms which has resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>The change can cause heat instability and affect differential spasms which resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>The change can cause heat instability and affect exon 13 juar in s1031 animals by being able to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>The change can cause heat instability and affect exon 13 juar in s1031 animals that may have resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>The change can cause heat instability and affect exon 13 juar in s1031 animals which has resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals after it has resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals that may have resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which can eventually result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which can result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which eventually resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which has finally resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which has resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>The change can cause heat instability and affect exon 13 jump in s1031 animals which will eventually result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>The change can cause heat instability and affect exon 13 jumping in animals s1031 by being able to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>The change can cause heat instability and affect exon 13 jumping in animals s1031 which can eventually result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>The change can cause heat instability and affect exon 13 jumping in animals s1031 which can result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>The change can cause heat instability and affect exon 13 jumping in animals s1031 which may eventually have resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>The change can cause heat instability and affect expression of cADNA DNA isoform II in COS7 cells by finally being able to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>The change can cause heat instability and affect expression of cADNA DNA isoform II in COS7 cells that may have resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>The change can cause heat instability and affect expression of cADNA DNA isoform II in COS7 cells which can result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>The change can cause heat instability and affect expression of cADNA DNA isoform II in COS7 cells which resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 after it has resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 by being able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 by finally being able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 that may have resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which can eventually result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>The change can cause heat instability and affect expression of cDNA ISOform II DNA in COS7 which has been shown to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells by finally being able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells which can eventually result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells which may eventually have resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II in COS7 cells which eventually resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II in COS7 cells which has been shown to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>The change can cause heat instability and affect expression of the DNA-cDNA ISOform II in COS7 cells which has resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>The change can cause heat instability and affect failure to use the normal donor site of the intron 12 ear which eventually resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>The change can cause heat instability and affect failure to use the normal donor site of the intron 12 ear which will eventually result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>The change can cause heat instability and affect float in ras-dependent signaling by finally being able to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>The change can cause heat instability and affect float in ras-dependent signaling that may have resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling after it has resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling after it has resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling by being able to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling by finally being able to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling that may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which can eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which can eventually result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which can eventually result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which can eventually result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which can result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which eventually resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has been shown to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has been shown to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="759">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has finally resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="760">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has finally resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="761">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="762">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which has resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="763">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which may eventually have resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="764">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="765">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="766">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="767">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="768">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which will eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="769">
                    <text>The change can cause heat instability and affect fluctuation in ras-dependent signaling which will eventually result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="770">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras after it has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="771">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras by being able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="772">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras by finally being able to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="773">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras that may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="774">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which can eventually result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="775">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="776">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which eventually resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="777">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on ras which may eventually have resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="778">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras by finally being able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="779">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which can eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="780">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which eventually resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="781">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which has been shown to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="782">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which has finally resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="783">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="784">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which has resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="785">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="786">
                    <text>The change can cause heat instability and affect fluctuation in signaling depending on the ras which will eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="787">
                    <text>The change can cause heat instability and affect glow in signaling depending on the ras by being able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="788">
                    <text>The change can cause heat instability and affect glow in signaling depending on the ras which can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="789">
                    <text>The change can cause heat instability and affect glow in signaling depending on the ras which has finally resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="790">
                    <text>The change can cause heat instability and affect glow in signalling depending on the ras by finally being able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="791">
                    <text>The change can cause heat instability and affect glow in signalling depending on the ras which may eventually have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="792">
                    <text>The change can cause heat instability and affect glow-dependent signaling fluctuation by being able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="793">
                    <text>The change can cause heat instability and affect glow-dependent signaling fluctuation which can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="794">
                    <text>The change can cause heat instability and affect glow-dependent signaling fluctuation which has finally resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="795">
                    <text>The change can cause heat instability and affect glow-dependent signaling fluctuation which has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="796">
                    <text>The change can cause heat instability and affect grid-dependent fluctuation in signaling after it has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="797">
                    <text>The change can cause heat instability and affect grid-dependent fluctuation in signaling which can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="798">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits after it has resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="799">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits after it has resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="800">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits by being able to result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="801">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits by being able to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="802">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits that may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="803">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits which can result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="804">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits which has resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="805">
                    <text>The change can cause heat instability and affect liquid charge of varying subunits which resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="806">
                    <text>The change can cause heat instability and affect liquid load of the variable subunit which eventually resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="807">
                    <text>The change can cause heat instability and affect liquid load of the variable subunit which has finally resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="808">
                    <text>The change can cause heat instability and affect liquid load of the variable subunit which resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="809">
                    <text>The change can cause heat instability and affect liquid load of the variant subunit that may have resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="810">
                    <text>The change can cause heat instability and affect liquid load of the variant subunit which resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="811">
                    <text>The change can cause heat instability and affect liquid load of variant subunit by being able to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="812">
                    <text>The change can cause heat instability and affect liquid load of variant subunit which may eventually have resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="813">
                    <text>The change can cause heat instability and affect multiple alternate subdomains which eventually resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="814">
                    <text>The change can cause heat instability and affect multiple alternate subdomains which has resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="815">
                    <text>The change can cause heat instability and affect multiple alternative subdomains that may have resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="816">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which can result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="817">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which has finally resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="818">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="819">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 which eventually resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="820">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 which has finally resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="821">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the coupling of intron 12 which resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="822">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the intron 12 ear by finally being able to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="823">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the intron 12 ear that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="824">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the intron 12 ear which can result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="825">
                    <text>The change can cause heat instability and affect not to use the normal donor site of the intron 12 ear which eventually resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="826">
                    <text>The change can cause heat instability and affect reduction of signaling as a function of ras after it has resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="827">
                    <text>The change can cause heat instability and affect reduction of signaling as a function of ras which can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="828">
                    <text>The change can cause heat instability and affect reduction of signaling as a function of ras which has finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="829">
                    <text>The change can cause heat instability and affect some alternative subdomains after it has resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="830">
                    <text>The change can cause heat instability and affect some alternative subdomains which has finally resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="831">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit by finally being able to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="832">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which can result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="833">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which can result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="834">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which can result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="835">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which eventually resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="836">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which has finally resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="837">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which has resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="838">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which may eventually have resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="839">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which may eventually have resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="840">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="841">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="842">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit which will eventually result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="843">
                    <text>The change can cause heat instability and affect the net charge of the varying subunit that may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="844">
                    <text>The change can cause heat instability and affect the net load of the variant subunit after it has resulted in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="845">
                    <text>The change can cause heat instability and affect the net load of the variant subunit which eventually resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="846">
                    <text>The change can cause heat instability and affect the net load of the variant subunit which has finally resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="847">
                    <text>The change can cause heat instability and affect the net load of the variant subunit which may eventually have resulted in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="848">
                    <text>The change can cause thermal instability and affect CdNA II DNA expression of isoform II in COS7 cells and is shown to finally result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="849">
                    <text>The change can cause thermal instability and affect DNA II expression of Isoform II DNA in COS7 and is shown to finally result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="850">
                    <text>The change can cause thermal instability and affect Expression of cDNA isoform II DNA in COS7 cells and is shown to ultimately result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="851">
                    <text>The change can cause thermal instability and affect Expression of cdNA II DNA of isoform II in COS7 cells and is shown to finally result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="852">
                    <text>The change can cause thermal instability and affect Expression of isoform II cDNA in COS7 cells and is shown to ultimately result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="853">
                    <text>The change can cause thermal instability and affect Expression of isoform II cDNA in COS7 cells that is observed to finally result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="854">
                    <text>The change can cause thermal instability and affect Expression of the cdNA II DNA from isoform II in COS7 that is observed to finally result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="855">
                    <text>The change can cause thermal instability and affect a new mutation in codon 210 and is shown to finally result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="856">
                    <text>The change can cause thermal instability and affect a new mutation in codon 210 and is shown to finally result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="857">
                    <text>The change can cause thermal instability and affect alternative exon 2 cutting (139 nt) and alternative transcriptional start and is shown to ultimately result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="858">
                    <text>The change can cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start and is shown to ultimately result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="859">
                    <text>The change can cause thermal instability and affect alternative mixed subdomains and is shown to ultimately result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="860">
                    <text>The change can cause thermal instability and affect differential spacing and is shown to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="861">
                    <text>The change can cause thermal instability and affect exon 13 juar in s1031 animals and is shown to finally result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="862">
                    <text>The change can cause thermal instability and affect exon 13 jump in s1031 animals and is shown to ultimately result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="863">
                    <text>The change can cause thermal instability and affect exon 13 jump in s1031 animals that is observed to finally result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="864">
                    <text>The change can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 and is shown to finally result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="865">
                    <text>The change can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 and is shown to ultimately result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="866">
                    <text>The change can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 and is shown to ultimately result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="867">
                    <text>The change can cause thermal instability and affect expression of cDNA ISOform II DNA in COS7 and is shown to ultimately result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="868">
                    <text>The change can cause thermal instability and affect expression of the DNA-cDNA ISOform II DNA in COS7 cells that is observed to finally result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="869">
                    <text>The change can cause thermal instability and affect failure to use the normal donor site of the intron 12 ear that is observed to finally result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="870">
                    <text>The change can cause thermal instability and affect float in ras-dependent signaling and is shown to ultimately result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="871">
                    <text>The change can cause thermal instability and affect fluctuation in ras-dependent signaling and is shown to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="872">
                    <text>The change can cause thermal instability and affect fluctuation in ras-dependent signaling and is shown to finally result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="873">
                    <text>The change can cause thermal instability and affect fluctuation in ras-dependent signaling and is shown to finally result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="874">
                    <text>The change can cause thermal instability and affect fluctuation in ras-dependent signaling that is observed to finally result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="875">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on ras and is shown to ultimately result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="876">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on ras and is shown to ultimately result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="877">
                    <text>The change can cause thermal instability and affect fluctuation in signaling depending on the ras and is shown to finally result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="878">
                    <text>The change can cause thermal instability and affect glow in signaling depending on the ras and is shown to ultimately result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="879">
                    <text>The change can cause thermal instability and affect glow-dependent signaling fluctuation and is shown to ultimately result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="880">
                    <text>The change can cause thermal instability and affect liquid charge of varying subunits and is shown to finally result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="881">
                    <text>The change can cause thermal instability and affect liquid load of the variable subunit that is observed to finally result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="882">
                    <text>The change can cause thermal instability and affect missing to use the normal donor site of the ear 12 intron and is shown to finally result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="883">
                    <text>The change can cause thermal instability and affect multiple alternative subdomains and is shown to finally result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="884">
                    <text>The change can cause thermal instability and affect multiple alternative subdomains that is observed to finally result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="885">
                    <text>The change can cause thermal instability and affect the net charge of the variant subunit and is shown to finally result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="886">
                    <text>The change can cause thermal instability and affect the net charge of the variant subunit and is shown to finally result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="887">
                    <text>The change can cause thermal instability and affect the net charge of the variant subunit and is shown to ultimately result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="888">
                    <text>The change can cause thermal instability and affect the net charge of the variant subunit and is shown to ultimately result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="889">
                    <text>The change can cause thermal instability and affect the net charge of the variant subunit that is observed to finally result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="890">
                    <text>The change can cause thermal instability and affect the net charge of the varying subunit and is shown to ultimately result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="891">
                    <text>The change can cause thermal instability and affect the net charge of the varying subunit that is observed to finally result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="892">
                    <text>The change can cause thermal instability and affect the net load of the variant subunit that is observed to finally result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="893">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed Expression of the cD DNA of isoform II in COS7 cells that has the ability to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="894">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 that has the ability to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="895">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional start that has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="896">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon coupling 139 nt that has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="897">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 juar in s1031 animals that has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="898">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jump in s1031 animals that has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="899">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed expression of cADNA DNA isoform II in COS7 cells that has the ability to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="900">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras that has the ability to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="901">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="902">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="903">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that has the ability to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="904">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed grid-dependent fluctuation in signaling that has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="905">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that has the ability to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="906">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the intron 12 ear that has the ability to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="907">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that has the ability to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="908">
                    <text>The differential spasms, as predicted, has resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="909">
                    <text>The differentiated xis and alternative transcriptional initiation, as result in our study, are capable of giving rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="910">
                    <text>The differentiated xis, as predicted, has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="911">
                    <text>The exon 13 juar in s1031 animals resulted in the a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="912">
                    <text>The exon 13 jump in s1031 animals has resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="913">
                    <text>The exon 13 jump in s1031 animals has the ability to result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="914">
                    <text>The exon 13 jump in s1031 animals has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="915">
                    <text>The exon 13 jumping in animals s1031 may have resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="916">
                    <text>The expression of cDNA ISOform II DNA in COS7 and alternative transcriptional initiation, as result in our study, are capable of giving rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="917">
                    <text>The expression of cDNA ISOform II DNA in COS7 has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="918">
                    <text>The expression of cDNA ISOform II DNA in COS7 resulted in the a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="919">
                    <text>The expression of cDNA ISOform II DNA in COS7, as predicted, has resulted in the a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="920">
                    <text>The expression of cDNA ISOform II DNA in COS7, as predicted, has the ability to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="921">
                    <text>The expression of the DNA-cDNA ISOform II in COS7 cells may have resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="922">
                    <text>The expression of the DNA-cDNA ISOform II in COS7 cells, as predicted, has the ability to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="923">
                    <text>The failure to use the normal donor site of the intron 12 ear is capable of result rise to a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="924">
                    <text>The failure to use the normal donor site of the intron 12 ear may have resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="925">
                    <text>The float in ras-dependent signaling resulted in the a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="926">
                    <text>The float in ras-dependent signaling will result in the a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="927">
                    <text>The fluctuation in ras-dependent signaling has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="928">
                    <text>The fluctuation in ras-dependent signaling has resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="929">
                    <text>The fluctuation in ras-dependent signaling has resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="930">
                    <text>The fluctuation in ras-dependent signaling has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="931">
                    <text>The fluctuation in ras-dependent signaling has the ability to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="932">
                    <text>The fluctuation in ras-dependent signaling is capable of result rise to a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="933">
                    <text>The fluctuation in ras-dependent signaling is capable of result rise to a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="934">
                    <text>The fluctuation in ras-dependent signaling resulted in the a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="935">
                    <text>The fluctuation in ras-dependent signaling resulted in the a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="936">
                    <text>The fluctuation in ras-dependent signaling resulted in the a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="937">
                    <text>The fluctuation in ras-dependent signaling will result in the a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="938">
                    <text>The fluctuation in ras-dependent signaling, as predicted, has resulted in the a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="939">
                    <text>The fluctuation in ras-dependent signaling, as predicted, has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="940">
                    <text>The fluctuation in ras-dependent signaling, as predicted, has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="941">
                    <text>The fluctuation in ras-dependent signaling, as predicted, has the ability to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="942">
                    <text>The fluctuation in ras-dependent signaling, as predicted, has the ability to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="943">
                    <text>The fluctuation in signaling depending on ras and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="944">
                    <text>The fluctuation in signaling depending on ras and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="945">
                    <text>The fluctuation in signaling depending on ras has resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="946">
                    <text>The fluctuation in signaling depending on ras, as predicted, has resulted in the a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="947">
                    <text>The fluctuation in signaling depending on the ras and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="948">
                    <text>The fluctuation in signaling depending on the ras has resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="949">
                    <text>The fluctuation in signaling depending on the ras may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="950">
                    <text>The fluctuation in signaling depending on the ras resulted in the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="951">
                    <text>The fluctuation in signaling depending on the ras resulted in the a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="952">
                    <text>The fluctuation in signaling depending on the ras will result in the a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="953">
                    <text>The fluctuation in signaling depending on the ras, as predicted, has resulted in the a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="954">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed CdNA II DNA expression of isoform II in COS7 cells that resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="955">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed DNA II expression of Isoform II DNA in COS7 that is able to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="956">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed DNA II expression of Isoform II DNA in COS7 that resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="957">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed DNA II expression of Isoform II DNA in COS7 that was observed to result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="958">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Exon 13 jumping in s1031 animals that is able to result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="959">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Exon 13 jumping in s1031 animals that may have resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="960">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 and was able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="961">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 cells that resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="962">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 that has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="963">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells that has the ability to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="964">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells that may result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="965">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells that was observed to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="966">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of isoform II cDNA in COS7 cells resulting in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="967">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of isoform II cDNA in COS7 cells that will result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="968">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of the cD DNA of isoform II in COS7 cells that was observed to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="969">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of the cD DNA of isoform II in COS7 cells that will result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="970">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Expression of the cdNA II DNA from isoform II in COS7 that resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="971">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 resulting in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="972">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 resulting in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="973">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that has the ability to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="974">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that is able to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="975">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that may result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="976">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that was observed to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="977">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that was observed to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="978">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that will result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="979">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that will result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="980">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that will result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="981">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 and was able to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="982">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 that resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="983">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation to codon 210 that will result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="984">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that is able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="985">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional start that was observed to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="986">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon coupling 139 nt that may result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="987">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon coupling 139 nt that was observed to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="988">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains and was able to result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="989">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains resulting in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="990">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains that has the ability to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="991">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains that was observed to result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="992">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains that will result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="993">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative mixed subdomains that will result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="994">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative spacer of a single transcription resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="995">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative spacer of a single transcription that may result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="996">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative spacer of a single transcription that resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="997">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative spacer of a single transcription that will result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="998">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential slicing that may result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="999">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential slicing that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1000">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential slicing that was observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1001">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spacing resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1002">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spasms resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1003">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spasms that has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1004">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential spasms that may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1005">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differentiated xis that was observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1006">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 juar in s1031 animals resulting in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1007">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 juar in s1031 animals that has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1008">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 juar in s1031 animals that is able to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1009">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 juar in s1031 animals that was observed to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1010">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jump in s1031 animals that is able to result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1011">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jump in s1031 animals that may result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1012">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jump in s1031 animals that resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1013">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jumping in animals s1031 resulting in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1014">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 jumping in animals s1031 that resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1015">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cADNA DNA isoform II in COS7 cells that is able to result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1016">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 and was able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1017">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 resulting in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1018">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 that has the ability to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1019">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 that was observed to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1020">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of the DNA-cDNA ISOform II DNA in COS7 cells resulting in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1021">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of the DNA-cDNA ISOform II DNA in COS7 cells that may result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1022">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed failure to use the normal donor site of the intron 12 ear that may have resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1023">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed failure to use the normal donor site of the intron 12 ear that resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1024">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed float in ras-dependent signaling and was able to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1025">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling and was able to result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1026">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling and was able to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1027">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling resulting in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1028">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that is able to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1029">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1030">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1031">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1032">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that may result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1033">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that was observed to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1034">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in ras-dependent signaling that will result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1035">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras that has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1036">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras that may have resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1037">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras that may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1038">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras that resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1039">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on ras that was observed to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1040">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras and was able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1041">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1042">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1043">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that is able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1044">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that is able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1045">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1046">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed fluctuation in signaling depending on the ras that resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1047">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signaling depending on the ras resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1048">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signaling depending on the ras that has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1049">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signaling depending on the ras that is able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1050">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signaling depending on the ras that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1051">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signaling depending on the ras that may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1052">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow in signalling depending on the ras that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1053">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow-dependent signaling fluctuation that may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1054">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow-dependent signaling fluctuation that was observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1055">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed glow-dependent signaling fluctuation that will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1056">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid charge of varying subunits that has the ability to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1057">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid charge of varying subunits that may have resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1058">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid load of the variable subunit that resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1059">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid load of the variable subunit that was observed to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1060">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid load of variant subunit that may have resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1061">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed missing to use the normal donor site of the ear 12 intron and was able to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1062">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed missing to use the normal donor site of the ear 12 intron resulting in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1063">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed missing to use the normal donor site of the ear 12 intron that has the ability to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1064">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed missing to use the normal donor site of the ear 12 intron that may have resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1065">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed missing to use the normal donor site of the ear 12 intron that will result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1066">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternate subdomains that may have resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1067">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains resulting in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1068">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that is able to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1069">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that is able to result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1070">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that may result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1071">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1072">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the coupling of intron 12 and was able to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1073">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the coupling of intron 12 that may result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1074">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the intron 12 ear resulting in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1075">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the intron 12 ear that has the ability to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1076">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed not to use the normal donor site of the intron 12 ear that was observed to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1077">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras resulting in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1078">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1079">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1080">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1081">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that was observed to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1082">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of signaling as a function of ras that will result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1083">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains and was able to result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1084">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that has the ability to result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1085">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1086">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that will result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1087">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit and was able to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1088">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit and was able to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1089">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit resulting in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1090">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit resulting in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1091">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that is able to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1092">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that is able to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1093">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that is able to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1094">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1095">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that may result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1096">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that may result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1097">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1098">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that was observed to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1099">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that will result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1100">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that will result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1101">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the varying subunit resulting in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1102">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the varying subunit that resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1103">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that is able to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1104">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net load of the variant subunit that resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1105">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed CdNA II DNA expression of isoform II in COS7 cells which resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1106">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed DNA II expression of Isoform II DNA in COS7 that may result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1107">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Exon 13 jumping in s1031 animals that may result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1108">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 cells that could resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1109">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 cells which resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1110">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 resulting in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1111">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 results in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1112">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 that may result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1113">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cDNA isoform II DNA in COS7 which resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1114">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells results in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1115">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of cdNA II DNA of isoform II in COS7 cells that could resulted in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1116">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of isoform II cDNA in COS7 cells results in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1117">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Expression of the cD DNA of isoform II in COS7 cells that may result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1118">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 results in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1119">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 that could resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1120">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 that could resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1121">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 that may result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1122">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation in codon 210 which resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1123">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a new mutation to codon 210 resulting in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1124">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional initiation resulting in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1125">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional start results in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1126">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon 2 cutting (139 nt) and alternative transcriptional start that could resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1127">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start resulting in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1128">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative mixed subdomains results in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1129">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative spacer of a single transcription which resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1130">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential slicing that could resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1131">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential spasms results in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1132">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential spasms that may result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1133">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differentiated xis that may result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1134">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 juar in s1031 animals resulting in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1135">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 juar in s1031 animals that may result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1136">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 juar in s1031 animals which resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1137">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 jump in s1031 animals resulting in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1138">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed exon 13 jump in s1031 animals which resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1139">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of cADNA DNA isoform II in COS7 cells results in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1140">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of cADNA DNA isoform II in COS7 cells which resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1141">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 resulting in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1142">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of cDNA ISOform II DNA in COS7 which resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1143">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of the DNA-cDNA ISOform II DNA in COS7 cells resulting in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1144">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of the DNA-cDNA ISOform II DNA in COS7 cells which resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1145">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of the DNA-cDNA ISOform II in COS7 cells results in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1146">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed float in ras-dependent signaling which resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1147">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1148">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling results in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1149">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling results in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1150">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling results in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1151">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling that could resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1152">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling that may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1153">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling that may result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1154">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in ras-dependent signaling which resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1155">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on ras resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1156">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on ras resulting in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1157">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on ras results in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1158">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on ras that may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1159">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on ras which resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1160">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on the ras results in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1161">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on the ras that could resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1162">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed fluctuation in signaling depending on the ras that may result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1163">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed glow-dependent signaling fluctuation that could resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1164">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed glow-dependent signaling fluctuation which resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1165">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid charge of varying subunits resulting in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1166">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid charge of varying subunits results in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1167">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid charge of varying subunits that may result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1168">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed liquid load of the variable subunit results in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1169">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed missing to use the normal donor site of the ear 12 intron that could resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1170">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed multiple alternate subdomains which resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1171">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed not to use the normal donor site of the coupling of intron 12 that could resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1172">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed not to use the normal donor site of the intron 12 ear that may result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1173">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of signaling as a function of ras resulting in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1174">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of signaling as a function of ras that could resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1175">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of signaling as a function of ras that may result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1176">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of signaling as a function of ras which resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1177">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed some alternative subdomains that may result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1178">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed some alternative subdomains which resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1179">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that DNA II expression of Isoform II DNA in COS7 could result in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1180">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that DNA II expression of Isoform II DNA in COS7 resulted in a marked increase in the activity of PAF acetylhydase.</text>
                    <arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
                </example>
                <example src="PERMUTATE" no="1181">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Exon 13 jumping in s1031 animals could result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1182">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of cDNA isoform II DNA in COS7 cells could result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1183">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of cDNA isoform II DNA in COS7 could result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1184">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of cDNA isoform II DNA in COS7 resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1185">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of cDNA isoform II DNA in COS7 resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1186">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of isoform II cDNA in COS7 cells could result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1187">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Expression of the cD DNA of isoform II in COS7 cells could result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1188">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a new mutation to codon 210 could result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1189">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a new mutation to codon 210 resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1190">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative exon 2 cutting (139 nt) and alternative transcriptional start had the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1191">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative exon 2 exhaustion (139 nt) and alternative transcriptional start could result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1192">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative exon 2 exhaustion (139 nt) and alternative transcriptional start resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1193">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that differential slicing resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1194">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that differential spasms could result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1195">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that differentiated xis could result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1196">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that differentiated xis resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1197">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that exon 13 juar in s1031 animals could result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1198">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that exon 13 juar in s1031 animals resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1199">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that exon 13 jump in s1031 animals could result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1200">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that exon 13 jumping in animals s1031 could result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1201">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that expression of cDNA ISOform II DNA in COS7 could result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1202">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that expression of cDNA ISOform II DNA in COS7 had the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1203">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that expression of cDNA ISOform II DNA in COS7 had the ability to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1204">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that expression of cDNA ISOform II DNA in COS7 resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1205">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that failure to use the normal donor site of the intron 12 ear had the ability to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1206">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that float in ras-dependent signaling had the ability to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1207">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in ras-dependent signaling could result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1208">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in ras-dependent signaling had the ability to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1209">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in ras-dependent signaling resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1210">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in ras-dependent signaling resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1211">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on ras could result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1212">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on ras resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1213">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on ras resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1214">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on the ras could result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1215">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on the ras could result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1216">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that fluctuation in signaling depending on the ras resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1217">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that glow in signaling depending on the ras had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1218">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that glow in signaling depending on the ras resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1219">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that glow in signalling depending on the ras could result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1220">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that glow in signalling depending on the ras resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1221">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that glow-dependent signaling fluctuation could result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1222">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that liquid charge of varying subunits could result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1223">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that liquid charge of varying subunits had the ability to result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1224">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that liquid charge of varying subunits had the ability to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1225">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that liquid load of variant subunit resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1226">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that missing to use the normal donor site of the ear 12 intron resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1227">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that multiple alternative subdomains resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1228">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that reduction of signaling as a function of ras resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1229">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the net charge of the variant subunit resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1230">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the net charge of the varying subunit had the ability to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1231">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net charge of the variant subunit resulting in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1232">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net charge of the variant subunit that could resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1233">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net charge of the variant subunit that could resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1234">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net charge of the variant subunit that may result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1235">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net load of the variant subunit results in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1236">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net load of the variant subunit which resulted in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1237">
                    <text>The glow in signalling depending on the ras has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1238">
                    <text>The glow in signalling depending on the ras will result in the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1239">
                    <text>The glow in signalling depending on the ras, as predicted, has resulted in the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1240">
                    <text>The glow-dependent signaling fluctuation has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1241">
                    <text>The glow-dependent signaling fluctuation resulted in the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1242">
                    <text>The glow-dependent signaling fluctuation, as predicted, has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1243">
                    <text>The grid-dependent fluctuation in signaling may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1244">
                    <text>The grid-dependent fluctuation in signaling resulted in the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1245">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes CdNA II DNA expression of isoform II in COS7 cells after having resulted a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1246">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes CdNA II DNA expression of isoform II in COS7 cells that results in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1247">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Exon 13 jumping in s1031 animals after having resulted a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1248">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Exon 13 jumping in s1031 animals that resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1249">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Exon 13 jumping in s1031 animals with ability to entirely result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1250">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 and may result rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1251">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 cells and may result rise to a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1252">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1253">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 with ability to entirely result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1254">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of cdNA II DNA of isoform II in COS7 cells with ability to result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1255">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of isoform II cDNA in COS7 cells after having resulted a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1256">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of isoform II cDNA in COS7 cells and may result rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1257">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of isoform II cDNA in COS7 cells that resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1258">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Expression of isoform II cDNA in COS7 cells with ability to entirely result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1259">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 and may result rise to replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1260">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 and may result rise to replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1261">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 and may result rise to replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1262">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 resulted in the complete substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1263">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that are result as entirely replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1264">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that are result as entirely replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1265">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that are result as entirely substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1266">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that results in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1267">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 that results in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1268">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 with ability to entirely result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1269">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 with ability to entirely result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1270">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation in codon 210 with ability to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1271">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a new mutation to codon 210 that are result as entirely replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1272">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that are result as entirely mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1273">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1274">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional start that are result as entirely mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1275">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional start that resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1276">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional start with ability to entirely result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1277">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that results in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1278">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start with ability to entirely result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1279">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon coupling 139 nt that are result as entirely mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1280">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon coupling 139 nt that resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1281">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains resulted in the complete superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1282">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains that are result as entirely superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1283">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative spacer of a single transcription with ability to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1284">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential slicing resulted in the complete existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1285">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential spacing and may result rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1286">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential spacing that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1287">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential spasms after having resulted existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1288">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 juar in s1031 animals with ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1289">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jump in s1031 animals after having resulted a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1290">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jump in s1031 animals resulted in the complete a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1291">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jump in s1031 animals that are result as entirely a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1292">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jump in s1031 animals that are result as entirely a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1293">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jump in s1031 animals with ability to result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1294">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes exon 13 jumping in animals s1031 with ability to entirely result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1295">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cADNA DNA isoform II in COS7 cells and may result rise to a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1296">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 after having resulted a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1297">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 after having resulted a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1298">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1299">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 with ability to entirely result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1300">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 with ability to entirely result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1301">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II DNA in COS7 cells after having resulted a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1302">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II DNA in COS7 cells that are result as entirely a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1303">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II in COS7 cells after having resulted a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1304">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II in COS7 cells that results in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1305">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes float in ras-dependent signaling and may result rise to a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1306">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes float in ras-dependent signaling with ability to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1307">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling after having resulted a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1308">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling and may result rise to a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1309">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling and may result rise to a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1310">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling resulted in the complete a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1311">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1312">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that results in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1313">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling with ability to entirely result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1314">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling with ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1315">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in ras-dependent signaling with ability to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1316">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on ras and may result rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1317">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on ras with ability to entirely result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1318">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on the ras after having resulted a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1319">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on the ras resulted in the complete a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1320">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on the ras resulted in the complete a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1321">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on the ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1322">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on the ras with ability to entirely result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1323">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes fluctuation in signaling depending on the ras with ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1324">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow in signaling depending on the ras that results in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1325">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow in signaling depending on the ras with ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1326">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow in signalling depending on the ras after having resulted a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1327">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow in signalling depending on the ras that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1328">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes glow-dependent signaling fluctuation with ability to entirely result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1329">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes grid-dependent fluctuation in signaling and may result rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1330">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of the variable subunit with ability to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1331">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid load of variant subunit that resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1332">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron that are result as entirely a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1333">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron that resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1334">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron with ability to entirely result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1335">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternate subdomains that resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1336">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternate subdomains with ability to entirely result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1337">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains that results in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1338">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains with ability to entirely result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1339">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains with ability to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1340">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes not to use the normal donor site of the coupling of intron 12 and may result rise to a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1341">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes not to use the normal donor site of the coupling of intron 12 that are result as entirely a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1342">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes not to use the normal donor site of the intron 12 ear after having resulted a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1343">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes not to use the normal donor site of the intron 12 ear with ability to entirely result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1344">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of signaling as a function of ras after having resulted a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1345">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of signaling as a function of ras resulted in the complete a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1346">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains after having resulted superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1347">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains resulted in the complete superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1348">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains that are result as entirely super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1349">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains that are result as entirely superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1350">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit after having resulted an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1351">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit and may result rise to an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1352">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit that are result as entirely a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1353">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit that are result as entirely an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1354">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit that resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1355">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit with ability to entirely result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1356">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit with ability to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1357">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the varying subunit that results in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1358">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net load of the variant subunit after having resulted a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1359">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net load of the variant subunit with ability to entirely result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1360">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net load of the variant subunit with ability to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1361">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net load of the variant subunit with ability to result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1362">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes Expression of cDNA isoform II DNA in COS7 cells that are able to completely result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1363">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes Expression of cdNA II DNA of isoform II in COS7 cells that are able to completely result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1364">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes Expression of the cD DNA of isoform II in COS7 cells that are able to completely result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1365">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes Expression of the cdNA II DNA from isoform II in COS7 that are able to completely result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1366">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes a new mutation in codon 210 that are able to completely result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1367">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes a new mutation in codon 210 that are able to completely result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1368">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes a new mutation in codon 210 that are able to completely result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1369">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes a new mutation in codon 210 that are able to completely result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1370">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that are able to completely result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1371">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes expression of cDNA ISOform II DNA in COS7 that are able to completely result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1372">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes fluctuation in signaling depending on ras that are able to completely result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1373">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes fluctuation in signaling depending on ras that are able to completely result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1374">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes fluctuation in signaling depending on the ras that are able to completely result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1375">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes glow in signalling depending on the ras that are able to completely result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1376">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes liquid load of variant subunit that are able to completely result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1377">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes some alternative subdomains that are able to completely result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1378">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes the net charge of the variant subunit that are able to completely result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1379">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes the net charge of the variant subunit that are able to completely result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1380">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes the net load of the variant subunit that are able to completely result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1381">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes CdNA II DNA expression of isoform II in COS7 cells that has the ability to completely result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1382">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes Exon 13 jumping in s1031 animals that has the ability to completely result in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1383">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes Expression of cdNA II DNA of isoform II in COS7 cells that has the ability to completely result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1384">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes Expression of cdNA II DNA of isoform II in COS7 cells that has the ability to completely result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1385">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a new mutation in codon 210 that has the ability to completely result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1386">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes alternative mixed subdomains that has the ability to completely result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1387">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes exon 13 jump in s1031 animals that has the ability to completely result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1388">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes expression of cDNA ISOform II DNA in COS7 that has the ability to completely result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1389">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes fluctuation in ras-dependent signaling that has the ability to completely result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1390">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes fluctuation in ras-dependent signaling that has the ability to completely result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1391">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes glow-dependent signaling fluctuation that has the ability to completely result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1392">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes liquid load of the variant subunit that has the ability to completely result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1393">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes multiple alternative subdomains that has the ability to completely result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1394">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes the net charge of the variant subunit that has the ability to completely result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1395">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes the net charge of the varying subunit that has the ability to completely result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1396">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes CdNA II DNA expression of isoform II in COS7 cells that will result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1397">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Exon 13 jumping in s1031 animals that resulted in a product of 543 bp.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1398">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 and is observed to result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1399">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Expression of cDNA isoform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1400">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Expression of cdNA II DNA of isoform II in COS7 cells that will result in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1401">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Expression of the cD DNA of isoform II in COS7 cells and is observed to result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1402">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Expression of the cD DNA of isoform II in COS7 cells that will result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1403">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Expression of the cdNA II DNA from isoform II in COS7 that can result entirely in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1404">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 and is observed to result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1405">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that can result entirely in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1406">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1407">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1408">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation in codon 210 that will result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1409">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation to codon 210 that will result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1410">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a new mutation to codon 210 that will result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1411">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that can result entirely in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1412">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional initiation that resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1413">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains and is observed to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1414">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains that resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1415">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains that will result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1416">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains that will result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1417">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative spacer of a single transcription that will result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1418">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes differential slicing that can result entirely in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1419">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes differential spacing that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1420">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes differentiated xis that will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1421">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes exon 13 juar in s1031 animals that will result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1422">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes exon 13 jump in s1031 animals that can result entirely in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1423">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes exon 13 jump in s1031 animals that resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1424">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes exon 13 jumping in animals s1031 that resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1425">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 and is observed to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1426">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of cDNA ISOform II DNA in COS7 that will result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1427">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II DNA in COS7 cells and is observed to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1428">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II DNA in COS7 cells that can result entirely in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1429">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II DNA in COS7 cells that resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1430">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II in COS7 cells and is observed to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1431">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes expression of the DNA-cDNA ISOform II in COS7 cells that can result entirely in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1432">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that can result entirely in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1433">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in ras-dependent signaling that can result entirely in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1434">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in signaling depending on ras and is observed to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1435">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in signaling depending on ras that resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1436">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in signaling depending on the ras that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1437">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes fluctuation in signaling depending on the ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1438">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes glow in signaling depending on the ras and is observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1439">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes glow in signaling depending on the ras that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1440">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes glow in signalling depending on the ras and is observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1441">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes glow-dependent signaling fluctuation and is observed to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1442">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes grid-dependent fluctuation in signaling that will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1443">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid charge of varying subunits that can result entirely in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1444">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid charge of varying subunits that can result entirely in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1445">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid load of the variable subunit that can result entirely in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1446">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid load of variant subunit that can result entirely in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1447">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid load of variant subunit that will result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1448">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes missing to use the normal donor site of the ear 12 intron that can result entirely in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1449">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes multiple alternative subdomains that resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1450">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes not to use the normal donor site of the coupling of intron 12 and is observed to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1451">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes not to use the normal donor site of the coupling of intron 12 that can result entirely in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1452">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduction of signaling as a function of ras that resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1453">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes some alternative subdomains and is observed to result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1454">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the net charge of the variant subunit and is observed to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1455">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the net charge of the variant subunit that can result entirely in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1456">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the net charge of the variant subunit that will result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1457">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the net charge of the varying subunit that resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1458">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the net load of the variant subunit and is observed to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1459">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes Expression of cdNA II DNA of isoform II in COS7 cells that has the ability to result in a marked increase in the acetylhydrase activity of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1460">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes Expression of the cdNA II DNA from isoform II in COS7 that resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1461">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a new mutation in codon 210 that has the ability to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1462">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a new mutation in codon 210 that resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1463">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative exon 2 cutting (139 nt) and alternative transcriptional start that has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1464">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative exon coupling 139 nt that has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1465">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative mixed subdomains that has the ability to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1466">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative mixed subdomains that resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1467">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes differential spacing that has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1468">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes differential spasms that has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1469">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes differentiated xis that has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1470">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes expression of cDNA ISOform II DNA in COS7 that has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1471">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes expression of the DNA-cDNA ISOform II in COS7 cells that has the ability to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1472">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes expression of the DNA-cDNA ISOform II in COS7 cells that resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1473">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in ras-dependent signaling that resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1474">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in ras-dependent signaling that resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1475">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in signaling depending on ras that has the ability to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1476">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in signaling depending on ras that resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1477">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes fluctuation in signaling depending on the ras that has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1478">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes glow-dependent signaling fluctuation that has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1479">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes glow-dependent signaling fluctuation that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1480">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes liquid charge of varying subunits that has the ability to result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1481">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes missing to use the normal donor site of the ear 12 intron that has the ability to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1482">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes missing to use the normal donor site of the ear 12 intron that resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1483">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes multiple alternative subdomains that has the ability to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1484">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes not to use the normal donor site of the intron 12 ear that has the ability to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1485">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cDNA isoform II DNA in COS7 cells that may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1486">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cDNA isoform II DNA in COS7 that may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1487">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cDNA isoform II DNA in COS7 that result able to give rise to a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1488">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cDNA isoform II DNA in COS7 which may have resulted entirely in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1489">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cdNA II DNA of isoform II in COS7 cells that may have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1490">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of cdNA II DNA of isoform II in COS7 cells which may have resulted entirely in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1491">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of isoform II cDNA in COS7 cells that may have resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1492">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of isoform II cDNA in COS7 cells that result able to give rise to a marked increase in the activity of acetylhydralase of PAF.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1493">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of the cD DNA of isoform II in COS7 cells which may have resulted entirely in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1494">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Expression of the cdNA II DNA from isoform II in COS7 which may have resulted entirely in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1495">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that may have resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1496">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that result able to give rise to replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1497">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1498">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 that resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1499">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation in codon 210 which may have resulted entirely in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1500">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation to codon 210 that may have resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1501">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation to codon 210 that result able to give rise to replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1502">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a new mutation to codon 210 that result able to give rise to replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1503">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative exon 2 cutting (139 nt) and alternative transcriptional start that may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1504">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that may have resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1505">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that result able to give rise to mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1506">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative mixed subdomains that resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1507">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative spacer of a single transcription that resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1508">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differential slicing that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1509">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differential slicing which may have resulted entirely in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1510">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differential spacing which may have resulted entirely in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1511">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differentiated xis that may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1512">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differentiated xis that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1513">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes exon 13 jump in s1031 animals that result able to give rise to a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1514">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes exon 13 jump in s1031 animals which may have resulted entirely in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1515">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes exon 13 jumping in animals s1031 that result able to give rise to a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1516">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of cADNA DNA isoform II in COS7 cells that may have resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1517">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of cDNA ISOform II DNA in COS7 that may have resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1518">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of cDNA ISOform II DNA in COS7 that result able to give rise to a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1519">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of cDNA ISOform II DNA in COS7 that resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1520">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of the DNA-cDNA ISOform II DNA in COS7 cells that resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1521">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of the DNA-cDNA ISOform II in COS7 cells that may have resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1522">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in ras-dependent signaling that result able to give rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1523">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on ras which may have resulted entirely in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1524">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on the ras that may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1525">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on the ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1526">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes fluctuation in signaling depending on the ras which may have resulted entirely in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1527">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes glow in signaling depending on the ras that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1528">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes glow in signalling depending on the ras that result able to give rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1529">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes grid-dependent fluctuation in signaling that may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1530">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes grid-dependent fluctuation in signaling that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1531">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid charge of varying subunits that resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1532">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid charge of varying subunits that resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1533">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid charge of varying subunits which may have resulted entirely in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1534">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid load of the variant subunit that may have resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1535">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid load of the variant subunit which may have resulted entirely in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1536">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid load of variant subunit that may have resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1537">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes multiple alternate subdomains that may have resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1538">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes multiple alternate subdomains that result able to give rise to superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1539">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes not to use the normal donor site of the coupling of intron 12 that resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1540">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes not to use the normal donor site of the intron 12 ear that may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1541">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of signaling as a function of ras that resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1542">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of signaling as a function of ras which may have resulted entirely in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1543">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes some alternative subdomains which may have resulted entirely in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1544">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net charge of the variant subunit that may have resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1545">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net charge of the variant subunit that may have resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1546">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net charge of the variant subunit that result able to give rise to an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1547">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net charge of the variant subunit that result able to give rise to an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1548">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net charge of the variant subunit that result able to give rise to an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1549">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net charge of the variant subunit which may have resulted entirely in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1550">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net load of the variant subunit that may have resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1551">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net load of the variant subunit that may have resulted in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1552">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the net load of the variant subunit which may have resulted entirely in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1553">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes Expression of cDNA isoform II DNA in COS7 cells that will result in a marked increase in the activity of PAF acetylhydrolase.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1554">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a new mutation in codon 210 that will result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1555">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a new mutation in codon 210 that will result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1556">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes alternative exon coupling 139 nt that will result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1557">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes alternative mixed subdomains that will result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1558">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes fluctuation in ras-dependent signaling that will result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1559">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes fluctuation in signaling depending on the ras that will result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1560">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes glow-dependent signaling fluctuation that will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1561">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes multiple alternate subdomains that will result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1562">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes reduction of signaling as a function of ras that will result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1563">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes the net charge of the variant subunit that will result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1564">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes the net charge of the variant subunit that will result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1565">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes the net charge of the variant subunit that will result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1566">
                    <text>The liquid charge of varying subunits and alternative transcriptional initiation, as result in our study, are capable of giving rise to a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1567">
                    <text>The liquid charge of varying subunits and alternative transcriptional initiation, as result in our study, are capable of giving rise to an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1568">
                    <text>The liquid charge of varying subunits has resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1569">
                    <text>The liquid load of the variable subunit will result in the fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1570">
                    <text>The liquid load of the variant subunit has the ability to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1571">
                    <text>The missing to use the normal donor site of the ear 12 intron has the ability to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1572">
                    <text>The missing to use the normal donor site of the ear 12 intron is capable of result rise to a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1573">
                    <text>The multiple alternate subdomains and alternative transcriptional initiation, as result in our study, are capable of giving rise to superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1574">
                    <text>The multiple alternative subdomains, as predicted, has the ability to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1575">
                    <text>The not to use the normal donor site of the coupling of intron 12 will result in the a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1576">
                    <text>The not to use the normal donor site of the intron 12 ear resulted in the a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1577">
                    <text>The not to use the normal donor site of the intron 12 ear will result in the a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1578">
                    <text>The reduction of signaling as a function of ras and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1579">
                    <text>The reduction of signaling as a function of ras has the ability to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1580">
                    <text>The reduction of signaling as a function of ras may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1581">
                    <text>The reduction of signaling as a function of ras will result in the a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1582">
                    <text>The research shows a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity resulting from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1583">
                    <text>The research shows a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity resulting from glow in signaling depending on the ras.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1584">
                    <text>The research shows a marked increase in acetylhydrolase PAF activity resulting from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1585">
                    <text>The research shows a marked increase in acetylhydrolase activity PAF resulting from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1586">
                    <text>The research shows a marked increase in the acetylhydrase activity of PAF resulting from Expression of cdNA II DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1587">
                    <text>The research shows a marked increase in the activity of PAF acetylhydrolase resulting from Expression of the cdNA II DNA from isoform II in COS7.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1588">
                    <text>The research shows a product of 543 bp resulting from exon 13 jump in s1031 animals.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1589">
                    <text>The research shows a product of 543 bp resulting from exon 13 jumping in animals s1031.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1590">
                    <text>The research shows a variant electrophoretic subunit LDH-B fast type resulting from the net load of the variant subunit.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1591">
                    <text>The research shows a variant electrophoretic subunit LDH-B resulting from the net load of the variant subunit.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1592">
                    <text>The research shows mRNA species with 5 different UTRs resulting from alternative exon 2 cutting (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1593">
                    <text>The research shows super-repetitor resulting from multiple alternative subdomains.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1594">
                    <text>The research shows superrepetition resulting from alternative mixed subdomains.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1595">
                    <text>The research shows superrepetition resulting from multiple alternate subdomains.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1596">
                    <text>The sequence analysis of the HDIbeta gene indicates that a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from glow in signalling depending on the ras.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1597">
                    <text>The sequence analysis of the HDIbeta gene indicates that a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from fluctuation in signaling depending on ras.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1598">
                    <text>The sequence analysis of the HDIbeta gene indicates that a fast-type LDH-B electrophoretic subunit has the ability to result from the net charge of the varying subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1599">
                    <text>The sequence analysis of the HDIbeta gene indicates that a marked increase in the activity of PAF acetylhydrolase has the ability to result from Expression of the cdNA II DNA from isoform II in COS7.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1600">
                    <text>The sequence analysis of the HDIbeta gene indicates that a marked increase in the activity of acetylhydrolase PAF has the ability to result from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1601">
                    <text>The sequence analysis of the HDIbeta gene indicates that a product of 543 bp has the ability to result from exon 13 jumping in animals s1031.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1602">
                    <text>The sequence analysis of the HDIbeta gene indicates that a variant electrophoretic subunit LDH-B has the ability to result from the net load of the variant subunit.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1603">
                    <text>The sequence analysis of the HDIbeta gene indicates that a variant has the ability to result from not to use the normal donor site of the coupling of intron 12.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1604">
                    <text>The sequence analysis of the HDIbeta gene indicates that an electrophoretic subunit variant of the fast type LDH-B has the ability to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1605">
                    <text>The sequence analysis of the HDIbeta gene indicates that existence of NF-YA isoforms has the ability to result from differential spacing.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1606">
                    <text>The sequence analysis of the HDIbeta gene indicates that existence of NF-YA isoforms has the ability to result from differential spasms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1607">
                    <text>The sequence analysis of the HDIbeta gene indicates that mRNA species with different 5 UTRs has the ability to result from alternative exon 2 exhaustion (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1608">
                    <text>The sequence analysis of the HDIbeta gene indicates that replacement of isoleucine with valine has the ability to result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1609">
                    <text>The sequence analysis of the HDIbeta gene indicates that replacing isoleukin with valine has the ability to result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1610">
                    <text>The some alternative subdomains and alternative transcriptional initiation, as result in our study, are capable of giving rise to superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1611">
                    <text>The some alternative subdomains has resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1612">
                    <text>The some alternative subdomains has resulted in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1613">
                    <text>The some alternative subdomains is capable of result rise to super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1614">
                    <text>The some alternative subdomains resulted in the super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1615">
                    <text>The some alternative subdomains, as predicted, has the ability to result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="1616">
                    <text>The the net charge of the variant subunit and alternative transcriptional initiation, as result in our study, are capable of giving rise to an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1617">
                    <text>The the net charge of the variant subunit and alternative transcriptional initiation, as result in our study, are capable of giving rise to an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1618">
                    <text>The the net charge of the variant subunit and alternative transcriptional initiation, as result in our study, are capable of giving rise to an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1619">
                    <text>The the net charge of the variant subunit has the ability to result in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1620">
                    <text>The the net charge of the variant subunit is capable of result rise to an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1621">
                    <text>The the net charge of the variant subunit will result in the a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1622">
                    <text>The the net charge of the variant subunit will result in the an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1623">
                    <text>The the net charge of the variant subunit, as predicted, has resulted in the an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1624">
                    <text>The the net charge of the variant subunit, as predicted, has the ability to result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1625">
                    <text>The the net charge of the varying subunit resulted in the a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1626">
                    <text>The the net load of the variant subunit has resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1627">
                    <text>The the net load of the variant subunit resulted in the a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1628">
                    <text>The the net load of the variant subunit, as predicted, has the ability to result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="1629">
                    <text>We also report a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity that may have resulted from glow in signaling depending on the ras.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1630">
                    <text>We also report a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity that may have resulted from glow-dependent signaling fluctuation.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1631">
                    <text>We also report a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity that may have resulted from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1632">
                    <text>We also report a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity that may have resulted from fluctuation in signaling depending on the ras.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1633">
                    <text>We also report a fast-type LDH-B electrophoretic subunit that may have resulted from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="1634">
                    <text>We also report a marked increase in acetylhydrolase activity PAF that may have resulted from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1635">
                    <text>We also report a marked increase in the activity of acetylhydralase of PAF that may have resulted from Expression of isoform II cDNA in COS7 cells.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1636">
                    <text>We also report a marked increase in the activity of acetylhydrolase PAF that may have resulted from Expression of the cD DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1637">
                    <text>We also report a rapid type of electrophoretic subunit LDH-B that may have resulted from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1638">
                    <text>We also report an electrophoretic subunit LDH-B that may have resulted from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1639">
                    <text>We also report existence of NF-YA isoforms that may have resulted from differential spasms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1640">
                    <text>We also report mRNA species with different 5 UTRs that may have resulted from alternative exon 2 exhaustion (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1641">
                    <text>We also report super-repetitor that may have resulted from multiple alternative subdomains.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1642">
                    <text>We also report superrepetition that may have resulted from alternative mixed subdomains.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1643">
                    <text>We also report the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity with the capability to result from glow-dependent signaling fluctuation.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1644">
                    <text>We also report the a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1 with the capability to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1645">
                    <text>We also report the a marked increase in acetylhydrolase activity PAF with the capability to result from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1646">
                    <text>We also report the a marked increase in the activity of PAF acetylhydrolase with the capability to result from Expression of cDNA isoform II DNA in COS7.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1647">
                    <text>We also report the a marked increase in the activity of PAF acetylhydrolase with the capability to result from Expression of the cdNA II DNA from isoform II in COS7.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1648">
                    <text>We also report the a marked increase in the activity of acetylhydroxylase PAF with the capability to result from expression of the DNA-cDNA ISOform II in COS7 cells.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1649">
                    <text>We also report the a product of 543 bp with the capability to result from Exon 13 jumping in s1031 animals.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1650">
                    <text>We also report the a variant electrophoretic subunit LDH-B with the capability to result from the net load of the variant subunit.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1651">
                    <text>We also report the a variant with the capability to result from failure to use the normal donor site of the intron 12 ear.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1652">
                    <text>We also report the difference in the 28 C-terminal amino acids between beta(1) and beta(2) with the capability to result from alternative spacer of a single transcription.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1653">
                    <text>We also report the fast-type electrophoretic subunit LDH-B with the capability to result from liquid load of the variant subunit.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1654">
                    <text>We also report the mRNA species with 5 different UTRs with the capability to result from alternative exon 2 cutting (139 nt) and alternative transcriptional initiation.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1655">
                    <text>We also report the replacing isoleucine in valine with the capability to result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1656">
                    <text>We also report the superrepetition with the capability to result from alternative mixed subdomains.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1657">
                    <text>We also reported that a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity is able to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1658">
                    <text>We also reported that a marked increase in the activity of PAF acetylhydrolase is able to result from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1659">
                    <text>We also reported that a marked increase in the activity of acetylhydralase of PAF is able to result from Expression of cdNA II DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1660">
                    <text>We also reported that a marked increase in the activity of acetylhydrolase PAF is able to result from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1661">
                    <text>We also reported that a variant electrophoretic subunit LDH-B is able to result from the net load of the variant subunit.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1662">
                    <text>We also reported that a variant is able to result from not to use the normal donor site of the coupling of intron 12.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1663">
                    <text>We also reported that mRNA species with 5 different UTRs is able to result from alternative exon 2 cutting (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1664">
                    <text>We also reported that replacement of isoleucine with valine is able to result from a new mutation to codon 210.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1665">
                    <text>a 543 bp product has the ability to result from exon 13 jump in s1031 animals.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1666">
                    <text>a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to probably result from float in ras-dependent signaling.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1667">
                    <text>a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was able to result from float in ras-dependent signaling.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1668">
                    <text>a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was also reported to be able to result from float in ras-dependent signaling.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1669">
                    <text>a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to result from glow in signalling depending on the ras.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1670">
                    <text>a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity was also reported to be able to result from glow in signaling depending on the ras.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1671">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was able to result from fluctuation in signaling depending on ras.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1672">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was able to result from reduction of signaling as a function of ras.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1673">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was also reported to be able to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1674">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was also reported to be able to result from reduction of signaling as a function of ras.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1675">
                    <text>a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1 has the ability to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1676">
                    <text>a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1 was also reported to be able to result from fluctuation in ras-dependent signaling.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1677">
                    <text>a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity has the ability to probably result from fluctuation in signaling depending on ras.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1678">
                    <text>a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity was also reported to be able to result from fluctuation in signaling depending on ras.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1679">
                    <text>a marked increase in acetylhydratelase PAF activity has the ability to result from expression of cADNA DNA isoform II in COS7 cells.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1680">
                    <text>a marked increase in acetylhydrolase activity PAF has the ability to probably result from Expression of cDNA isoform II DNA in COS7.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1681">
                    <text>a marked increase in acetylhydrolase activity PAF was also reported to be able to result from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1682">
                    <text>a marked increase in the acetylhydrase activity of PAF has the ability to probably result from Expression of cdNA II DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1683">
                    <text>a marked increase in the acetylhydrase activity of PAF has the ability to result from Expression of cdNA II DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1684">
                    <text>a marked increase in the acetylhydrase activity of PAF was also reported to be able to result from CdNA II DNA expression of isoform II in COS7 cells.</text>
                    <arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1685">
                    <text>a marked increase in the acetylhydrase activity of PAF was also reported to be able to result from Expression of cdNA II DNA of isoform II in COS7 cells.</text>
                    <arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1686">
                    <text>a marked increase in the activity of PAF acetylhydrolase has the ability to probably result from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1687">
                    <text>a marked increase in the activity of PAF acetylhydrolase has the ability to result from Expression of the cdNA II DNA from isoform II in COS7.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1688">
                    <text>a marked increase in the activity of PAF acetylhydrolase was also reported to be able to result from Expression of cDNA isoform II DNA in COS7 cells.</text>
                    <arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1689">
                    <text>a marked increase in the activity of PAF acetylhydrolase was also reported to be able to result from Expression of the cdNA II DNA from isoform II in COS7.</text>
                    <arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
                    <arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
                </example>
                <example src="PERMUTATE" no="1690">
                    <text>a marked increase in the activity of acetylhydralase of PAF was also reported to be able to result from Expression of isoform II cDNA in COS7 cells.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
                </example>
                <example src="PERMUTATE" no="1691">
                    <text>a marked increase in the activity of acetylhydrolase PAF was able to result from expression of cDNA ISOform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1692">
                    <text>a marked increase in the activity of acetylhydroxylase PAF has the ability to probably result from expression of the DNA-cDNA ISOform II DNA in COS7 cells.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1693">
                    <text>a marked increase in the activity of acetylhydroxylase PAF was able to result from expression of the DNA-cDNA ISOform II in COS7 cells.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1694">
                    <text>a new mutation in codon 210 can result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1695">
                    <text>a new mutation in codon 210 cells can result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1696">
                    <text>a new mutation in codon 210 cells can result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1697">
                    <text>a new mutation in codon 210 cells eventually resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1698">
                    <text>a new mutation in codon 210 cells eventually resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1699">
                    <text>a new mutation in codon 210 cells has resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1700">
                    <text>a new mutation in codon 210 cells has resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1701">
                    <text>a new mutation in codon 210 cells is eventually able to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1702">
                    <text>a new mutation in codon 210 cells is eventually able to result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1703">
                    <text>a new mutation in codon 210 cells is eventually able to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1704">
                    <text>a new mutation in codon 210 cells is eventually able to result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1705">
                    <text>a new mutation in codon 210 cells may have resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1706">
                    <text>a new mutation in codon 210 eventually resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1707">
                    <text>a new mutation in codon 210 finally resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1708">
                    <text>a new mutation in codon 210 has resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1709">
                    <text>a new mutation in codon 210 has the ability to eventually result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1710">
                    <text>a new mutation in codon 210 has the ability to eventually result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1711">
                    <text>a new mutation in codon 210 has the ability to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1712">
                    <text>a new mutation in codon 210 is able to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1713">
                    <text>a new mutation in codon 210 is able to result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1714">
                    <text>a new mutation in codon 210 is capable of result rise to substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1715">
                    <text>a new mutation in codon 210 is likely to resulting in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1716">
                    <text>a new mutation in codon 210 is shown to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1717">
                    <text>a new mutation in codon 210 is shown to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1718">
                    <text>a new mutation in codon 210 is shown to ultimately result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1719">
                    <text>a new mutation in codon 210 may eventually result in replace isoleucine with valine</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1720">
                    <text>a new mutation in codon 210 may eventually result in replacing isoleucine in valine</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1721">
                    <text>a new mutation in codon 210 may eventually result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1722">
                    <text>a new mutation in codon 210 may eventually result in replacing isoleukin with valine</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1723">
                    <text>a new mutation in codon 210 may have resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1724">
                    <text>a new mutation in codon 210 may result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1725">
                    <text>a new mutation in codon 210 may result in replacement of isoleucine with valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1726">
                    <text>a new mutation in codon 210 may result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1727">
                    <text>a new mutation in codon 210 may ultimately resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1728">
                    <text>a new mutation in codon 210 resulted in replacement of isoleucine to valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1729">
                    <text>a new mutation in codon 210 resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1730">
                    <text>a new mutation in codon 210 resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1731">
                    <text>a new mutation in codon 210 will eventually result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1732">
                    <text>a new mutation in codon 210 will eventually result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1733">
                    <text>a new mutation in codon 210 will eventually result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1734">
                    <text>a new mutation in codon 210 will result in replacement of isoleucine to valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1735">
                    <text>a new mutation in codon 210 will result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1736">
                    <text>a new mutation in codon 210 will result in replacing isoleucine in valine .</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1737">
                    <text>a new mutation in codon 210 will result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1738">
                    <text>a new mutation in codon 210, as predicted, may have resulted in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1739">
                    <text>a new mutation in codon 210, as predicted, may have resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1740">
                    <text>a new mutation in codon 210, as predicted, will result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1741">
                    <text>a new mutation in codon 210, as we have predicted, has the ability to result in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1742">
                    <text>a new mutation in codon 210, as we have predicted, is able to result in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1743">
                    <text>a new mutation in codon 210, as we have predicted, may have resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1744">
                    <text>a new mutation in codon 210, as we have predicted, may result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1745">
                    <text>a new mutation in codon 210, as we have predicted, may result in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1746">
                    <text>a new mutation in codon 210, as we have predicted, may resulting in replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1747">
                    <text>a new mutation in codon 210, as we have predicted, may resulting in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1748">
                    <text>a new mutation in codon 210, as we have predicted, resulted in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1749">
                    <text>a new mutation in codon 210, as we have predicted, resulted in replacing isoleukin with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleukin with valine</arg>
                </example>
                <example src="PERMUTATE" no="1750">
                    <text>a new mutation in codon 210, as we have predicted, resulted in substitution of isoleucine to valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">substitution of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1751">
                    <text>a new mutation in codon 210, as we have predicted, will result in replacing isoleucine in valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacing isoleucine in valine</arg>
                </example>
                <example src="PERMUTATE" no="1752">
                    <text>a new mutation in codon 210, as we have result, is able to give rise to replace isoleucine with valine.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1753">
                    <text>a new mutation to codon 210 can eventually result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1754">
                    <text>a new mutation to codon 210 can ultimately resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1755">
                    <text>a new mutation to codon 210 cells has resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1756">
                    <text>a new mutation to codon 210 has the ability to eventually result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1757">
                    <text>a new mutation to codon 210 is able to result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1758">
                    <text>a new mutation to codon 210 may eventually result in replacement of isoleucine to valine</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1759">
                    <text>a new mutation to codon 210 may have resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1760">
                    <text>a new mutation to codon 210 may result in replacement of isoleucine with valine .</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1761">
                    <text>a new mutation to codon 210 may ultimately result in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1762">
                    <text>a new mutation to codon 210 resulted in replacement of isoleucine to valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="1763">
                    <text>a new mutation to codon 210 will result in replacement of isoleucine with valine .</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1764">
                    <text>a new mutation to codon 210, as predicted, can result in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1765">
                    <text>a new mutation to codon 210, as we have predicted, resulted in replacement of isoleucine with valine.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="1766">
                    <text>a product of 543 bp has the ability to probably result from exon 13 jump in s1031 animals.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1767">
                    <text>a product of 543 bp has the ability to probably result from exon 13 jumping in animals s1031.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1768">
                    <text>a product of 543 bp was able to result from Exon 13 jumping in s1031 animals.</text>
                    <arg n="0">Exon 13 jumping in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1769">
                    <text>a rapid type of electrophoretic subunit LDH-B has the ability to probably result from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1770">
                    <text>a rapid type of electrophoretic subunit LDH-B was also reported to be able to result from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1771">
                    <text>a variant was able to result from missing to use the normal donor site of the ear 12 intron.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1772">
                    <text>a variant was able to result from not to use the normal donor site of the intron 12 ear.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1773">
                    <text>a variant was also reported to be able to result from failure to use the normal donor site of the intron 12 ear.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1774">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation is shown to ultimately result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1775">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1776">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation resulted in mRNA species with 5 different UTRs .</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1777">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation will result in mRNA species with 5 different UTRs .</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1778">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start cells can result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1779">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start cells has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1780">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start cells has the ability to ultimately result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1781">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start has finally resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1782">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start has resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1783">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start has the ability to eventually result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1784">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start has the ability to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1785">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start is shown to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1786">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start may eventually result in mRNA species with 5 different UTRs</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1787">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start may eventually result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1788">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start will result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1789">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start, as we have predicted, may have resulted in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1790">
                    <text>alternative exon 2 cutting (139 nt) and alternative transcriptional start, as we have predicted, may resulting in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1791">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start finally resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1792">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start has finally resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1793">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start has resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1794">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may eventually result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1795">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may result in mRNA species with different 5 UTRs .</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1796">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may ultimately resulted in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1797">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, as predicted, will result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1798">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, as we have predicted, will result in mRNA species with different 5 UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5 UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1799">
                    <text>alternative exon coupling 139 nt, as we have predicted, is able to result in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1800">
                    <text>alternative exon coupling 139 nt, as we have predicted, is likely to resulting in mRNA species with 5 different UTRs.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="1801">
                    <text>alternative mixed subdomains can ultimately resulted in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1802">
                    <text>alternative mixed subdomains cells is eventually able to result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1803">
                    <text>alternative mixed subdomains finally resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1804">
                    <text>alternative mixed subdomains has finally resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1805">
                    <text>alternative mixed subdomains may have resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1806">
                    <text>alternative mixed subdomains resulted in super-repetitor .</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1807">
                    <text>alternative mixed subdomains will finally result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1808">
                    <text>alternative mixed subdomains, as predicted, can result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1809">
                    <text>alternative mixed subdomains, as predicted, resulted in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1810">
                    <text>alternative mixed subdomains, as we have predicted, may result in superrepetition.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="1811">
                    <text>alternative mixed subdomains, as we have predicted, will result in super-repetitor.</text>
                    <arg n="0">alternative mixed subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="1812">
                    <text>alternative spacer of a single transcription has finally resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1813">
                    <text>alternative spacer of a single transcription has resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1814">
                    <text>alternative spacer of a single transcription is capable of result rise to difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1815">
                    <text>alternative spacer of a single transcription resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2) .</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1816">
                    <text>alternative spacer of a single transcription, as we have predicted, has the ability to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1817">
                    <text>alternative spacer of a single transcription, as we have predicted, resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1818">
                    <text>alternative spacer of a single transcription, as we have predicted, will result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="PERMUTATE" no="1819">
                    <text>an electrophoretic subunit LDH-B has the ability to probably result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1820">
                    <text>an electrophoretic subunit LDH-B has the ability to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1821">
                    <text>an electrophoretic subunit fast type LDH-B has the ability to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1822">
                    <text>an electrophoretic subunit fast type LDH-B was also reported to be able to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1823">
                    <text>an electrophoretic subunit of fast-type LDH-B subunits has the ability to probably result from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="1824">
                    <text>an electrophoretic subunit variant of the fast type LDH-B was able to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1825">
                    <text>differential slicing cells may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1826">
                    <text>differential slicing is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1827">
                    <text>differential slicing may eventually result in existence of NF-YA isoforms</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1828">
                    <text>differential slicing may eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1829">
                    <text>differential slicing, as predicted, resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1830">
                    <text>differential slicing, as predicted, will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1831">
                    <text>differential slicing, as we have predicted, is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1832">
                    <text>differential slicing, as we have predicted, resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1833">
                    <text>differential slicing, as we have predicted, will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential slicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1834">
                    <text>differential spacing, as we have predicted, may result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1835">
                    <text>differential spacing, as we have predicted, resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1836">
                    <text>differential spacing, as we have result, is able to give rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential spacing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1837">
                    <text>differential spasms cells has the ability to ultimately result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1838">
                    <text>differential spasms cells may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1839">
                    <text>differential spasms finally resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1840">
                    <text>differential spasms is shown to ultimately result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1841">
                    <text>differential spasms may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1842">
                    <text>differential spasms resulted in existence of NF-YA isoforms .</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1843">
                    <text>differential spasms will eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1844">
                    <text>differential spasms, as predicted, resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1845">
                    <text>differential spasms, as we have predicted, is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential spasms</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1846">
                    <text>differentiated xis cells can result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1847">
                    <text>differentiated xis cells may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1848">
                    <text>differentiated xis has resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1849">
                    <text>differentiated xis is shown to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1850">
                    <text>differentiated xis, as we have predicted, is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1851">
                    <text>differentiated xis, as we have result, is able to give rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differentiated xis</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="PERMUTATE" no="1852">
                    <text>exon 13 juar in s1031 animals can ultimately resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1853">
                    <text>exon 13 juar in s1031 animals cells may have resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1854">
                    <text>exon 13 juar in s1031 animals has the ability to eventually result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1855">
                    <text>exon 13 juar in s1031 animals is shown to ultimately result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1856">
                    <text>exon 13 juar in s1031 animals may eventually result in a product of 543 bp</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1857">
                    <text>exon 13 juar in s1031 animals may ultimately result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1858">
                    <text>exon 13 juar in s1031 animals resulted in a product of 543 bp .</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1859">
                    <text>exon 13 juar in s1031 animals will finally result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1860">
                    <text>exon 13 juar in s1031 animals, as predicted, resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1861">
                    <text>exon 13 juar in s1031 animals, as predicted, will result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1862">
                    <text>exon 13 juar in s1031 animals, as we have predicted, has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1863">
                    <text>exon 13 juar in s1031 animals, as we have predicted, resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1864">
                    <text>exon 13 juar in s1031 animals, as we have predicted, will result in a product of 543 bp.</text>
                    <arg n="0">exon 13 juar in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1865">
                    <text>exon 13 jump in s1031 animals cells has resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1866">
                    <text>exon 13 jump in s1031 animals has finally resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1867">
                    <text>exon 13 jump in s1031 animals has resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1868">
                    <text>exon 13 jump in s1031 animals is capable of result rise to a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1869">
                    <text>exon 13 jump in s1031 animals may eventually result in a 543 bp product</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1870">
                    <text>exon 13 jump in s1031 animals may have resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1871">
                    <text>exon 13 jump in s1031 animals may result in a 543 bp product .</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1872">
                    <text>exon 13 jump in s1031 animals, as predicted, resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1873">
                    <text>exon 13 jump in s1031 animals, as we have predicted, is likely to resulting in a product of 543 bp.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1874">
                    <text>exon 13 jump in s1031 animals, as we have predicted, may resulting in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1875">
                    <text>exon 13 jump in s1031 animals, as we have predicted, will result in a 543 bp product.</text>
                    <arg n="0">exon 13 jump in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="PERMUTATE" no="1876">
                    <text>exon 13 jumping in animals s1031 cells can result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1877">
                    <text>exon 13 jumping in animals s1031 cells eventually resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1878">
                    <text>exon 13 jumping in animals s1031 has finally resulted in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1879">
                    <text>exon 13 jumping in animals s1031 is capable of result rise to a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1880">
                    <text>exon 13 jumping in animals s1031, as we have predicted, has the ability to result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1881">
                    <text>exon 13 jumping in animals s1031, as we have predicted, will result in a product of 543 bp.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                    <arg n="1">a product of 543 bp</arg>
                </example>
                <example src="PERMUTATE" no="1882">
                    <text>expression of cADNA DNA isoform II in COS7 cells has resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1883">
                    <text>expression of cADNA DNA isoform II in COS7 cells is shown to ultimately result in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1884">
                    <text>expression of cADNA DNA isoform II in COS7 cells, as predicted, may have resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1885">
                    <text>expression of cADNA DNA isoform II in COS7 cells, as predicted, resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1886">
                    <text>expression of cADNA DNA isoform II in COS7 cells, as we have predicted, is likely to resulting in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1887">
                    <text>expression of cADNA DNA isoform II in COS7 cells, as we have predicted, may have resulted in a marked increase in acetylhydratelase PAF activity.</text>
                    <arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
                    <arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1888">
                    <text>expression of cDNA ISOform II DNA in COS7 can eventually result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1889">
                    <text>expression of cDNA ISOform II DNA in COS7 can eventually result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1890">
                    <text>expression of cDNA ISOform II DNA in COS7 cells eventually resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1891">
                    <text>expression of cDNA ISOform II DNA in COS7 cells has the ability to ultimately result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1892">
                    <text>expression of cDNA ISOform II DNA in COS7 has finally resulted in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1893">
                    <text>expression of cDNA ISOform II DNA in COS7 has the ability to eventually result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1894">
                    <text>expression of cDNA ISOform II DNA in COS7 has the ability to result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1895">
                    <text>expression of cDNA ISOform II DNA in COS7 is shown to ultimately result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1896">
                    <text>expression of cDNA ISOform II DNA in COS7 may eventually result in a marked increase in acetylhydrolase PAF activity</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1897">
                    <text>expression of cDNA ISOform II DNA in COS7 may eventually result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1898">
                    <text>expression of cDNA ISOform II DNA in COS7 may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1899">
                    <text>expression of cDNA ISOform II DNA in COS7 may result in a marked increase in acetylhydrolase activity PAF .</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1900">
                    <text>expression of cDNA ISOform II DNA in COS7 may result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1901">
                    <text>expression of cDNA ISOform II DNA in COS7 may ultimately resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1902">
                    <text>expression of cDNA ISOform II DNA in COS7 resulted in a marked increase in acetylhydrolase PAF activity .</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1903">
                    <text>expression of cDNA ISOform II DNA in COS7 resulted in a marked increase in the activity of acetylhydrolase PAF .</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1904">
                    <text>expression of cDNA ISOform II DNA in COS7 will finally result in a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1905">
                    <text>expression of cDNA ISOform II DNA in COS7 will finally result in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1906">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have predicted, has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="PERMUTATE" no="1907">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have predicted, is likely to resulting in a marked increase in the activity of acetylhydrolase PAF.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1908">
                    <text>expression of cDNA ISOform II DNA in COS7, as we have result, is able to give rise to a marked increase in acetylhydrolase PAF activity.</text>
                    <arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
                </example>
                <example src="PERMUTATE" no="1909">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells cells can result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1910">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells cells has resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1911">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells has the ability to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1912">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells may have finally resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1913">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells may ultimately resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1914">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells will result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1915">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells, as predicted, may have resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1916">
                    <text>expression of the DNA-cDNA ISOform II DNA in COS7 cells, as we have predicted, may have resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1917">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells can eventually result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1918">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells can ultimately resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1919">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells cells eventually resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1920">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells will eventually result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1921">
                    <text>expression of the DNA-cDNA ISOform II in COS7 cells, as we have predicted, is able to result in a marked increase in the activity of acetylhydroxylase PAF.</text>
                    <arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
                    <arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
                </example>
                <example src="PERMUTATE" no="1922">
                    <text>failure to use the normal donor site of the intron 12 ear cells has resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1923">
                    <text>failure to use the normal donor site of the intron 12 ear cells has the ability to ultimately result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1924">
                    <text>failure to use the normal donor site of the intron 12 ear cells may have resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1925">
                    <text>failure to use the normal donor site of the intron 12 ear is able to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1926">
                    <text>failure to use the normal donor site of the intron 12 ear may result in a variant .</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1927">
                    <text>failure to use the normal donor site of the intron 12 ear may ultimately result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1928">
                    <text>failure to use the normal donor site of the intron 12 ear, as predicted, resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1929">
                    <text>failure to use the normal donor site of the intron 12 ear, as predicted, will result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1930">
                    <text>failure to use the normal donor site of the intron 12 ear, as we have predicted, may resulting in a variant.</text>
                    <arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="1931">
                    <text>fast-type electrophoretic subunit LDH-B has the ability to result from liquid load of the variable subunit.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1932">
                    <text>fast-type electrophoretic subunit LDH-B was also reported to be able to result from liquid load of the variant subunit.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="1933">
                    <text>float in ras-dependent signaling can eventually result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1934">
                    <text>float in ras-dependent signaling can ultimately resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1935">
                    <text>float in ras-dependent signaling cells eventually resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1936">
                    <text>float in ras-dependent signaling has the ability to eventually result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1937">
                    <text>float in ras-dependent signaling has the ability to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1938">
                    <text>float in ras-dependent signaling is likely to resulting in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1939">
                    <text>float in ras-dependent signaling is shown to ultimately result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1940">
                    <text>float in ras-dependent signaling resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1941">
                    <text>float in ras-dependent signaling will result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1942">
                    <text>float in ras-dependent signaling, as we have predicted, will result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">float in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1943">
                    <text>fluctuation in ras-dependent signaling can eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1944">
                    <text>fluctuation in ras-dependent signaling can eventually result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1945">
                    <text>fluctuation in ras-dependent signaling cells can result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1946">
                    <text>fluctuation in ras-dependent signaling cells can result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1947">
                    <text>fluctuation in ras-dependent signaling cells eventually resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1948">
                    <text>fluctuation in ras-dependent signaling cells has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1949">
                    <text>fluctuation in ras-dependent signaling cells has resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1950">
                    <text>fluctuation in ras-dependent signaling cells has resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1951">
                    <text>fluctuation in ras-dependent signaling cells has the ability to ultimately result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1952">
                    <text>fluctuation in ras-dependent signaling cells is eventually able to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1953">
                    <text>fluctuation in ras-dependent signaling finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1954">
                    <text>fluctuation in ras-dependent signaling has finally resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1955">
                    <text>fluctuation in ras-dependent signaling has finally resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1956">
                    <text>fluctuation in ras-dependent signaling has resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1957">
                    <text>fluctuation in ras-dependent signaling has resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1958">
                    <text>fluctuation in ras-dependent signaling has the ability to eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1959">
                    <text>fluctuation in ras-dependent signaling has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1960">
                    <text>fluctuation in ras-dependent signaling is able to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1961">
                    <text>fluctuation in ras-dependent signaling is able to result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1962">
                    <text>fluctuation in ras-dependent signaling is capable of result rise to a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1963">
                    <text>fluctuation in ras-dependent signaling is likely to resulting in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1964">
                    <text>fluctuation in ras-dependent signaling is shown to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1965">
                    <text>fluctuation in ras-dependent signaling may eventually result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1966">
                    <text>fluctuation in ras-dependent signaling may have finally resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1967">
                    <text>fluctuation in ras-dependent signaling may result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1968">
                    <text>fluctuation in ras-dependent signaling may result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1 .</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1969">
                    <text>fluctuation in ras-dependent signaling may ultimately result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1970">
                    <text>fluctuation in ras-dependent signaling will eventually result in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1971">
                    <text>fluctuation in ras-dependent signaling will eventually result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1972">
                    <text>fluctuation in ras-dependent signaling will result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1 .</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1973">
                    <text>fluctuation in ras-dependent signaling will result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1974">
                    <text>fluctuation in ras-dependent signaling, as predicted, may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1975">
                    <text>fluctuation in ras-dependent signaling, as predicted, resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1976">
                    <text>fluctuation in ras-dependent signaling, as predicted, resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1977">
                    <text>fluctuation in ras-dependent signaling, as predicted, resulted in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1978">
                    <text>fluctuation in ras-dependent signaling, as predicted, will result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1979">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, may result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1980">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1981">
                    <text>fluctuation in ras-dependent signaling, as we have predicted, will result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1982">
                    <text>fluctuation in ras-dependent signaling, as we have result, is able to give rise to a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
                </example>
                <example src="PERMUTATE" no="1983">
                    <text>fluctuation in signaling depending on ras cells can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1984">
                    <text>fluctuation in signaling depending on ras cells can result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1985">
                    <text>fluctuation in signaling depending on ras cells eventually resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1986">
                    <text>fluctuation in signaling depending on ras eventually resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1987">
                    <text>fluctuation in signaling depending on ras has resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1988">
                    <text>fluctuation in signaling depending on ras is capable of result rise to a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1989">
                    <text>fluctuation in signaling depending on ras may have resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1990">
                    <text>fluctuation in signaling depending on ras may ultimately result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1991">
                    <text>fluctuation in signaling depending on ras may ultimately result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1992">
                    <text>fluctuation in signaling depending on ras resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1993">
                    <text>fluctuation in signaling depending on ras, as predicted, can result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1994">
                    <text>fluctuation in signaling depending on ras, as predicted, resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1995">
                    <text>fluctuation in signaling depending on ras, as predicted, will result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1996">
                    <text>fluctuation in signaling depending on ras, as we have predicted, is likely to resulting in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1997">
                    <text>fluctuation in signaling depending on ras, as we have predicted, may have resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1998">
                    <text>fluctuation in signaling depending on ras, as we have predicted, will result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="1999">
                    <text>fluctuation in signaling depending on the ras can ultimately resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2000">
                    <text>fluctuation in signaling depending on the ras cells has the ability to ultimately result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2001">
                    <text>fluctuation in signaling depending on the ras cells is eventually able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2002">
                    <text>fluctuation in signaling depending on the ras eventually resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2003">
                    <text>fluctuation in signaling depending on the ras finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2004">
                    <text>fluctuation in signaling depending on the ras has finally resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2005">
                    <text>fluctuation in signaling depending on the ras is capable of result rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2006">
                    <text>fluctuation in signaling depending on the ras is likely to resulting in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2007">
                    <text>fluctuation in signaling depending on the ras is shown to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2008">
                    <text>fluctuation in signaling depending on the ras is shown to ultimately result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2009">
                    <text>fluctuation in signaling depending on the ras may eventually result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2010">
                    <text>fluctuation in signaling depending on the ras may have finally resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2011">
                    <text>fluctuation in signaling depending on the ras may result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2012">
                    <text>fluctuation in signaling depending on the ras may ultimately resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2013">
                    <text>fluctuation in signaling depending on the ras resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2014">
                    <text>fluctuation in signaling depending on the ras resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2015">
                    <text>fluctuation in signaling depending on the ras, as predicted, resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2016">
                    <text>fluctuation in signaling depending on the ras, as we have predicted, is able to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2017">
                    <text>fluctuation in signaling depending on the ras, as we have predicted, is able to result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2018">
                    <text>fluctuation in signaling depending on the ras, as we have predicted, is likely to resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2019">
                    <text>fluctuation in signaling depending on the ras, as we have predicted, may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2020">
                    <text>fluctuation in signaling depending on the ras, as we have predicted, may have resulted in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2021">
                    <text>fluctuation in signaling depending on the ras, as we have result, is able to give rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">fluctuation in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2022">
                    <text>glow in signaling depending on the ras cells can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2023">
                    <text>glow in signaling depending on the ras cells has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2024">
                    <text>glow in signaling depending on the ras finally resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2025">
                    <text>glow in signaling depending on the ras is shown to ultimately result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2026">
                    <text>glow in signaling depending on the ras may have finally resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2027">
                    <text>glow in signaling depending on the ras may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2028">
                    <text>glow in signaling depending on the ras may ultimately result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2029">
                    <text>glow in signaling depending on the ras, as we have predicted, resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signaling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2030">
                    <text>glow in signalling depending on the ras has the ability to eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2031">
                    <text>glow in signalling depending on the ras has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2032">
                    <text>glow in signalling depending on the ras is able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2033">
                    <text>glow in signalling depending on the ras will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2034">
                    <text>glow in signalling depending on the ras, as predicted, will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2035">
                    <text>glow in signalling depending on the ras, as we have predicted, is likely to resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2036">
                    <text>glow in signalling depending on the ras, as we have predicted, may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2037">
                    <text>glow in signalling depending on the ras, as we have predicted, resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow in signalling depending on the ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2038">
                    <text>glow-dependent signaling fluctuation, as predicted, resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2039">
                    <text>glow-dependent signaling fluctuation, as we have predicted, is likely to resulting in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2040">
                    <text>glow-dependent signaling fluctuation, as we have predicted, may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">glow-dependent signaling fluctuation</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2041">
                    <text>grid-dependent fluctuation in signaling has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2042">
                    <text>grid-dependent fluctuation in signaling may eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2043">
                    <text>grid-dependent fluctuation in signaling may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2044">
                    <text>grid-dependent fluctuation in signaling resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2045">
                    <text>grid-dependent fluctuation in signaling will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity .</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2046">
                    <text>grid-dependent fluctuation in signaling will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2047">
                    <text>grid-dependent fluctuation in signaling, as we have predicted, is able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2048">
                    <text>grid-dependent fluctuation in signaling, as we have predicted, may have resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">grid-dependent fluctuation in signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2049">
                    <text>liquid charge of varying subunits cells may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="2050">
                    <text>liquid charge of varying subunits has resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2051">
                    <text>liquid charge of varying subunits is able to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="2052">
                    <text>liquid charge of varying subunits is capable of result rise to an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="2053">
                    <text>liquid charge of varying subunits is shown to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="2054">
                    <text>liquid charge of varying subunits may eventually result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2055">
                    <text>liquid charge of varying subunits may have resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2056">
                    <text>liquid charge of varying subunits may result in a rapid type of electrophoretic subunit LDH-B .</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2057">
                    <text>liquid charge of varying subunits resulted in an electrophoretic subunit of fast-type LDH-B subunits .</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="2058">
                    <text>liquid charge of varying subunits, as predicted, may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="2059">
                    <text>liquid charge of varying subunits, as predicted, resulted in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2060">
                    <text>liquid charge of varying subunits, as we have predicted, is likely to resulting in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="PERMUTATE" no="2061">
                    <text>liquid charge of varying subunits, as we have predicted, will result in a rapid type of electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2062">
                    <text>liquid load of the variable subunit may ultimately result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2063">
                    <text>liquid load of the variable subunit, as we have predicted, may resulting in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variable subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2064">
                    <text>liquid load of the variant subunit can ultimately resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2065">
                    <text>liquid load of the variant subunit has the ability to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2066">
                    <text>liquid load of the variant subunit is shown to result in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2067">
                    <text>liquid load of the variant subunit may eventually result in fast-type electrophoretic subunit LDH-B</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2068">
                    <text>liquid load of the variant subunit may have finally resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2069">
                    <text>liquid load of the variant subunit resulted in fast-type electrophoretic subunit LDH-B .</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2070">
                    <text>liquid load of the variant subunit, as predicted, resulted in fast-type electrophoretic subunit LDH-B.</text>
                    <arg n="0">liquid load of the variant subunit</arg>
                    <arg n="1">fast-type electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2071">
                    <text>liquid load of variant subunit eventually resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2072">
                    <text>liquid load of variant subunit may ultimately resulted in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2073">
                    <text>liquid load of variant subunit will finally result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2074">
                    <text>liquid load of variant subunit, as we have predicted, will result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2075">
                    <text>mRNA species with 5 different UTRs has the ability to probably result from alternative exon 2 cutting (139 nt) and alternative transcriptional initiation.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="2076">
                    <text>mRNA species with 5 different UTRs was able to result from alternative exon 2 cutting (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="2077">
                    <text>mRNA species with 5 different UTRs was also reported to be able to result from alternative exon 2 cutting (139 nt) and alternative transcriptional initiation.</text>
                    <arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with 5 different UTRs</arg>
                </example>
                <example src="PERMUTATE" no="2078">
                    <text>missing to use the normal donor site of the ear 12 intron can ultimately resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2079">
                    <text>missing to use the normal donor site of the ear 12 intron may ultimately resulted in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2080">
                    <text>missing to use the normal donor site of the ear 12 intron will result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2081">
                    <text>missing to use the normal donor site of the ear 12 intron, as predicted, can result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2082">
                    <text>missing to use the normal donor site of the ear 12 intron, as we have predicted, has the ability to result in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2083">
                    <text>missing to use the normal donor site of the ear 12 intron, as we have predicted, may resulting in a variant.</text>
                    <arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2084">
                    <text>multiple alternate subdomains has resulted in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2085">
                    <text>multiple alternate subdomains may eventually result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2086">
                    <text>multiple alternate subdomains may result in superrepetition .</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2087">
                    <text>multiple alternate subdomains, as we have predicted, may result in superrepetition.</text>
                    <arg n="0">multiple alternate subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="PERMUTATE" no="2088">
                    <text>multiple alternative subdomains can result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2089">
                    <text>multiple alternative subdomains can ultimately resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2090">
                    <text>multiple alternative subdomains finally resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2091">
                    <text>multiple alternative subdomains has resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2092">
                    <text>multiple alternative subdomains has the ability to eventually result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2093">
                    <text>multiple alternative subdomains has the ability to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2094">
                    <text>multiple alternative subdomains is capable of result rise to super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2095">
                    <text>multiple alternative subdomains is shown to result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2096">
                    <text>multiple alternative subdomains may eventually result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2097">
                    <text>multiple alternative subdomains may have resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2098">
                    <text>multiple alternative subdomains may result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2099">
                    <text>multiple alternative subdomains may ultimately result in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2100">
                    <text>multiple alternative subdomains may ultimately result in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2101">
                    <text>multiple alternative subdomains may ultimately resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2102">
                    <text>multiple alternative subdomains, as we have predicted, may resulting in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2103">
                    <text>multiple alternative subdomains, as we have predicted, resulted in super-repetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2104">
                    <text>multiple alternative subdomains, as we have predicted, resulted in superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2105">
                    <text>not to use the normal donor site of the coupling of intron 12 can eventually result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2106">
                    <text>not to use the normal donor site of the coupling of intron 12 is capable of result rise to a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2107">
                    <text>not to use the normal donor site of the coupling of intron 12 may eventually result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2108">
                    <text>not to use the normal donor site of the coupling of intron 12 may have finally resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2109">
                    <text>not to use the normal donor site of the intron 12 ear has the ability to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2110">
                    <text>not to use the normal donor site of the intron 12 ear is able to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2111">
                    <text>not to use the normal donor site of the intron 12 ear is likely to resulting in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2112">
                    <text>not to use the normal donor site of the intron 12 ear, as we have predicted, is likely to resulting in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2113">
                    <text>not to use the normal donor site of the intron 12 ear, as we have predicted, may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 ear</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="PERMUTATE" no="2114">
                    <text>reduction of signaling as a function of ras can eventually result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2115">
                    <text>reduction of signaling as a function of ras can ultimately resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2116">
                    <text>reduction of signaling as a function of ras cells has resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2117">
                    <text>reduction of signaling as a function of ras cells has the ability to ultimately result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2118">
                    <text>reduction of signaling as a function of ras eventually resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2119">
                    <text>reduction of signaling as a function of ras has finally resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2120">
                    <text>reduction of signaling as a function of ras is likely to resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2121">
                    <text>reduction of signaling as a function of ras is shown to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2122">
                    <text>reduction of signaling as a function of ras may have resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2123">
                    <text>reduction of signaling as a function of ras will eventually result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2124">
                    <text>reduction of signaling as a function of ras will finally result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2125">
                    <text>reduction of signaling as a function of ras, as predicted, may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2126">
                    <text>reduction of signaling as a function of ras, as predicted, resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2127">
                    <text>reduction of signaling as a function of ras, as we have predicted, is able to result in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2128">
                    <text>reduction of signaling as a function of ras, as we have predicted, is likely to resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">reduction of signaling as a function of ras</arg>
                    <arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="PERMUTATE" no="2129">
                    <text>replace isoleucine with valine has the ability to probably result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="2130">
                    <text>replace isoleucine with valine has the ability to result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replace isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="2131">
                    <text>replacement of isoleucine to valine was able to result from a new mutation to codon 210.</text>
                    <arg n="0">a new mutation to codon 210</arg>
                    <arg n="1">replacement of isoleucine to valine</arg>
                </example>
                <example src="PERMUTATE" no="2132">
                    <text>replacement of isoleucine with valine has the ability to result from a new mutation in codon 210.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                    <arg n="1">replacement of isoleucine with valine</arg>
                </example>
                <example src="PERMUTATE" no="2133">
                    <text>some alternative subdomains can eventually result in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2134">
                    <text>some alternative subdomains can ultimately resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2135">
                    <text>some alternative subdomains cells can result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2136">
                    <text>some alternative subdomains cells eventually resulted in super-repetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2137">
                    <text>some alternative subdomains has resulted in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2138">
                    <text>some alternative subdomains may have resulted in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2139">
                    <text>some alternative subdomains may result in super-repetitor .</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2140">
                    <text>some alternative subdomains will eventually result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2141">
                    <text>some alternative subdomains will finally result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2142">
                    <text>some alternative subdomains will result in superrepetitor .</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2143">
                    <text>some alternative subdomains, as predicted, can result in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2144">
                    <text>some alternative subdomains, as we have predicted, may have resulted in superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2145">
                    <text>super-repetitor has the ability to probably result from some alternative subdomains.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">super-repetitor</arg>
                </example>
                <example src="PERMUTATE" no="2146">
                    <text>superrepetitor has the ability to result from multiple alternative subdomains.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetitor</arg>
                </example>
                <example src="PERMUTATE" no="2147">
                    <text>the net charge of the variant subunit can result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2148">
                    <text>the net charge of the variant subunit cells has resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2149">
                    <text>the net charge of the variant subunit cells is eventually able to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2150">
                    <text>the net charge of the variant subunit eventually resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2151">
                    <text>the net charge of the variant subunit finally resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2152">
                    <text>the net charge of the variant subunit finally resulted in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2153">
                    <text>the net charge of the variant subunit has resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2154">
                    <text>the net charge of the variant subunit is capable of result rise to a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2155">
                    <text>the net charge of the variant subunit is shown to ultimately result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2156">
                    <text>the net charge of the variant subunit may eventually result in an electrophoretic subunit LDH-B</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2157">
                    <text>the net charge of the variant subunit may have finally resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2158">
                    <text>the net charge of the variant subunit may ultimately result in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2159">
                    <text>the net charge of the variant subunit may ultimately resulted in an electrophoretic subunit variant of the fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2160">
                    <text>the net charge of the variant subunit, as predicted, can result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2161">
                    <text>the net charge of the variant subunit, as predicted, can result in an electrophoretic subunit fast type LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit fast type LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2162">
                    <text>the net charge of the variant subunit, as we have predicted, is likely to resulting in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2163">
                    <text>the net charge of the variant subunit, as we have predicted, may have resulted in an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2164">
                    <text>the net charge of the variant subunit, as we have result, is able to give rise to an electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2165">
                    <text>the net charge of the varying subunit cells eventually resulted in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2166">
                    <text>the net charge of the varying subunit has the ability to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2167">
                    <text>the net charge of the varying subunit may result in a fast-type LDH-B electrophoretic subunit .</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2168">
                    <text>the net charge of the varying subunit, as we have predicted, has the ability to result in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2169">
                    <text>the net charge of the varying subunit, as we have predicted, is likely to resulting in a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2170">
                    <text>the net charge of the varying subunit, as we have result, is able to give rise to a fast-type LDH-B electrophoretic subunit.</text>
                    <arg n="0">the net charge of the varying subunit</arg>
                    <arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
                </example>
                <example src="PERMUTATE" no="2171">
                    <text>the net load of the variant subunit is shown to ultimately result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2172">
                    <text>the net load of the variant subunit may eventually result in a variant electrophoretic subunit LDH-B fast type</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2173">
                    <text>the net load of the variant subunit may have resulted in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2174">
                    <text>the net load of the variant subunit may ultimately result in a variant electrophoretic subunit LDH-B fast type.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
                </example>
                <example src="PERMUTATE" no="2175">
                    <text>the net load of the variant subunit will result in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="PERMUTATE" no="2176">
                    <text>the net load of the variant subunit, as predicted, resulted in a variant electrophoretic subunit LDH-B.</text>
                    <arg n="0">the net load of the variant subunit</arg>
                    <arg n="1">a variant electrophoretic subunit LDH-B</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling cells eventually resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling has the ability to eventually result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling is likely to resulting in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, as we have predicted, may resulting in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>Change can cause heat instability and affect Loading Signor of the EGL-15 resulting in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>Change can cause heat instability and affect a decrease in transcription of the csgA gene encoding csgA resulting in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Change can cause heat instability and affect a decrease in transcription of the csgA gene from csglin encoding results in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Change can cause heat instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Change can cause heat instability and affect a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF results in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor results in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling results in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Change can cause heat instability and affect alternative deflection of a single transcription results in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Change can cause heat instability and affect alternative exon splicing 139 nt results in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>Change can cause heat instability and affect both 5 and 3 splice local mutations resulting in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Change can cause heat instability and affect decreases the EGL-15 signaling results in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Change can cause heat instability and affect mixed alternative subdomains results in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>Change can cause heat instability and affect multiple alternative subdomains resulting in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Change can cause heat instability and affect reduced transcription of the csgA gene encoding for the clinic results in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Change can cause heat instability and affect reduction of EGL-15 signaling results in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>Change can cause heat instability and affect the normal docking donor site of intron 12 could not be used results in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Change can cause heat instability and affect the other three alterations results in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Change can cause heat instability and affect the other three changes results in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Change can cause heat instability and affect the other three mutations results in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Decrease Signor of the EGL-15 can result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>Decrease Signor of the EGL-15 can ultimately resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Decrease Signor of the EGL-15 cells can result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Decrease Signor of the EGL-15 cells has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Decrease Signor of the EGL-15 is capable of result rise to a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Decrease Signor of the EGL-15 may eventually result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Decrease Signor of the EGL-15 resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Diminutive EGL-15 signal cells is eventually able to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>Diminutive EGL-15 signal cells is eventually able to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>Diminutive EGL-15 signal eventually resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>Diminutive EGL-15 signal may eventually result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>Diminutive EGL-15 signal may eventually result in a phenotype of scruwny body morphology</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>Diminutive EGL-15 signal may ultimately resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>Diminutive EGL-15 signal, as we have predicted, is able to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>Diminutive EGL-15 signal, as we have predicted, may have resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>Diminutive EGL-15 signal, as we have predicted, may resulting in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that Decrease Signor of the EGL-15 had the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that Diminutive EGL-15 signal had the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors had the ability to result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a decrease in csgA gene transcription from csglin coding had the ability to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a decrease in the transcription of the csgA gene from csglin encoding had the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling had the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that alternative deflection of a single transcription had the ability to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that alternative exon 2 exhaustion (139 nt) and alternative transcriptional start had the ability to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that alternative splicing of a single transcription had the ability to result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that both the mutations at the site of 5 and 3 splices had the ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that both the mutations of 5 and 3 splices had the ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that exon 13 skipping in animals s1031 had the ability to result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that growth in ras-dependent signaling had the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that multiple alternative subdomains had the ability to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that reduced signaling by EGL-15 had the ability to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that reduced transcription of the csgA gene encoding for the clinic had the ability to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that the donor place of normal helix of intron 12 could not be used had the ability to result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>GL-15 Decrease Flag cells has the ability to ultimately result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>GL-15 Decrease Flag has finally resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>GL-15 Decrease Flag is able to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>GL-15 Decrease Flag may result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>GL-15 Decrease Flag may ultimately result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>GL-15 Decrease Flag, as predicted, can result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>GL-15 Decrease Flag, as we have predicted, is likely to resulting in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>It has also been reported that a Clr phenotype resulted from a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>It has also been reported that a Clr phenotype resulted from a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>It has also been reported that a phenotype of scrubbing body morphology resulted from declining EGL-15.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>It has also been reported that a phenotype of scruwny body morphology resulted from Diminutive EGL-15 signal.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>It has also been reported that a superrepetitor resulted from mixed alternative subdomains.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>It has also been reported that a variant resulted from the normal donor site of intron 12 donation could not be used.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>It has also been reported that bodys dirty morphology phenotype resulted from reduction of the EGL-15 signaling.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>It has also been reported that non-functional truncated proteins resulted from the other three alterations.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>It has also been reported that pulled body morphology phenotype resulted from reduced signaling by EGL-15.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>It has also been reported that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) resulted from alternative splicing of a single transcription.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>It has also been reported that the existence of isoforms of NF-YA resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>It has also been reported that the negative effect of the mutation cpxA resulted from a decrease in transcription of the csgA gene encoding csgA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>It has also been reported that the negative effect of the mutation cpxA resulted from a decrease in transcription of the csgA gene from csglin encoding.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>Loading Signor of the EGL-15 can eventually result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>Loading Signor of the EGL-15 has the ability to eventually result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>Loading Signor of the EGL-15 is shown to ultimately result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>Loading Signor of the EGL-15 may have finally resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>Loading Signor of the EGL-15 resulted in a phenotype of scrawny morphology .</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>Loading Signor of the EGL-15 will result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>Mutations that are able to result in Decrease Signor of the EGL-15 may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>Mutations that are able to result in a decrease in the transcription of csgA coding gene csgA csgA may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>Mutations that are able to result in a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>Mutations that are able to result in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>Mutations that are able to result in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>Mutations that are able to result in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>Mutations that are able to result in expression of Nrf1 isoforms may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>Mutations that are able to result in liquid charge of varying subunits may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>Mutations that are able to result in liquid load of variant subunit may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>Mutations that are able to result in loss due to transcriptional repression of the lacZ gene may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">loss due to transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>Mutations that are able to result in loss of transcriptional repression of the lacZ gene may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>Mutations that are able to result in reduced transcription of the csgA gene encoding for curline may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>Mutations that are able to result in the normal site of the intron 12 splice donor could not be used may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>Mutations that can result in Decrease Signor of the EGL-15 can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>Mutations that can result in a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>Mutations that can result in a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>Mutations that can result in a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>Mutations that can result in a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>Mutations that can result in a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>Mutations that can result in a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>Mutations that can result in a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>Mutations that can result in a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>Mutations that can result in alternative spacer of a single transcription can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>Mutations that can result in alternative splicing of a single transcription can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>Mutations that can result in both 5 and 3 splice mutations can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>Mutations that can result in both the mutations of 5 and 3 splices can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>Mutations that can result in declining EGL-15 can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">declining EGL-15</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>Mutations that can result in differential encryption can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">differential encryption</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>Mutations that can result in differential spasms can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">differential spasms</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>Mutations that can result in differential spasms can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">differential spasms</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>Mutations that can result in liquid charge of varying subunits can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>Mutations that can result in liquid load of variant subunit can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>Mutations that can result in loss due to transcriptional repression of the lacZ gene can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">loss due to transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>Mutations that can result in reduced EGL-15 signal can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>Mutations that can result in the expression of isoforms of Nrf1 can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>Mutations that can result in the net charge of the variant subunit can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>Mutations that can result in the normal splice donor site of the 12th intron could not be used can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>Mutations that can resulted in Loading Signor of the EGL-15 can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>Mutations that can resulted in a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>Mutations that can resulted in both the mutations of 5 and 3 splices can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>Mutations that can resulted in cooperative bonding of the repressor to its two sites can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>Mutations that can resulted in reduced EGL-15 signaling can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>Mutations that can resulted in the normal site of the intron 12 splice donor could not be used can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>Mutations that can resulted in the normal splice donor site of the 12th intron could not be used can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>Mutations that can resulted in the other three changes can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the other three changes</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>Mutations that have the ability to result in a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>Mutations that have the ability to result in a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>Mutations that have the ability to result in a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>Mutations that have the ability to result in a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>Mutations that have the ability to result in a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>Mutations that have the ability to result in a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>Mutations that have the ability to result in a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>Mutations that have the ability to result in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>Mutations that have the ability to result in alternative spacer of a single transcription can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>Mutations that have the ability to result in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>Mutations that have the ability to result in both the mutations at the site of 5 and 3 splices can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>Mutations that have the ability to result in both the mutations at the site of 5 and 3 splices may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>Mutations that have the ability to result in decreasing EGL-15 signal can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>Mutations that have the ability to result in differential spacing can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">differential spacing</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>Mutations that have the ability to result in differential spasms can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">differential spasms</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>Mutations that have the ability to result in exon 13 jumping in animals s1031 may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">exon 13 jumping in animals s1031</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>Mutations that have the ability to result in exon 13 skipping in animals s1031 may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>Mutations that have the ability to result in growth in ras-dependent signaling can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>Mutations that have the ability to result in liquid load of variant subunit can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>Mutations that have the ability to result in reduced EGL-15 signal may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>Mutations that have the ability to result in reduced transcription of the csgA curlin encoder gene may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>Mutations that have the ability to result in reduction of csgA gene transcription csgA coding can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>Mutations that have the ability to result in reduction of csgA gene transcription csgA coding may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>Mutations that have the ability to result in reduction of the EGL-15 signaling can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>Mutations that have the ability to result in the normal site of the intron 12 fitting donor could not be used can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>Mutations that have the ability to result in the normal splice donor site of intron 12 could not be used can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>Mutations that have the ability to result in the other three changes may prevent the binding of repressors to the site or change the binding site phase.</text>
                    <arg n="0">the other three changes</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>Mutations that may result in GL-15 Decrease Flag may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>Mutations that may result in a decrease in the transcription of the csgA gene from csglin encoding may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>Mutations that may result in a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>Mutations that may result in a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>Mutations that may result in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>Mutations that may result in alternative deflection of a single transcription may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>Mutations that may result in cooperative bonding of the repressor to its two sites may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>Mutations that may result in decreasing EGL-15 sign may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>Mutations that may result in growth in ras-dependent signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>Mutations that may result in liquid load of variant subunit may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>Mutations that may result in reduced signaling by EGL-15 may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>Mutations that may result in reduced transcription of the csgA gene encoding for the clinic may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>Mutations that may resulted in a new mutation in codon 210 may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a new mutation in codon 210</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>Mutations that may resulted in a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>Mutations that may resulted in a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>Mutations that may resulted in both 5 and 3 splice mutations may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>Mutations that may resulted in decreases the EGL-15 signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>Mutations that may resulted in the normal splice donor site of the 12th intron could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>Mutations that may resulted in the other three mutations may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the other three mutations</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>Mutations that result in GL-15 Decrease Flag may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>Mutations that result in a decrease in the transcription of the csgA gene encoding csgA may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>Mutations that result in a decrease in the transcription of the csgA gene from csglin encoding can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>Mutations that result in a decrease in transcription of the csgA gene from csglin encoding can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>Mutations that result in a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>Mutations that result in a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>Mutations that result in a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>Mutations that result in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>Mutations that result in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>Mutations that result in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>Mutations that result in a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>Mutations that result in a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>Mutations that result in a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>Mutations that result in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>Mutations that result in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>Mutations that result in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>Mutations that result in both 5 and 3 splice local mutations may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>Mutations that result in cooperative binding of the repressor to its two sites can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>Mutations that result in cooperative bonding of the repressor to its two sites can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>Mutations that result in decreases the EGL-15 signaling can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>Mutations that result in differential encryption may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">differential encryption</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>Mutations that result in expression of Nrf1 isoforms can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>Mutations that result in expression of Nrf1 isoforms may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>Mutations that result in failure to use the normal site of the intron 12 splice donor can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>Mutations that result in growth in ras-dependent signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>Mutations that result in liquid charge of the variant subunit may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>Mutations that result in liquid charge of varying subunits can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>Mutations that result in loss due to transcriptional repression of the lacZ gene may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">loss due to transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>Mutations that result in not to use the normal donor site of the intron 12 splice can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>Mutations that result in reduced signaling by EGL-15 can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>Mutations that result in reduced transcription of the csgA curlin encoder gene can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>Mutations that result in reduction of EGL-15 signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>Mutations that result in the normal site of the intron 12 fitting donor could not be used can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>Mutations that resulted in A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>Mutations that resulted in GL-15 Decrease Flag may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>Mutations that resulted in a decrease in the transcription of the csgA gene encoding csgA may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>Mutations that resulted in a decrease in the transcription of the csgA gene from csglin encoding can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>Mutations that resulted in a decrease in the transcription of the csgA gene from csglin encoding may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>Mutations that resulted in a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>Mutations that resulted in a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>Mutations that resulted in a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>Mutations that resulted in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>Mutations that resulted in a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>Mutations that resulted in a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>Mutations that resulted in alternative deflection of a single transcription can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>Mutations that resulted in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>Mutations that resulted in alternative exon splicing 139 nt can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>Mutations that resulted in alternative of a single transcription cut may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>Mutations that resulted in both 5 and 3 splice mutations may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>Mutations that resulted in both the mutations at the site of 5 and 3 splices may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>Mutations that resulted in decreasing EGL-15 signal may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>Mutations that resulted in exon 13 skipping in animals s1031 can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>Mutations that resulted in failure to use the normal donor site of splice of intron 12 may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>Mutations that resulted in fluctuation in ras-dependent signaling may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">fluctuation in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>Mutations that resulted in growth in ras-dependent signaling can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>Mutations that resulted in liquid charge of the variant subunit may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>Mutations that resulted in liquid load of variant subunit may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">liquid load of variant subunit</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>Mutations that resulted in loss due to transcriptional repression of the lacZ gene may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">loss due to transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>Mutations that resulted in loss of transcriptional repression of the lacZ gene can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>Mutations that resulted in reduced transcription of the csgA curlin encoder gene can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>Mutations that resulted in reduction of EGL-15 signaling can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>Mutations that resulted in reduction of EGL-15 signaling may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>Mutations that resulted in the donor place of normal helix of intron 12 could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>Mutations that resulted in the donor site of the normal helix of intron 12 could not be used can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>Mutations that resulted in the expression of isoforms of Nrf1 can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>Mutations that resulted in the expression of isoforms of Nrf1 may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>Mutations that resulted in the normal docking donor site of intron 12 could not be used may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>Mutations that resulted in the normal donor site of intron 12 donation could not be used can prevent repressor binding to the site or change the site binding phase.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>Mutations that resulted in the normal splice donor site of the 12th intron could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>Mutations that resulted in the other three changes may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
                    <arg n="0">the other three changes</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>Mutations that resulted in the other three mutations may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the other three mutations</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>Mutations that resulting in a decrease in the transcription of csgA coding gene csgA csgA may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>Mutations that resulting in a decrease in the transcription of the csgA gene encoding csgA may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>Mutations that resulting in a decrease in the transcription of the csgA gene from csglin encoding may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>Mutations that resulting in a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>Mutations that resulting in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>Mutations that resulting in a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>Mutations that resulting in a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>Mutations that resulting in alternative exon 2 exhaustion (139 nt) and alternative transcriptional start can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>Mutations that resulting in alternative exon coupling 139 nt may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative exon coupling 139 nt</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>Mutations that resulting in alternative splicing of a single transcription can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>Mutations that resulting in alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>Mutations that resulting in both 5 and 3 splice local mutations can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>Mutations that resulting in decreasing EGL-15 signal may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>Mutations that resulting in differential splicing can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">differential splicing</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>Mutations that resulting in failure to use the normal donor site of splice of intron 12 may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>Mutations that resulting in failure to use the normal site of the intron 12 splice donor can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>Mutations that resulting in reduction of the EGL-15 signaling may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>Mutations that resulting in the donor place of normal helix of intron 12 could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>Mutations that resulting in the normal docking donor site of intron 12 could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>Mutations that resulting in the normal site of the intron 12 fitting donor could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>Mutations that resulting in the normal site of the intron 12 splice donor could not be used may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>Mutations that resulting in the normal splice donor site of intron 12 could not be used can avoid binding of repressors to the site or change the site binding phase.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>Mutations that resulting in the other three alterations may prevent the binding of the repressors to the site or change the binding site phase.</text>
                    <arg n="0">the other three alterations</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>The Decrease Signor of the EGL-15 has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>The Decrease Signor of the EGL-15 may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>The Decrease Signor of the EGL-15, as predicted, has the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>The Diminutive EGL-15 signal has resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>The Diminutive EGL-15 signal resulted in the a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>The Diminutive EGL-15 signal, as predicted, has the ability to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>The GL-15 Decrease Flag, as predicted, has resulted in the a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>The Loading Signor of the EGL-15 is capable of result rise to a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>The a decrease in csgA gene transcription from csglin coding may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>The a decrease in csgA gene transcription from csglin coding, as predicted, has resulted in the the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>The a decrease in csgA gene transcription from csglin coding, as predicted, has the ability to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>The a decrease in the transcription of csgA coding gene csgA csgA resulted in the the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>The a decrease in the transcription of the csgA gene encoding csgA will result in the the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>The a decrease in the transcription of the csgA gene from csglin encoding resulted in the the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>The a decrease in transcription of the csgA gene encoding csgA has resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>The a decrease in transcription of the csgA gene from csglin encoding resulted in the the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>The a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF will result in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>The a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>The a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive, as predicted, has resulted in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development resulted in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive resulted in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive, as predicted, has resulted in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF will result in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor resulted in the a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>The a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, as predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, as predicted, has resulted in the a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>The a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF resulted in the a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling will result in the a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>The a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF and alternative transcriptional initiation, as result in our study, are capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>The alteration can cause thermal instability and affect A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which is observed to result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>The alteration can cause thermal instability and affect A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, which can result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>The alteration can cause thermal instability and affect Decrease Signor of the EGL-15 which is able to finally result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>The alteration can cause thermal instability and affect Decrease Signor of the EGL-15 which is observed to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>The alteration can cause thermal instability and affect Diminutive EGL-15 signal that may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>The alteration can cause thermal instability and affect Diminutive EGL-15 signal which is shown to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>The alteration can cause thermal instability and affect Diminutive EGL-15 signal, which ended up resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>The alteration can cause thermal instability and affect a decrease in the transcription of the csgA gene encoding csgA, which can result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>The alteration can cause thermal instability and affect a decrease in transcription of the csgA gene encoding csgA which has proven to result finally in the negative effect of the mutation cpxA .</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>The alteration can cause thermal instability and affect a decrease in transcription of the csgA gene encoding csgA which is shown to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF because it is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, which can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor because it is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor being observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor which has proven to result finally in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development being observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development, which can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive which has proven to result finally in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor, which can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor because it is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor which has proven to result finally in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors which is able to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="331">
                    <text>The alteration can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors which is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="332">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="333">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF being observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="334">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="335">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="336">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling which has proven to result finally in a Clr phenotype .</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="337">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling which is able to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="338">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="339">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling, which can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="340">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling being observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="341">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling, which ended up resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="342">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF being observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="343">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="344">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF, which can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="345">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF which is able to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="346">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF which is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="347">
                    <text>The alteration can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling because it is able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="348">
                    <text>The alteration can cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, which ended up resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="349">
                    <text>The alteration can cause thermal instability and affect alternative exon splicing 139 nt that may have resulted in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="350">
                    <text>The alteration can cause thermal instability and affect alternative of a single transcription cut which is observed to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="351">
                    <text>The alteration can cause thermal instability and affect alternative spacer of a single transcription because it is able to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="352">
                    <text>The alteration can cause thermal instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, which is observed to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="353">
                    <text>The alteration can cause thermal instability and affect both 5 and 3 splice local mutations being observed to finally result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="354">
                    <text>The alteration can cause thermal instability and affect both 5 and 3 splice mutations after having resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="355">
                    <text>The alteration can cause thermal instability and affect both 5 and 3 splice mutations after having resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="356">
                    <text>The alteration can cause thermal instability and affect both 5 and 3 splice mutations because it is able to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="357">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices after having resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="358">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices which is able to finally result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="359">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices, which can result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="360">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices, which can result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="361">
                    <text>The alteration can cause thermal instability and affect both the mutations at the site of 5 and 3 splices, which ended up resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="362">
                    <text>The alteration can cause thermal instability and affect both the mutations of 5 and 3 splices being observed to finally result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="363">
                    <text>The alteration can cause thermal instability and affect both the mutations of 5 and 3 splices being observed to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="364">
                    <text>The alteration can cause thermal instability and affect cooperative bonding of the repressor to its two sites, which ended up resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="365">
                    <text>The alteration can cause thermal instability and affect declining EGL-15 which is shown to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="366">
                    <text>The alteration can cause thermal instability and affect decreases the EGL-15 signaling which is shown to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="367">
                    <text>The alteration can cause thermal instability and affect decreasing EGL-15 sign being observed to finally result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="368">
                    <text>The alteration can cause thermal instability and affect decreasing EGL-15 sign, which can result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="369">
                    <text>The alteration can cause thermal instability and affect differential encryption which is able to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="370">
                    <text>The alteration can cause thermal instability and affect differential encryption which is observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="371">
                    <text>The alteration can cause thermal instability and affect differential splicing because it is able to result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="372">
                    <text>The alteration can cause thermal instability and affect differential splicing that may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="373">
                    <text>The alteration can cause thermal instability and affect expression of Nrf1 isoforms which is able to finally result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="374">
                    <text>The alteration can cause thermal instability and affect expression of Nrf1 isoforms which is observed to result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="375">
                    <text>The alteration can cause thermal instability and affect expression of cDNA isoform II DNA in COS7 which is able to finally result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="376">
                    <text>The alteration can cause thermal instability and affect failure to use the normal site of the intron 12 splice donor after having resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="377">
                    <text>The alteration can cause thermal instability and affect growth in ras-dependent signaling which is shown to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="378">
                    <text>The alteration can cause thermal instability and affect liquid charge of the variant subunit which is able to finally result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="379">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits being observed to finally result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="380">
                    <text>The alteration can cause thermal instability and affect liquid charge of varying subunits which is able to finally result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="381">
                    <text>The alteration can cause thermal instability and affect mixed alternative subdomains which is able to finally result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="382">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains which has proven to result finally in a superrepetitor .</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="383">
                    <text>The alteration can cause thermal instability and affect multiple alternative subdomains which is able to finally result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="384">
                    <text>The alteration can cause thermal instability and affect reduced EGL-15 signaling that may have resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="385">
                    <text>The alteration can cause thermal instability and affect reduced signaling by EGL-15 which has proven to result finally in a phenotype of dirty body morphology .</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="386">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA curlin encoder gene being observed to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="387">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for curline after having resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="388">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for curline which is observed to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="389">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for curline which is shown to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="390">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic which is able to finally result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="391">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic which is observed to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="392">
                    <text>The alteration can cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic, which ended up resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="393">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling which has proven to result finally in a dirty body morphology phenotype .</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="394">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling, which can result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="395">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling, which can result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="396">
                    <text>The alteration can cause thermal instability and affect reduction of EGL-15 signaling, which ended up resulted in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="397">
                    <text>The alteration can cause thermal instability and affect reduction of csgA gene transcription csgA coding after having resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="398">
                    <text>The alteration can cause thermal instability and affect reduction of csgA gene transcription csgA coding which is shown to result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="399">
                    <text>The alteration can cause thermal instability and affect reduction of the EGL-15 signaling being observed to finally result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="400">
                    <text>The alteration can cause thermal instability and affect reduction of the EGL-15 signaling which is able to finally result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="401">
                    <text>The alteration can cause thermal instability and affect reduction of the EGL-15 signaling which is shown to result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="402">
                    <text>The alteration can cause thermal instability and affect reduction of the EGL-15 signaling, which can result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="403">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="404">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains which has proven to result finally in a superrepetitor .</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="405">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains which is able to finally result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="406">
                    <text>The alteration can cause thermal instability and affect some alternative subdomains, which can result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="407">
                    <text>The alteration can cause thermal instability and affect the donor place of normal helix of intron 12 could not be used, which ended up resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="408">
                    <text>The alteration can cause thermal instability and affect the donor site of the normal helix of intron 12 could not be used that may have resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="409">
                    <text>The alteration can cause thermal instability and affect the donor site of the normal helix of intron 12 could not be used, which ended up resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="410">
                    <text>The alteration can cause thermal instability and affect the expression of isoforms of Nrf1 after having resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="411">
                    <text>The alteration can cause thermal instability and affect the normal docking donor site of intron 12 could not be used, which can result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="412">
                    <text>The alteration can cause thermal instability and affect the normal docking donor site of intron 12 could not be used, which ended up resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="413">
                    <text>The alteration can cause thermal instability and affect the normal donor site of intron 12 donation could not be used which is able to finally result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="414">
                    <text>The alteration can cause thermal instability and affect the normal site of the intron 12 fitting donor could not be used being observed to finally result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="415">
                    <text>The alteration can cause thermal instability and affect the normal site of the intron 12 splice donor could not be used that may have resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="416">
                    <text>The alteration can cause thermal instability and affect the normal site of the intron 12 splice donor could not be used which has proven to result finally in a variant .</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="417">
                    <text>The alteration can cause thermal instability and affect the normal site of the intron 12 splice donor could not be used which is shown to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="418">
                    <text>The alteration can cause thermal instability and affect the normal site of the intron 12 splice donor could not be used, which ended up resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="419">
                    <text>The alteration can cause thermal instability and affect the normal splice donor site of intron 12 could not be used, which ended up resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="420">
                    <text>The alteration can cause thermal instability and affect the other three alterations after having resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="421">
                    <text>The alteration can cause thermal instability and affect the other three alterations being observed to finally result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="422">
                    <text>The alteration can cause thermal instability and affect the other three alterations being observed to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="423">
                    <text>The alteration can cause thermal instability and affect the other three alterations, which can result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="424">
                    <text>The alteration can cause thermal instability and affect the other three changes being observed to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="425">
                    <text>The alteration can cause thermal instability and affect the other three changes which is observed to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="426">
                    <text>The alteration can cause thermal instability and affect the other three mutations because it is able to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="427">
                    <text>The alteration can cause thermal instability and affect the other three mutations that may have resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="428">
                    <text>The alteration can cause thermal instability and affect the place of normal splice donor of intron 12 could not be used because it is able to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="429">
                    <text>The alteration can cause thermal instability and affect the place of normal splice donor of intron 12 could not be used being observed to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="430">
                    <text>The alteration can result thermal instability and affect Diminutive EGL-15 signal which has finally been shown to be a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="431">
                    <text>The alteration can result thermal instability and affect a decrease in the transcription of the csgA gene from csglin encoding which has finally been shown to be the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="432">
                    <text>The alteration can result thermal instability and affect a decrease in the transcription of the csgA gene from csglin encoding which is capable of giving rise to the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="433">
                    <text>The alteration can result thermal instability and affect a decrease in transcription of the csgA gene encoding csgA which has finally been shown to be the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="434">
                    <text>The alteration can result thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor which is capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="435">
                    <text>The alteration can result thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor which is capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="436">
                    <text>The alteration can result thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors which has finally been shown to be a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="437">
                    <text>The alteration can result thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which is capable of giving rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="438">
                    <text>The alteration can result thermal instability and affect alternative exon splicing 139 nt which has finally been shown to be mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="439">
                    <text>The alteration can result thermal instability and affect both 5 and 3 splice mutations which has finally been shown to be high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="440">
                    <text>The alteration can result thermal instability and affect both the mutations at the site of 5 and 3 splices which has finally been shown to be high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="441">
                    <text>The alteration can result thermal instability and affect both the mutations at the site of 5 and 3 splices which is capable of giving rise to high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="442">
                    <text>The alteration can result thermal instability and affect both the mutations of 5 and 3 splices which has finally been shown to be of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="443">
                    <text>The alteration can result thermal instability and affect both the mutations of 5 and 3 splices which is capable of giving rise to of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="444">
                    <text>The alteration can result thermal instability and affect cooperative binding of the repressor to its two sites which has finally been shown to be repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="445">
                    <text>The alteration can result thermal instability and affect decreasing EGL-15 signal which has finally been shown to be scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="446">
                    <text>The alteration can result thermal instability and affect liquid charge of the variant subunit which is capable of giving rise to an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="447">
                    <text>The alteration can result thermal instability and affect reduced EGL-15 signaling which has finally been shown to be a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="448">
                    <text>The alteration can result thermal instability and affect reduction of EGL-15 signaling which has finally been shown to be scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="449">
                    <text>The alteration can result thermal instability and affect reduction of EGL-15 signaling which is capable of giving rise to scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="450">
                    <text>The alteration can result thermal instability and affect reduction of csgA gene transcription csgA coding which has finally been shown to be negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="451">
                    <text>The alteration can result thermal instability and affect the donor site of the normal helix of intron 12 could not be used which has finally been shown to be a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="452">
                    <text>The alteration can result thermal instability and affect the normal docking donor site of intron 12 could not be used which is capable of giving rise to a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="453">
                    <text>The alteration can result thermal instability and affect the normal donor site of intron 12 donation could not be used which has finally been shown to be a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="454">
                    <text>The alteration can result thermal instability and affect the normal site of the intron 12 splice donor could not be used which is capable of giving rise to a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="455">
                    <text>The alteration can result thermal instability and affect the normal splice donor site of the 12th intron could not be used which has finally been shown to be a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="456">
                    <text>The alteration can result thermal instability and affect the other three alterations which is capable of giving rise to non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="457">
                    <text>The alteration may cause thermal instability and affect A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which has been demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="458">
                    <text>The alteration may cause thermal instability and affect A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, which may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="459">
                    <text>The alteration may cause thermal instability and affect Decrease Signor of the EGL-15 being demonstrated to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="460">
                    <text>The alteration may cause thermal instability and affect Decrease Signor of the EGL-15 which finally resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="461">
                    <text>The alteration may cause thermal instability and affect Decrease Signor of the EGL-15 which may result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="462">
                    <text>The alteration may cause thermal instability and affect Diminutive EGL-15 signal which finally resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="463">
                    <text>The alteration may cause thermal instability and affect Diminutive EGL-15 signal which has been demonstrated to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="464">
                    <text>The alteration may cause thermal instability and affect Diminutive EGL-15 signal which resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="465">
                    <text>The alteration may cause thermal instability and affect Diminutive EGL-15 signal, which may eventually result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="466">
                    <text>The alteration may cause thermal instability and affect Diminutive EGL-15 signal, which may eventually result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="467">
                    <text>The alteration may cause thermal instability and affect GL-15 Decrease Flag which finally resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="468">
                    <text>The alteration may cause thermal instability and affect GL-15 Decrease Flag which has been demonstrated to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="469">
                    <text>The alteration may cause thermal instability and affect GL-15 Decrease Flag which resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="470">
                    <text>The alteration may cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors which has been demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="471">
                    <text>The alteration may cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors which may result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="472">
                    <text>The alteration may cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors, which may eventually result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="473">
                    <text>The alteration may cause thermal instability and affect a decrease in the transcription of the csgA gene encoding csgA which may result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="474">
                    <text>The alteration may cause thermal instability and affect a decrease in the transcription of the csgA gene from csglin encoding, which may ultimately resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="475">
                    <text>The alteration may cause thermal instability and affect a decrease in transcription of the csgA gene from csglin encoding which may result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="476">
                    <text>The alteration may cause thermal instability and affect a decrease in transcription of the csgA gene from csglin encoding, which may eventually result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="477">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="478">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="479">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor which resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="480">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="481">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor which resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="482">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="483">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors which resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="484">
                    <text>The alteration may cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="485">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="486">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, which may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="487">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling which finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="488">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF being demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="489">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF which finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="490">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling which has been demonstrated to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="491">
                    <text>The alteration may cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling which is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="492">
                    <text>The alteration may cause thermal instability and affect alternative deflection of a single transcription which may result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="493">
                    <text>The alteration may cause thermal instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, which may ultimately resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="494">
                    <text>The alteration may cause thermal instability and affect alternative exon splicing 139 nt which finally resulted in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="495">
                    <text>The alteration may cause thermal instability and affect alternative of a single transcription cut being demonstrated to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="496">
                    <text>The alteration may cause thermal instability and affect alternative of a single transcription cut which finally resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="497">
                    <text>The alteration may cause thermal instability and affect alternative of a single transcription cut which has been demonstrated to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="498">
                    <text>The alteration may cause thermal instability and affect alternative of a single transcription cut which is observed to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="499">
                    <text>The alteration may cause thermal instability and affect alternative spacer of a single transcription which finally resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="500">
                    <text>The alteration may cause thermal instability and affect alternative splicing of a single transcription which finally resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="501">
                    <text>The alteration may cause thermal instability and affect alternative splicing of a single transcription which resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="502">
                    <text>The alteration may cause thermal instability and affect alternative splicing of a single transcription, which may eventually result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="503">
                    <text>The alteration may cause thermal instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation being demonstrated to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="504">
                    <text>The alteration may cause thermal instability and affect both 5 and 3 splice mutations being demonstrated to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="505">
                    <text>The alteration may cause thermal instability and affect both 5 and 3 splice mutations which may result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="506">
                    <text>The alteration may cause thermal instability and affect both 5 and 3 splice mutations, which may ultimately resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="507">
                    <text>The alteration may cause thermal instability and affect both the mutations at the site of 5 and 3 splices which is observed to result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="508">
                    <text>The alteration may cause thermal instability and affect both the mutations at the site of 5 and 3 splices, which may ultimately resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="509">
                    <text>The alteration may cause thermal instability and affect both the mutations of 5 and 3 splices which finally resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="510">
                    <text>The alteration may cause thermal instability and affect both the mutations of 5 and 3 splices which is observed to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="511">
                    <text>The alteration may cause thermal instability and affect cooperative bonding of the repressor to its two sites which resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="512">
                    <text>The alteration may cause thermal instability and affect decreases the EGL-15 signaling which finally resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="513">
                    <text>The alteration may cause thermal instability and affect decreases the EGL-15 signaling which has been demonstrated to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="514">
                    <text>The alteration may cause thermal instability and affect decreases the EGL-15 signaling, which may ultimately resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="515">
                    <text>The alteration may cause thermal instability and affect decreasing EGL-15 sign which may result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="516">
                    <text>The alteration may cause thermal instability and affect differential encryption which resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="517">
                    <text>The alteration may cause thermal instability and affect differential splicing which has been demonstrated to result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="518">
                    <text>The alteration may cause thermal instability and affect differential splicing which has been demonstrated to result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="519">
                    <text>The alteration may cause thermal instability and affect differential splicing which is observed to result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="520">
                    <text>The alteration may cause thermal instability and affect exon 13 skipping in animals s1031 which resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="521">
                    <text>The alteration may cause thermal instability and affect exon 13 skipping in animals s1031, which may eventually result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="522">
                    <text>The alteration may cause thermal instability and affect expression of Nrf1 isoforms which resulted in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="523">
                    <text>The alteration may cause thermal instability and affect expression of Nrf1 isoforms, which may eventually result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="524">
                    <text>The alteration may cause thermal instability and affect expression of cDNA isoform II DNA in COS7 being demonstrated to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="525">
                    <text>The alteration may cause thermal instability and affect failure to use the normal site of the intron 12 splice donor which is observed to result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="526">
                    <text>The alteration may cause thermal instability and affect liquid charge of the variant subunit which finally resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="527">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains being demonstrated to result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="528">
                    <text>The alteration may cause thermal instability and affect multiple alternative subdomains, which may eventually result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="529">
                    <text>The alteration may cause thermal instability and affect not to use the normal donor site of the intron 12 splice which is observed to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="530">
                    <text>The alteration may cause thermal instability and affect reduced EGL-15 signal which is observed to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="531">
                    <text>The alteration may cause thermal instability and affect reduced EGL-15 signal which may result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="532">
                    <text>The alteration may cause thermal instability and affect reduced signaling by EGL-15 which is observed to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="533">
                    <text>The alteration may cause thermal instability and affect reduced signaling by EGL-15, which may eventually result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="534">
                    <text>The alteration may cause thermal instability and affect reduced transcription of the csgA curlin encoder gene, which may ultimately resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="535">
                    <text>The alteration may cause thermal instability and affect reduced transcription of the csgA gene encoding for the clinic which may result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="536">
                    <text>The alteration may cause thermal instability and affect reduction of EGL-15 signaling which finally resulted in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="537">
                    <text>The alteration may cause thermal instability and affect reduction of EGL-15 signaling which has been demonstrated to result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="538">
                    <text>The alteration may cause thermal instability and affect reduction of EGL-15 signaling which is observed to result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="539">
                    <text>The alteration may cause thermal instability and affect reduction of EGL-15 signaling, which may eventually result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="540">
                    <text>The alteration may cause thermal instability and affect reduction of the EGL-15 signaling which may result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="541">
                    <text>The alteration may cause thermal instability and affect some alternative subdomains which resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="542">
                    <text>The alteration may cause thermal instability and affect the donor place of normal helix of intron 12 could not be used which may result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="543">
                    <text>The alteration may cause thermal instability and affect the donor place of normal helix of intron 12 could not be used, which may ultimately resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="544">
                    <text>The alteration may cause thermal instability and affect the normal docking donor site of intron 12 could not be used, which may ultimately resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="545">
                    <text>The alteration may cause thermal instability and affect the normal donor site of intron 12 donation could not be used which resulted in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="546">
                    <text>The alteration may cause thermal instability and affect the normal site of the intron 12 splice donor could not be used which may result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="547">
                    <text>The alteration may cause thermal instability and affect the normal splice donor site of intron 12 could not be used, which may eventually result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="548">
                    <text>The alteration may cause thermal instability and affect the normal splice donor site of the 12th intron could not be used which may result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="549">
                    <text>The alteration may cause thermal instability and affect the normal splice donor site of the 12th intron could not be used which resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="550">
                    <text>The alteration may cause thermal instability and affect the other three alterations, which may eventually result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="551">
                    <text>The alteration may cause thermal instability and affect the other three mutations which may result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="552">
                    <text>The alteration may cause thermal instability and affect the other three mutations, which may eventually result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="553">
                    <text>The alternative deflection of a single transcription has resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="554">
                    <text>The alternative deflection of a single transcription will result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="555">
                    <text>The alternative deflection of a single transcription, as predicted, has resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="556">
                    <text>The alternative exon 2 exhaustion (139 nt) and alternative transcriptional start and alternative transcriptional initiation, as result in our study, are capable of giving rise to mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="557">
                    <text>The alternative exon 2 exhaustion (139 nt) and alternative transcriptional start has the ability to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="558">
                    <text>The alternative exon 2 exhaustion (139 nt) and alternative transcriptional start resulted in the mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="559">
                    <text>The alternative spacer of a single transcription has the ability to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="560">
                    <text>The alternative splicing of a single transcription and alternative transcriptional initiation, as result in our study, are capable of giving rise to the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="561">
                    <text>The alternative splicing of a single transcription, as predicted, has resulted in the the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="562">
                    <text>The alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation is capable of result rise to mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="563">
                    <text>The alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, has resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="564">
                    <text>The alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, is capable of result rise to mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="565">
                    <text>The both 5 and 3 splice local mutations resulted in the high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="566">
                    <text>The both 5 and 3 splice local mutations will result in the high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="567">
                    <text>The both 5 and 3 splice mutations has resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="568">
                    <text>The both 5 and 3 splice mutations, as predicted, has the ability to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="569">
                    <text>The both the mutations at the site of 5 and 3 splices and alternative transcriptional initiation, as result in our study, are capable of giving rise to of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="570">
                    <text>The both the mutations at the site of 5 and 3 splices has resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="571">
                    <text>The both the mutations at the site of 5 and 3 splices has the ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="572">
                    <text>The both the mutations at the site of 5 and 3 splices is capable of result rise to of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="573">
                    <text>The both the mutations at the site of 5 and 3 splices, as predicted, has the ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="574">
                    <text>The both the mutations of 5 and 3 splices, as predicted, has the ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="575">
                    <text>The change can cause heat instability and affect Decrease Signor of the EGL-15 by being able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="576">
                    <text>The change can cause heat instability and affect Diminutive EGL-15 signal by finally being able to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="577">
                    <text>The change can cause heat instability and affect Diminutive EGL-15 signal which will eventually result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="578">
                    <text>The change can cause heat instability and affect GL-15 Decrease Flag that may have resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="579">
                    <text>The change can cause heat instability and affect GL-15 Decrease Flag which has resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="580">
                    <text>The change can cause heat instability and affect Loading Signor of the EGL-15 which has resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="581">
                    <text>The change can cause heat instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="582">
                    <text>The change can cause heat instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors which can eventually result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="583">
                    <text>The change can cause heat instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors which can result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="584">
                    <text>The change can cause heat instability and affect a decrease in csgA gene transcription from csglin coding by being able to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="585">
                    <text>The change can cause heat instability and affect a decrease in csgA gene transcription from csglin coding which can eventually result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="586">
                    <text>The change can cause heat instability and affect a decrease in transcription of the csgA gene from csglin encoding by finally being able to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="587">
                    <text>The change can cause heat instability and affect a decrease in transcription of the csgA gene from csglin encoding which has finally resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="588">
                    <text>The change can cause heat instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="589">
                    <text>The change can cause heat instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="590">
                    <text>The change can cause heat instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor which can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="591">
                    <text>The change can cause heat instability and affect a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor which eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="592">
                    <text>The change can cause heat instability and affect a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive which eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="593">
                    <text>The change can cause heat instability and affect a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive which resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="594">
                    <text>The change can cause heat instability and affect a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive which will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="595">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development by being able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="596">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development which may eventually have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="597">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="598">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF which has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="599">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor by being able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="600">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor which eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="601">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor which has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="602">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor which has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="603">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors after it has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="604">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="605">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors which will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="606">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="607">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="608">
                    <text>The change can cause heat instability and affect a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor which has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="609">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling after it has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="610">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="611">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="612">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="613">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF after it has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="614">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="615">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF which resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="616">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling by being able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="617">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling which has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="618">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling by finally being able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="619">
                    <text>The change can cause heat instability and affect a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling which may eventually have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="620">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="621">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF which has been shown to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="622">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="623">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF which can eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="624">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF which can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="625">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF which has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="626">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF which will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="627">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling after it has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="628">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling which will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="629">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF which may eventually have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="630">
                    <text>The change can cause heat instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF which resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="631">
                    <text>The change can cause heat instability and affect alternative deflection of a single transcription by being able to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="632">
                    <text>The change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start that may have resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="633">
                    <text>The change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which has resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="634">
                    <text>The change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which may eventually have resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="635">
                    <text>The change can cause heat instability and affect alternative exon 2 exhaustion (139 nt) and alternative transcriptional start which resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="636">
                    <text>The change can cause heat instability and affect alternative exon splicing 139 nt after it has resulted in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="637">
                    <text>The change can cause heat instability and affect alternative of a single transcription cut after it has resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="638">
                    <text>The change can cause heat instability and affect alternative of a single transcription cut by finally being able to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="639">
                    <text>The change can cause heat instability and affect alternative of a single transcription cut that may have resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="640">
                    <text>The change can cause heat instability and affect alternative splicing of a single transcription by finally being able to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="641">
                    <text>The change can cause heat instability and affect alternative splicing of a single transcription that may have resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="642">
                    <text>The change can cause heat instability and affect alternative splicing of a single transcription which can eventually result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="643">
                    <text>The change can cause heat instability and affect alternative splicing of a single transcription which can eventually result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="644">
                    <text>The change can cause heat instability and affect alternative splicing of a single transcription which will eventually result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="645">
                    <text>The change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that may have resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="646">
                    <text>The change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which can eventually result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="647">
                    <text>The change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which eventually resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="648">
                    <text>The change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which has been shown to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="649">
                    <text>The change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation which has finally resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="650">
                    <text>The change can cause heat instability and affect alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, which has resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="651">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations by being able to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="652">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations which eventually resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="653">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations which eventually resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="654">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations which has finally resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="655">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations which will eventually result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="656">
                    <text>The change can cause heat instability and affect both 5 and 3 splice mutations which will eventually result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="657">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices by finally being able to result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="658">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices that may have resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="659">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices which has been shown to result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="660">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices which has resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="661">
                    <text>The change can cause heat instability and affect both the mutations at the site of 5 and 3 splices which will eventually result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="662">
                    <text>The change can cause heat instability and affect both the mutations of 5 and 3 splices by finally being able to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="663">
                    <text>The change can cause heat instability and affect both the mutations of 5 and 3 splices which has finally resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="664">
                    <text>The change can cause heat instability and affect cooperative binding of the repressor to its two sites which will eventually result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="665">
                    <text>The change can cause heat instability and affect declining EGL-15 which eventually resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="666">
                    <text>The change can cause heat instability and affect declining EGL-15 which will eventually result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="667">
                    <text>The change can cause heat instability and affect decreases the EGL-15 signaling by finally being able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="668">
                    <text>The change can cause heat instability and affect decreasing EGL-15 sign after it has resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="669">
                    <text>The change can cause heat instability and affect decreasing EGL-15 sign by being able to result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="670">
                    <text>The change can cause heat instability and affect decreasing EGL-15 sign by finally being able to result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="671">
                    <text>The change can cause heat instability and affect decreasing EGL-15 sign that may have resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="672">
                    <text>The change can cause heat instability and affect differential encryption by finally being able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="673">
                    <text>The change can cause heat instability and affect differential encryption that may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="674">
                    <text>The change can cause heat instability and affect differential encryption which can result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="675">
                    <text>The change can cause heat instability and affect differential encryption which may eventually have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="676">
                    <text>The change can cause heat instability and affect differential splicing by being able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="677">
                    <text>The change can cause heat instability and affect differential splicing by being able to result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="678">
                    <text>The change can cause heat instability and affect differential splicing which may eventually have resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="679">
                    <text>The change can cause heat instability and affect differential splicing which will eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="680">
                    <text>The change can cause heat instability and affect differential splicing which will eventually result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="681">
                    <text>The change can cause heat instability and affect exon 13 skipping in animals s1031 that may have resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="682">
                    <text>The change can cause heat instability and affect exon 13 skipping in animals s1031 which has finally resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="683">
                    <text>The change can cause heat instability and affect expression of Nrf1 isoforms that may have resulted in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="684">
                    <text>The change can cause heat instability and affect expression of Nrf1 isoforms which has resulted in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="685">
                    <text>The change can cause heat instability and affect failure to use the normal donor site of splice of intron 12 that may have resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="686">
                    <text>The change can cause heat instability and affect failure to use the normal donor site of splice of intron 12 which resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="687">
                    <text>The change can cause heat instability and affect failure to use the normal site of the intron 12 splice donor which can result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="688">
                    <text>The change can cause heat instability and affect failure to use the normal site of the intron 12 splice donor which resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="689">
                    <text>The change can cause heat instability and affect growth in ras-dependent signaling by being able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="690">
                    <text>The change can cause heat instability and affect growth in ras-dependent signaling which eventually resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="691">
                    <text>The change can cause heat instability and affect liquid charge of the variant subunit after it has resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="692">
                    <text>The change can cause heat instability and affect liquid charge of the variant subunit that may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="693">
                    <text>The change can cause heat instability and affect mixed alternative subdomains which can eventually result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="694">
                    <text>The change can cause heat instability and affect mixed alternative subdomains which has finally resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="695">
                    <text>The change can cause heat instability and affect multiple alternative subdomains by being able to result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="696">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which can result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="697">
                    <text>The change can cause heat instability and affect multiple alternative subdomains which has finally resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="698">
                    <text>The change can cause heat instability and affect reduced EGL-15 signal after it has resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="699">
                    <text>The change can cause heat instability and affect reduced EGL-15 signal which can result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="700">
                    <text>The change can cause heat instability and affect reduced EGL-15 signal which may eventually have resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="701">
                    <text>The change can cause heat instability and affect reduced EGL-15 signal which resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="702">
                    <text>The change can cause heat instability and affect reduced EGL-15 signal which will eventually result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="703">
                    <text>The change can cause heat instability and affect reduced EGL-15 signaling by being able to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="704">
                    <text>The change can cause heat instability and affect reduced EGL-15 signaling that may have resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="705">
                    <text>The change can cause heat instability and affect reduced EGL-15 signaling which has been shown to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="706">
                    <text>The change can cause heat instability and affect reduced EGL-15 signaling which will eventually result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="707">
                    <text>The change can cause heat instability and affect reduced signaling by EGL-15 by finally being able to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="708">
                    <text>The change can cause heat instability and affect reduced signaling by EGL-15 that may have resulted in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="709">
                    <text>The change can cause heat instability and affect reduced signaling by EGL-15 which may eventually have resulted in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="710">
                    <text>The change can cause heat instability and affect reduced signaling by EGL-15 which resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="711">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA curlin encoder gene which can result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="712">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA curlin encoder gene which resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="713">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA curlin encoder gene which will eventually result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="714">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA gene encoding for curline which resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="715">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA gene encoding for the clinic which eventually resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="716">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA gene encoding for the clinic which eventually resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="717">
                    <text>The change can cause heat instability and affect reduced transcription of the csgA gene encoding for the clinic which resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="718">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling which can eventually result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="719">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling which can eventually result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="720">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling which can result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="721">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling which eventually resulted in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="722">
                    <text>The change can cause heat instability and affect reduction of EGL-15 signaling which eventually resulted in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="723">
                    <text>The change can cause heat instability and affect reduction of the EGL-15 signaling which can result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="724">
                    <text>The change can cause heat instability and affect reduction of the EGL-15 signaling which eventually resulted in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="725">
                    <text>The change can cause heat instability and affect reduction of the EGL-15 signaling which has finally resulted in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="726">
                    <text>The change can cause heat instability and affect reduction of the EGL-15 signaling which may eventually have resulted in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="727">
                    <text>The change can cause heat instability and affect some alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="728">
                    <text>The change can cause heat instability and affect some alternative subdomains which has finally resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="729">
                    <text>The change can cause heat instability and affect the donor place of normal helix of intron 12 could not be used which eventually resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="730">
                    <text>The change can cause heat instability and affect the donor site of the normal helix of intron 12 could not be used which resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="731">
                    <text>The change can cause heat instability and affect the expression of isoforms of Nrf1 by finally being able to result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="732">
                    <text>The change can cause heat instability and affect the expression of isoforms of Nrf1 which will eventually result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="733">
                    <text>The change can cause heat instability and affect the net charge of the variant subunit after it has resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="734">
                    <text>The change can cause heat instability and affect the normal docking donor site of intron 12 could not be used after it has resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="735">
                    <text>The change can cause heat instability and affect the normal docking donor site of intron 12 could not be used by being able to result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="736">
                    <text>The change can cause heat instability and affect the normal docking donor site of intron 12 could not be used which eventually resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="737">
                    <text>The change can cause heat instability and affect the normal docking donor site of intron 12 could not be used which resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="738">
                    <text>The change can cause heat instability and affect the normal docking donor site of intron 12 could not be used which will eventually result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="739">
                    <text>The change can cause heat instability and affect the normal donor site of intron 12 donation could not be used which can result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="740">
                    <text>The change can cause heat instability and affect the normal donor site of intron 12 donation could not be used which eventually resulted in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="741">
                    <text>The change can cause heat instability and affect the normal donor site of intron 12 donation could not be used which has finally resulted in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="742">
                    <text>The change can cause heat instability and affect the normal site of the intron 12 fitting donor could not be used which resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="743">
                    <text>The change can cause heat instability and affect the normal site of the intron 12 splice donor could not be used which has finally resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="744">
                    <text>The change can cause heat instability and affect the normal splice donor site of intron 12 could not be used by being able to result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="745">
                    <text>The change can cause heat instability and affect the normal splice donor site of the 12th intron could not be used that may have resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="746">
                    <text>The change can cause heat instability and affect the normal splice donor site of the 12th intron could not be used which will eventually result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="747">
                    <text>The change can cause heat instability and affect the other three alterations which can eventually result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="748">
                    <text>The change can cause heat instability and affect the place of normal splice donor of intron 12 could not be used after it has resulted in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="749">
                    <text>The change can cause heat instability and affect the place of normal splice donor of intron 12 could not be used which can result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="750">
                    <text>The change can cause heat instability and affect the place of normal splice donor of intron 12 could not be used which has finally resulted in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="751">
                    <text>The change can cause heat instability and affect the place of normal splice donor of intron 12 could not be used which will eventually result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="752">
                    <text>The change can cause thermal instability and affect Diminutive EGL-15 signal and is shown to ultimately result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="753">
                    <text>The change can cause thermal instability and affect Diminutive EGL-15 signal that is observed to finally result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="754">
                    <text>The change can cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="755">
                    <text>The change can cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors and is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="756">
                    <text>The change can cause thermal instability and affect a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that is observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="757">
                    <text>The change can cause thermal instability and affect a decrease in the transcription of csgA coding gene csgA csgA and is shown to finally result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="758">
                    <text>The change can cause thermal instability and affect a decrease in the transcription of csgA coding gene csgA csgA and is shown to ultimately result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="759">
                    <text>The change can cause thermal instability and affect a decrease in transcription of the csgA gene from csglin encoding and is shown to finally result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="760">
                    <text>The change can cause thermal instability and affect a decrease in transcription of the csgA gene from csglin encoding that is observed to finally result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="761">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="762">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive that is observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="763">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="764">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="765">
                    <text>The change can cause thermal instability and affect a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="766">
                    <text>The change can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors and is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="767">
                    <text>The change can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors that is observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="768">
                    <text>The change can cause thermal instability and affect a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="769">
                    <text>The change can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling and is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="770">
                    <text>The change can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling that is observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="771">
                    <text>The change can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF and is shown to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="772">
                    <text>The change can cause thermal instability and affect a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF that is observed to finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="773">
                    <text>The change can cause thermal instability and affect alternative exon splicing 139 nt that is observed to finally result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="774">
                    <text>The change can cause thermal instability and affect alternative splicing of a single transcription and is shown to ultimately result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="775">
                    <text>The change can cause thermal instability and affect both the mutations at the site of 5 and 3 splices that is observed to finally result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="776">
                    <text>The change can cause thermal instability and affect both the mutations at the site of 5 and 3 splices that is observed to finally result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="777">
                    <text>The change can cause thermal instability and affect decreases the EGL-15 signaling and is shown to ultimately result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="778">
                    <text>The change can cause thermal instability and affect differential splicing that is observed to finally result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="779">
                    <text>The change can cause thermal instability and affect expression of cDNA isoform II DNA in COS7 and is shown to ultimately result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="780">
                    <text>The change can cause thermal instability and affect reduced EGL-15 signal and is shown to ultimately result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="781">
                    <text>The change can cause thermal instability and affect reduction of EGL-15 signaling and is shown to finally result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="782">
                    <text>The change can cause thermal instability and affect reduction of csgA gene transcription csgA coding and is shown to ultimately result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="783">
                    <text>The change can cause thermal instability and affect reduction of the EGL-15 signaling and is shown to finally result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="784">
                    <text>The change can cause thermal instability and affect the donor place of normal helix of intron 12 could not be used that is observed to finally result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="785">
                    <text>The change can cause thermal instability and affect the expression of isoforms of Nrf1 and is shown to ultimately result in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="786">
                    <text>The change can cause thermal instability and affect the normal site of the intron 12 splice donor could not be used and is shown to finally result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="787">
                    <text>The change can cause thermal instability and affect the normal site of the intron 12 splice donor could not be used and is shown to ultimately result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="788">
                    <text>The change can cause thermal instability and affect the normal splice donor site of the 12th intron could not be used and is shown to finally result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="789">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in the transcription of the csgA gene from csglin encoding that has the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="790">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed alternative splicing of a single transcription that has the ability to result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="791">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice mutations that has the ability to result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="792">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed cooperative binding of the repressor to its two sites that has the ability to result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="793">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed exon 13 skipping in animals s1031 that has the ability to result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="794">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed growth in ras-dependent signaling that has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="795">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed mixed alternative subdomains that has the ability to result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="796">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that has the ability to result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="797">
                    <text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that has the ability to result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="798">
                    <text>The cooperative binding of the repressor to its two sites is capable of result rise to repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="799">
                    <text>The cooperative bonding of the repressor to its two sites is capable of result rise to repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="800">
                    <text>The cooperative bonding of the repressor to its two sites, as predicted, has the ability to result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="801">
                    <text>The declining EGL-15 and alternative transcriptional initiation, as result in our study, are capable of giving rise to a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="802">
                    <text>The declining EGL-15, as predicted, has resulted in the a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="803">
                    <text>The decreases the EGL-15 signaling and alternative transcriptional initiation, as result in our study, are capable of giving rise to a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="804">
                    <text>The decreases the EGL-15 signaling is capable of result rise to a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="805">
                    <text>The differential encryption has the ability to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="806">
                    <text>The differential encryption will result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="807">
                    <text>The differential splicing is capable of result rise to the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="808">
                    <text>The differential splicing resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="809">
                    <text>The exon 13 skipping in animals s1031 resulted in the a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="810">
                    <text>The exon 13 skipping in animals s1031, as predicted, has the ability to result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="811">
                    <text>The expression of cDNA isoform II DNA in COS7 has resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="812">
                    <text>The failure to use the normal donor site of splice of intron 12 will result in the a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="813">
                    <text>The failure to use the normal site of the intron 12 splice donor resulted in the a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="814">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling resulting in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="815">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Diminutive EGL-15 signal that has the ability to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="816">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Diminutive EGL-15 signal that is able to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="817">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Diminutive EGL-15 signal that may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="818">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Diminutive EGL-15 signal that may result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="819">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed Diminutive EGL-15 signal that was observed to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="820">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed GL-15 Decrease Flag that has the ability to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="821">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed GL-15 Decrease Flag that will result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="822">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that is able to result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="823">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in csgA gene transcription from csglin coding that may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="824">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in the transcription of csgA coding gene csgA csgA and was able to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="825">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in the transcription of csgA coding gene csgA csgA that may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="826">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in the transcription of the csgA gene from csglin encoding that was observed to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="827">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in transcription of the csgA gene encoding csgA that has the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="828">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in transcription of the csgA gene encoding csgA that resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="829">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in transcription of the csgA gene from csglin encoding that has the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="830">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in transcription of the csgA gene from csglin encoding that may have resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="831">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a decrease in transcription of the csgA gene from csglin encoding that may result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="832">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="833">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive that may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="834">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="835">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="836">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="837">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="838">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="839">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="840">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that was observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="841">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF and was able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="842">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="843">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling that may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="844">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="845">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative deflection of a single transcription resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="846">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative deflection of a single transcription that is able to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="847">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start and was able to result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="848">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative exon 2 exhaustion (139 nt) and alternative transcriptional start resulting in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="849">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative of a single transcription cut that may result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="850">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative splicing of a single transcription resulting in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="851">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative splicing of a single transcription that resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="852">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that will result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="853">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice local mutations that was observed to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="854">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both 5 and 3 splice mutations resulting in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="855">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations at the site of 5 and 3 splices resulting in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="856">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations at the site of 5 and 3 splices resulting in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="857">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations at the site of 5 and 3 splices that may have resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="858">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations at the site of 5 and 3 splices that may result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="859">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed both the mutations of 5 and 3 splices that may result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="860">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed cooperative bonding of the repressor to its two sites that resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="861">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed cooperative bonding of the repressor to its two sites that was observed to result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="862">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed declining EGL-15 that may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="863">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreases the EGL-15 signaling and was able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="864">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreases the EGL-15 signaling that may result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="865">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreasing EGL-15 sign that may have resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="866">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreasing EGL-15 sign that resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="867">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreasing EGL-15 signal resulting in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="868">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreasing EGL-15 signal that is able to result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="869">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed decreasing EGL-15 signal that may result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="870">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential encryption resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="871">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential encryption that is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="872">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential encryption that may result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="873">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential splicing that is able to result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="874">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential splicing that resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="875">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential splicing that was observed to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="876">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed differential splicing that was observed to result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="877">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of Nrf1 isoforms resulting in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="878">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of Nrf1 isoforms that resulted in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="879">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed expression of cDNA isoform II DNA in COS7 that may have resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="880">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed failure to use the normal donor site of splice of intron 12 that is able to result in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="881">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed failure to use the normal site of the intron 12 splice donor that may result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="882">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed failure to use the normal site of the intron 12 splice donor that resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="883">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed growth in ras-dependent signaling and was able to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="884">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid charge of the variant subunit resulting in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="885">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed liquid charge of varying subunits that was observed to result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="886">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed mixed alternative subdomains resulting in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="887">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed mixed alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="888">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed mixed alternative subdomains that resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="889">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that has the ability to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="890">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed multiple alternative subdomains that may result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="891">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced EGL-15 signal that is able to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="892">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced EGL-15 signal that was observed to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="893">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced signaling by EGL-15 and was able to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="894">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced signaling by EGL-15 that has the ability to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="895">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA curlin encoder gene that is able to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="896">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA curlin encoder gene that will result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="897">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA gene encoding for curline that may have resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="898">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA gene encoding for curline that was observed to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="899">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduced transcription of the csgA gene encoding for the clinic that resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="900">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of EGL-15 signaling resulting in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="901">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of EGL-15 signaling that may result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="902">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of EGL-15 signaling that was observed to result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="903">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed reduction of EGL-15 signaling that will result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="904">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains resulting in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="905">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed some alternative subdomains that may have resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="906">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the donor place of normal helix of intron 12 could not be used that may result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="907">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the donor site of the normal helix of intron 12 could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="908">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit and was able to result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="909">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit resulting in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="910">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that is able to result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="911">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the net charge of the variant subunit that may have resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="912">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal docking donor site of intron 12 could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="913">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal docking donor site of intron 12 could not be used that may result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="914">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal donor site of intron 12 donation could not be used that was observed to result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="915">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 fitting donor could not be used resulting in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="916">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 fitting donor could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="917">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 fitting donor could not be used that is able to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="918">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 fitting donor could not be used that may have resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="919">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 splice donor could not be used and was able to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="920">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal site of the intron 12 splice donor could not be used that may result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="921">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal splice donor site of intron 12 could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="922">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal splice donor site of intron 12 could not be used that resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="923">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal splice donor site of the 12th intron could not be used and was able to result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="924">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal splice donor site of the 12th intron could not be used resulting in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="925">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal splice donor site of the 12th intron could not be used that is able to result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="926">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the normal splice donor site of the 12th intron could not be used that resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="927">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the other three changes that will result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="928">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the other three mutations that resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="929">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the place of normal splice donor of intron 12 could not be used and was able to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="930">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the place of normal splice donor of intron 12 could not be used that has the ability to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="931">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the place of normal splice donor of intron 12 could not be used that may result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="932">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the place of normal splice donor of intron 12 could not be used that resulted in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="933">
                    <text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed the place of normal splice donor of intron 12 could not be used that will result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="934">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Decrease Signor of the EGL-15 that may result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="935">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Diminutive EGL-15 signal resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="936">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed Diminutive EGL-15 signal that could resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="937">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors which resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="938">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a decrease in the transcription of the csgA gene encoding csgA that could resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="939">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a decrease in the transcription of the csgA gene encoding csgA which resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="940">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a decrease in transcription of the csgA gene from csglin encoding that may result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="941">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor results in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="942">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development which resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="943">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF that could resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="944">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF that may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="945">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="946">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="947">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="948">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors which resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="949">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling that may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="950">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling that may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="951">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF results in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="952">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF results in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="953">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative deflection of a single transcription results in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="954">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative of a single transcription cut which resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="955">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative splicing of a single transcription results in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="956">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative splicing of a single transcription that could resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="957">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed alternative splicing of a single transcription which resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="958">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both 5 and 3 splice local mutations results in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="959">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both 5 and 3 splice mutations results in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="960">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both 5 and 3 splice mutations that may result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="961">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both 5 and 3 splice mutations which resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="962">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations at the site of 5 and 3 splices resulting in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="963">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations at the site of 5 and 3 splices resulting in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="964">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations at the site of 5 and 3 splices results in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="965">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations at the site of 5 and 3 splices that could resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="966">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations at the site of 5 and 3 splices that may result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="967">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations at the site of 5 and 3 splices which resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="968">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed both the mutations of 5 and 3 splices results in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="969">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed declining EGL-15 that may result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="970">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed decreases the EGL-15 signaling that could resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="971">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed decreases the EGL-15 signaling which resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="972">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed decreasing EGL-15 sign that may result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="973">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential encryption results in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="974">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential splicing resulting in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="975">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential splicing that may result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="976">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed differential splicing which resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="977">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed expression of cDNA isoform II DNA in COS7 resulting in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="978">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed failure to use the normal site of the intron 12 splice donor results in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="979">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed not to use the normal donor site of the intron 12 splice resulting in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="980">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed not to use the normal donor site of the intron 12 splice results in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="981">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed not to use the normal donor site of the intron 12 splice which resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="982">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduced EGL-15 signaling which resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="983">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduced signaling by EGL-15 resulting in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="984">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduced signaling by EGL-15 results in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="985">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduced signaling by EGL-15 that could resulted in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="986">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduced signaling by EGL-15 that may result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="987">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of EGL-15 signaling that could resulted in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="988">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed reduction of csgA gene transcription csgA coding that may result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="989">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed some alternative subdomains that could resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="990">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed some alternative subdomains which resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="991">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling had the ability to result in a Clr phenotype.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="992">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Decrease Signor of the EGL-15 could result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="993">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that Diminutive EGL-15 signal had the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="994">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="995">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a decrease in the transcription of csgA coding gene csgA csgA resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="996">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a decrease in transcription of the csgA gene from csglin encoding had the ability to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="997">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="998">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="999">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor had the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1000">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1001">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1002">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling had the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1003">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1004">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF could result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1005">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative of a single transcription cut could result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1006">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that alternative splicing of a single transcription had the ability to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1007">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that both 5 and 3 splice mutations could result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1008">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that both the mutations at the site of 5 and 3 splices had the ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1009">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that both the mutations at the site of 5 and 3 splices resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1010">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that both the mutations of 5 and 3 splices resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1011">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that declining EGL-15 resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1012">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that decreases the EGL-15 signaling had the ability to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1013">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that failure to use the normal donor site of splice of intron 12 resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1014">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that mixed alternative subdomains could result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1015">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that multiple alternative subdomains had the ability to result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1016">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that reduced signaling by EGL-15 had the ability to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1017">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that reduced transcription of the csgA curlin encoder gene could result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1018">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that reduction of EGL-15 signaling could result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1019">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the expression of isoforms of Nrf1 resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1020">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the normal site of the intron 12 splice donor could not be used could result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1021">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the normal site of the intron 12 splice donor could not be used had the ability to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1022">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the other three alterations resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1023">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the other three changes could result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1024">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed that the other three changes had the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1025">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the donor place of normal helix of intron 12 could not be used that could resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1026">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the donor place of normal helix of intron 12 could not be used which resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1027">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the net charge of the variant subunit which resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1028">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the normal docking donor site of intron 12 could not be used resulting in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1029">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the normal site of the intron 12 fitting donor could not be used results in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1030">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the normal site of the intron 12 splice donor could not be used resulting in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1031">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the normal splice donor site of intron 12 could not be used results in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1032">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the normal splice donor site of intron 12 could not be used that could resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1033">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the other three changes that could resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1034">
                    <text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakobs disease (JCD) revealed the other three mutations resulting in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1035">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Decrease Signor of the EGL-15 after having resulted a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1036">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Decrease Signor of the EGL-15 and may result rise to a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1037">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Diminutive EGL-15 signal after having resulted a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1038">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Diminutive EGL-15 signal that resulted in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1039">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes GL-15 Decrease Flag resulted in the complete a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1040">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes GL-15 Decrease Flag that results in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1041">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes Loading Signor of the EGL-15 after having resulted a phenotype of scrawny morphology.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1042">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that are result as entirely a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1043">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a decrease in csgA gene transcription from csglin coding that are result as entirely the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1044">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a decrease in the transcription of csgA coding gene csgA csgA with ability to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1045">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a decrease in the transcription of the csgA gene encoding csgA that results in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1046">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a decrease in the transcription of the csgA gene encoding csgA with ability to entirely result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1047">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a decrease in transcription of the csgA gene encoding csgA after having resulted the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1048">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a decrease in transcription of the csgA gene encoding csgA that resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1049">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a decrease in transcription of the csgA gene from csglin encoding and may result rise to the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1050">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a decrease in transcription of the csgA gene from csglin encoding that are result as entirely the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1051">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF resulted in the complete a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1052">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1053">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1054">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive with ability to entirely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1055">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive and may result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1056">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive with ability to entirely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1057">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive with ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1058">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF and may result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1059">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF with ability to entirely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1060">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF with ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1061">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that are result as entirely a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1062">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF after having resulted a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1063">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling resulted in the complete a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1064">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling resulted in the complete a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1065">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF after having resulted a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1066">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF with ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1067">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative deflection of a single transcription that results in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1068">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative exon 2 exhaustion (139 nt) and alternative transcriptional start and may result rise to mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1069">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative of a single transcription cut after having resulted difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1070">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative splicing of a single transcription after having resulted the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1071">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative splicing of a single transcription that are result as entirely the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1072">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that results in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1073">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both 5 and 3 splice local mutations with ability to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1074">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations at the site of 5 and 3 splices resulted in the complete high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1075">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations at the site of 5 and 3 splices with ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1076">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations at the site of 5 and 3 splices with ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1077">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations of 5 and 3 splices after having resulted of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1078">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes both the mutations of 5 and 3 splices that resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1079">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes cooperative binding of the repressor to its two sites and may result rise to repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1080">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes cooperative binding of the repressor to its two sites with ability to entirely result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1081">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes declining EGL-15 and may result rise to a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1082">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes decreasing EGL-15 signal and may result rise to scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1083">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes decreasing EGL-15 signal resulted in the complete scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1084">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential splicing and may result rise to the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1085">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes differential splicing with ability to entirely result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1086">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of Nrf1 isoforms resulted in the complete this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1087">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes expression of cDNA isoform II DNA in COS7 that resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1088">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes growth in ras-dependent signaling and may result rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1089">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes growth in ras-dependent signaling that resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1090">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid charge of the variant subunit with ability to entirely result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1091">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes liquid charge of varying subunits that are result as entirely an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1092">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes mixed alternative subdomains after having resulted a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1093">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes mixed alternative subdomains with ability to result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1094">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes not to use the normal donor site of the intron 12 splice that are result as entirely a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1095">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic after having resulted negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1096">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic and may result rise to negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1097">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic that resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1098">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic that resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1099">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic with ability to entirely result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1100">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of EGL-15 signaling after having resulted dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1101">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of EGL-15 signaling that results in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1102">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes reduction of csgA gene transcription csgA coding with ability to entirely result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1103">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains with ability to entirely result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1104">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the donor place of normal helix of intron 12 could not be used resulted in the complete a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1105">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the donor place of normal helix of intron 12 could not be used that resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1106">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the donor place of normal helix of intron 12 could not be used with ability to entirely result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1107">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the donor site of the normal helix of intron 12 could not be used after having resulted a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1108">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the expression of isoforms of Nrf1 that are result as entirely this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1109">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the expression of isoforms of Nrf1 that resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1110">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit and may result rise to a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1111">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the net charge of the variant subunit that are result as entirely a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1112">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal docking donor site of intron 12 could not be used after having resulted a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1113">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal docking donor site of intron 12 could not be used that resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1114">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal docking donor site of intron 12 could not be used that results in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1115">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 fitting donor could not be used that are result as entirely a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1116">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 fitting donor could not be used that resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1117">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 fitting donor could not be used with ability to entirely result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1118">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 splice donor could not be used and may result rise to a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1119">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 splice donor could not be used that are result as entirely a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1120">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 splice donor could not be used that results in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1121">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the normal site of the intron 12 splice donor could not be used with ability to entirely result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1122">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the other three alterations that resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1123">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the other three alterations that results in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1124">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the other three mutations that are result as entirely non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1125">
                    <text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes the place of normal splice donor of intron 12 could not be used resulted in the complete a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1126">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes a decrease in transcription of the csgA gene from csglin encoding that are able to completely result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1127">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor that are able to completely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1128">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that are able to completely result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1129">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes both the mutations at the site of 5 and 3 splices that are able to completely result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1130">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes differential splicing that are able to completely result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1131">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes liquid charge of varying subunits that are able to completely result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1132">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes multiple alternative subdomains that are able to completely result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1133">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes reduction of csgA gene transcription csgA coding that are able to completely result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1134">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes some alternative subdomains that are able to completely result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1135">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes the donor place of normal helix of intron 12 could not be used that are able to completely result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1136">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes the normal site of the intron 12 fitting donor could not be used that are able to completely result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1137">
                    <text>The human mucin gene MUC5B, the 10.7 kb central exon, codes the normal splice donor site of the 12th intron could not be used that are able to completely result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1138">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a decrease in the transcription of the csgA gene encoding csgA that has the ability to completely result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1139">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF that has the ability to completely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1140">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor that has the ability to completely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1141">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive that has the ability to completely result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1142">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling that has the ability to completely result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1143">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes reduced transcription of the csgA gene encoding for curline that has the ability to completely result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1144">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes reduction of the EGL-15 signaling that has the ability to completely result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1145">
                    <text>The human mucin gene MUC5B, the 10.7kb central exon, codes the donor place of normal helix of intron 12 could not be used that has the ability to completely result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1146">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes Diminutive EGL-15 signal and is observed to result in a phenotype of scruwny body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1147">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes GL-15 Decrease Flag that can result entirely in a phenotype of scruwny body morphology.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1148">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors and is observed to result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1149">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors that will result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1150">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1151">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a decrease in the transcription of csgA coding gene csgA csgA and is observed to result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1152">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a decrease in the transcription of csgA coding gene csgA csgA that will result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1153">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a decrease in the transcription of the csgA gene encoding csgA that can result entirely in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1154">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1155">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive and is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1156">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1157">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive that can result entirely in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1158">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that can result entirely in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1159">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1160">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1161">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors and is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1162">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling and is observed to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1163">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling that will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1164">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative of a single transcription cut and is observed to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1165">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative of a single transcription cut that can result entirely in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1166">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative of a single transcription cut that resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1167">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative of a single transcription cut that will result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1168">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative spacer of a single transcription that resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1169">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative splicing of a single transcription and is observed to result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1170">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes both 5 and 3 splice mutations that can result entirely in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1171">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes cooperative binding of the repressor to its two sites and is observed to result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1172">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes cooperative bonding of the repressor to its two sites and is observed to result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1173">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes cooperative bonding of the repressor to its two sites that will result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1174">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes decreases the EGL-15 signaling that can result entirely in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1175">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes decreasing EGL-15 signal that will result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1176">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes differential splicing that resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1177">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes differential splicing that will result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1178">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes liquid charge of varying subunits and is observed to result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1179">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes multiple alternative subdomains that resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1180">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes not to use the normal donor site of the intron 12 splice that resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1181">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduced EGL-15 signal that will result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1182">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduced signaling by EGL-15 and is observed to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1183">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduced transcription of the csgA curlin encoder gene and is observed to result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1184">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduced transcription of the csgA curlin encoder gene that resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1185">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic that can result entirely in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1186">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduced transcription of the csgA gene encoding for the clinic that will result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1187">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduction of EGL-15 signaling that can result entirely in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1188">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes reduction of csgA gene transcription csgA coding and is observed to result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1189">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the normal docking donor site of intron 12 could not be used and is observed to result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1190">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the normal site of the intron 12 splice donor could not be used that resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1191">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the normal splice donor site of intron 12 could not be used and is observed to result in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1192">
                    <text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes the place of normal splice donor of intron 12 could not be used that resulted in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1193">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes Diminutive EGL-15 signal that has the ability to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1194">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes Diminutive EGL-15 signal that resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1195">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1196">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1197">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor that resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1198">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF that has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1199">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative deflection of a single transcription that resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1200">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative of a single transcription cut that has the ability to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1201">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative of a single transcription cut that resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1202">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative spacer of a single transcription that has the ability to result in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1203">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative spacer of a single transcription that resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1204">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes alternative splicing of a single transcription that has the ability to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1205">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes both the mutations at the site of 5 and 3 splices that has the ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1206">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes both the mutations of 5 and 3 splices that has the ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1207">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes declining EGL-15 that resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1208">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes decreasing EGL-15 sign that resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1209">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes differential splicing that has the ability to result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1210">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes exon 13 skipping in animals s1031 that has the ability to result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1211">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes liquid charge of varying subunits that has the ability to result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1212">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes multiple alternative subdomains that resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1213">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes reduced signaling by EGL-15 that has the ability to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1214">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes reduction of EGL-15 signaling that has the ability to result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1215">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes reduction of csgA gene transcription csgA coding that resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1216">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the donor site of the normal helix of intron 12 could not be used that resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1217">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the expression of isoforms of Nrf1 that resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1218">
                    <text>The human mucin gene MUC5B, the central exon of 10.7kb, codes the net charge of the variant subunit that has the ability to result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1219">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Decrease Signor of the EGL-15 which may have resulted entirely in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">Decrease Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1220">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes Diminutive EGL-15 signal that result able to give rise to a phenotype of scrawny morphology.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1221">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors which may have resulted entirely in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1222">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a decrease in the transcription of the csgA gene encoding csgA that resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1223">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a decrease in the transcription of the csgA gene from csglin encoding that resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1224">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a decrease in transcription of the csgA gene encoding csgA which may have resulted entirely in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1225">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF that result able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1226">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive that result able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1227">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1228">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development which may have resulted entirely in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1229">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that result able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1230">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1231">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF that resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1232">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative deflection of a single transcription which may have resulted entirely in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1233">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative exon splicing 139 nt that result able to give rise to mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1234">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative of a single transcription cut that may have resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1235">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative splicing of a single transcription that may have resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1236">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation that resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1237">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, which may have resulted entirely in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1238">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes both 5 and 3 splice local mutations which may have resulted entirely in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1239">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes both 5 and 3 splice mutations that result able to give rise to high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1240">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes both the mutations at the site of 5 and 3 splices that result able to give rise to of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1241">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes both the mutations of 5 and 3 splices that result able to give rise to of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1242">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes cooperative bonding of the repressor to its two sites which may have resulted entirely in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1243">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes decreasing EGL-15 signal which may have resulted entirely in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1244">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes differential splicing that resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1245">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes exon 13 skipping in animals s1031 which may have resulted entirely in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1246">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes expression of Nrf1 isoforms that result able to give rise to this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1247">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes failure to use the normal donor site of splice of intron 12 that may have resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1248">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes failure to use the normal site of the intron 12 splice donor which may have resulted entirely in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1249">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes liquid charge of the variant subunit that may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1250">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes not to use the normal donor site of the intron 12 splice that resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1251">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduced EGL-15 signal that result able to give rise to a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1252">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduced EGL-15 signal that resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1253">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduced transcription of the csgA gene encoding for the clinic which may have resulted entirely in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1254">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes reduction of EGL-15 signaling that resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1255">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes some alternative subdomains that resulted in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1256">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes some alternative subdomains which may have resulted entirely in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1257">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the donor place of normal helix of intron 12 could not be used that result able to give rise to a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1258">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the donor site of the normal helix of intron 12 could not be used that resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1259">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the normal site of the intron 12 fitting donor could not be used that may have resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1260">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the normal splice donor site of the 12th intron could not be used that result able to give rise to a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1261">
                    <text>The human mucin gene MUC5B, the great 10.7kb of central exon codes the other three mutations that resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1262">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors that will result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1263">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1264">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1265">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors that will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1266">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling that will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1267">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes both the mutations at the site of 5 and 3 splices that will result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1268">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes both the mutations of 5 and 3 splices that will result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1269">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes cooperative binding of the repressor to its two sites that will result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1270">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes growth in ras-dependent signaling that will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1271">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes liquid charge of the variant subunit that will result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1272">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes liquid charge of varying subunits that will result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1273">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes mixed alternative subdomains that will result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1274">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes reduced transcription of the csgA gene encoding for curline that will result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1275">
                    <text>The human mucin gene MUC5B, the large 10.7kb of central exon codes the donor site of the normal helix of intron 12 could not be used that will result in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1276">
                    <text>The liquid charge of the variant subunit has resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1277">
                    <text>The liquid charge of the variant subunit may have resulted in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1278">
                    <text>The liquid charge of varying subunits and alternative transcriptional initiation, as result in our study, are capable of giving rise to an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1279">
                    <text>The liquid charge of varying subunits has resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1280">
                    <text>The liquid charge of varying subunits has the ability to result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1281">
                    <text>The mixed alternative subdomains, as predicted, has the ability to result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1282">
                    <text>The multiple alternative subdomains and alternative transcriptional initiation, as result in our study, are capable of giving rise to superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1283">
                    <text>The multiple alternative subdomains may have resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1284">
                    <text>The multiple alternative subdomains, as predicted, has the ability to result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1285">
                    <text>The not to use the normal donor site of the intron 12 splice is capable of result rise to a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1286">
                    <text>The not to use the normal donor site of the intron 12 splice will result in the a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1287">
                    <text>The reduced EGL-15 signaling may have resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1288">
                    <text>The reduced EGL-15 signaling will result in the a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1289">
                    <text>The reduced signaling by EGL-15 has the ability to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1290">
                    <text>The reduced signaling by EGL-15 is capable of result rise to pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1291">
                    <text>The reduced signaling by EGL-15 resulted in the a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1292">
                    <text>The reduced signaling by EGL-15, as predicted, has the ability to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1293">
                    <text>The reduced transcription of the csgA curlin encoder gene will result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1294">
                    <text>The reduced transcription of the csgA gene encoding for curline is capable of result rise to negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1295">
                    <text>The reduced transcription of the csgA gene encoding for curline will result in the negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1296">
                    <text>The reduced transcription of the csgA gene encoding for the clinic is capable of result rise to negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1297">
                    <text>The reduced transcription of the csgA gene encoding for the clinic resulted in the negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1298">
                    <text>The reduction of EGL-15 signaling and alternative transcriptional initiation, as result in our study, are capable of giving rise to a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1299">
                    <text>The reduction of EGL-15 signaling may have resulted in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1300">
                    <text>The reduction of EGL-15 signaling, as predicted, has the ability to result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1301">
                    <text>The reduction of csgA gene transcription csgA coding, as predicted, has resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1302">
                    <text>The reduction of the EGL-15 signaling will result in the bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1303">
                    <text>The research shows a Clr phenotype resulting from A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1304">
                    <text>The research shows a Clr phenotype resulting from a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1305">
                    <text>The research shows a Clr phenotype resulting from a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1306">
                    <text>The research shows a phenotype of dirty body morphology resulting from reduced EGL-15 signaling.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1307">
                    <text>The research shows a variant resulting from failure to use the normal site of the intron 12 splice donor.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1308">
                    <text>The research shows a variant resulting from the donor place of normal helix of intron 12 could not be used.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1309">
                    <text>The research shows an electrophoretic subunit of fast-type LDH-B subunits resulting from liquid charge of the variant subunit.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1310">
                    <text>The research shows high ratios of mature RNAm containing introns resulting from both 5 and 3 splice local mutations.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1311">
                    <text>The research shows mRNA species with different 5UTRs resulting from alternative exon 2 exhaustion (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1312">
                    <text>The research shows of high proportion of mature mRNA containing introns resulting from both the mutations at the site of 5 and 3 splices.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1313">
                    <text>The research shows scratched body morphology phenotype resulting from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1314">
                    <text>The research shows scrutinic body morphology phenotype resulting from decreasing EGL-15 sign.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1315">
                    <text>The research shows the negative effect of the mutation cpxA resulting from a decrease in transcription of the csgA gene from csglin encoding.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1316">
                    <text>The sequence analysis of the HDIbeta gene indicates that a Clr phenotype has the ability to result from A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling.</text>
                    <arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1317">
                    <text>The sequence analysis of the HDIbeta gene indicates that a Clr phenotype has the ability to result from a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1318">
                    <text>The sequence analysis of the HDIbeta gene indicates that a Clr phenotype has the ability to result from a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1319">
                    <text>The sequence analysis of the HDIbeta gene indicates that a fast-type electrophoretic subunit LDH-B of variant has the ability to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1320">
                    <text>The sequence analysis of the HDIbeta gene indicates that a phenotype of scrubbing body morphology has the ability to result from Diminutive EGL-15 signal.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1321">
                    <text>The sequence analysis of the HDIbeta gene indicates that an electrophoretic subunit of fast LDH-B subunits has the ability to result from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1322">
                    <text>The sequence analysis of the HDIbeta gene indicates that difference in the 28 C-terminal amino acids between beta(1) and beta(2) has the ability to result from alternative deflection of a single transcription.</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1323">
                    <text>The sequence analysis of the HDIbeta gene indicates that mRNA species with different 5UTRs has the ability to result from alternative exon 2 exhaustion (139 nt) and alternative transcriptional start.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1324">
                    <text>The sequence analysis of the HDIbeta gene indicates that negative effect of the mutation cpxA has the ability to result from reduced transcription of the csgA curlin encoder gene.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1325">
                    <text>The sequence analysis of the HDIbeta gene indicates that negative mutation effect cpxA has the ability to result from reduced transcription of the csgA gene encoding for the clinic.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1326">
                    <text>The sequence analysis of the HDIbeta gene indicates that non-functional truncated proteins has the ability to result from the other three mutations.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1327">
                    <text>The sequence analysis of the HDIbeta gene indicates that of high proportion of mature mRNA containing introns has the ability to result from both the mutations at the site of 5 and 3 splices.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1328">
                    <text>The sequence analysis of the HDIbeta gene indicates that the negative effect of the mutation cpxA has the ability to result from a decrease in transcription of the csgA gene encoding csgA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1329">
                    <text>The some alternative subdomains and alternative transcriptional initiation, as result in our study, are capable of giving rise to a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1330">
                    <text>The the expression of isoforms of Nrf1 is capable of result rise to this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1331">
                    <text>The the expression of isoforms of Nrf1 resulted in the this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1332">
                    <text>The the normal site of the intron 12 fitting donor could not be used is capable of result rise to a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1333">
                    <text>The the normal splice donor site of intron 12 could not be used and alternative transcriptional initiation, as result in our study, are capable of giving rise to a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1334">
                    <text>The the other three changes, as predicted, has resulted in the non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1335">
                    <text>The the other three changes, as predicted, has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1336">
                    <text>The the other three mutations has resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1337">
                    <text>The the other three mutations resulted in the non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1338">
                    <text>The the place of normal splice donor of intron 12 could not be used, as predicted, has resulted in the a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1339">
                    <text>The the place of normal splice donor of intron 12 could not be used, as predicted, has the ability to result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1340">
                    <text>We also report a Clr phenotype that may have resulted from a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1341">
                    <text>We also report a Clr phenotype that may have resulted from a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1342">
                    <text>We also report a fast-type electrophoretic subunit LDH-B of variant that may have resulted from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1343">
                    <text>We also report an electrophoretic subunit of fast LDH-B subunits that may have resulted from liquid charge of varying subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1344">
                    <text>We also report difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription) that may have resulted from alternative spacer of a single transcription.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1345">
                    <text>We also report existence of NF-YA isoforms that may have resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1346">
                    <text>We also report of high proportion of mature mRNA containing introns that may have resulted from both the mutations at the site of 5 and 3 splices.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1347">
                    <text>We also report repression that may have resulted from cooperative binding of the repressor to its two sites.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1348">
                    <text>We also report the a Clr phenotype with the capability to result from a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1349">
                    <text>We also report the a Clr phenotype with the capability to result from a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1350">
                    <text>We also report the a Clr phenotype with the capability to result from a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1351">
                    <text>We also report the a Clr phenotype with the capability to result from a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1352">
                    <text>We also report the a dirty body morphology phenotype with the capability to result from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1353">
                    <text>We also report the a phenotype of scrawny morphology with the capability to result from reduced EGL-15 signal.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1354">
                    <text>We also report the a variant with the capability to result from failure to use the normal donor site of splice of intron 12.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1355">
                    <text>We also report the a variant with the capability to result from the normal site of the intron 12 fitting donor could not be used.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1356">
                    <text>We also report the high proportion of mature RNA containing introns with the capability to result from both 5 and 3 splice mutations.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1357">
                    <text>We also report the mRNA species with different 5UTRs with the capability to result from alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1358">
                    <text>We also report the non-functional truncated proteins with the capability to result from the other three changes.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1359">
                    <text>We also report the of high proportion of mature mRNAs containing introns with the capability to result from both the mutations of 5 and 3 splices.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1360">
                    <text>We also report the scratched body morphology phenotype with the capability to result from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1361">
                    <text>We also report the superrepetition with the capability to result from multiple alternative subdomains.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1362">
                    <text>We also report the the existence of NF-YA isoforms with the capability to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1363">
                    <text>We also report the the negative effect of cpxA mutation with the capability to result from a decrease in csgA gene transcription from csglin coding.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1364">
                    <text>We also reported that a Clr phenotype is able to result from a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1365">
                    <text>We also reported that a fast-type electrophoretic subunit LDH-B of variant is able to result from the net charge of the variant subunit.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1366">
                    <text>We also reported that a phenotype of scrubbing body morphology is able to result from Diminutive EGL-15 signal.</text>
                    <arg n="0">Diminutive EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1367">
                    <text>We also reported that a phenotype of scrubbing body morphology is able to result from declining EGL-15.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1368">
                    <text>We also reported that a variant is able to result from the donor site of the normal helix of intron 12 could not be used.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1369">
                    <text>We also reported that high proportion of mature RNA containing introns is able to result from both 5 and 3 splice mutations.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1370">
                    <text>a Clr phenotype has the ability to probably result from a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1371">
                    <text>a Clr phenotype has the ability to probably result from a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1372">
                    <text>a Clr phenotype has the ability to result from a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1373">
                    <text>a Clr phenotype has the ability to result from a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1374">
                    <text>a Clr phenotype was able to result from a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1375">
                    <text>a Clr phenotype was also reported to be able to result from a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1376">
                    <text>a Clr phenotype was also reported to be able to result from a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1377">
                    <text>a Clr phenotype was also reported to be able to result from a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1378">
                    <text>a Clr phenotype was also reported to be able to result from a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1379">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors finally resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1380">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors resulted in a Clr phenotype .</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1381">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1382">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors, as we have predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1383">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors cells is eventually able to result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1384">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1385">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors may eventually result in a Clr phenotype</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1386">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors may have resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1387">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors may result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1388">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1389">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors will eventually result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1390">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors will result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1391">
                    <text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors, as predicted, can result in a Clr phenotype.</text>
                    <arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1392">
                    <text>a decrease in csgA gene transcription from csglin coding cells may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1393">
                    <text>a decrease in csgA gene transcription from csglin coding will eventually result in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1394">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA can ultimately resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1395">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA cells may have resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1396">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA finally resulted in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1397">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA may eventually result in the negative effect of cpxA mutation</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1398">
                    <text>a decrease in the transcription of csgA coding gene csgA csgA, as we have predicted, is likely to resulting in the negative effect of cpxA mutation.</text>
                    <arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1399">
                    <text>a decrease in the transcription of the csgA gene encoding csgA finally resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1400">
                    <text>a decrease in the transcription of the csgA gene encoding csgA is able to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1401">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding can eventually result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1402">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding can ultimately resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1403">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding cells can result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1404">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding cells eventually resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1405">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding is capable of result rise to the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1406">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding is shown to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1407">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding may ultimately resulted in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1408">
                    <text>a decrease in the transcription of the csgA gene from csglin encoding resulted in the negative effect of the mutation cpxA .</text>
                    <arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1409">
                    <text>a decrease in transcription of the csgA gene encoding csgA is able to result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1410">
                    <text>a decrease in transcription of the csgA gene encoding csgA may ultimately result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1411">
                    <text>a decrease in transcription of the csgA gene encoding csgA will result in the negative effect of the mutation cpxA .</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1412">
                    <text>a decrease in transcription of the csgA gene encoding csgA, as predicted, will result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1413">
                    <text>a decrease in transcription of the csgA gene encoding csgA, as we have predicted, may result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1414">
                    <text>a decrease in transcription of the csgA gene encoding csgA, as we have result, is able to give rise to the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1415">
                    <text>a decrease in transcription of the csgA gene from csglin encoding may eventually result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1416">
                    <text>a decrease in transcription of the csgA gene from csglin encoding resulted in the negative effect of the mutation cpxA .</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1417">
                    <text>a decrease in transcription of the csgA gene from csglin encoding, as predicted, can result in the negative effect of the mutation cpxA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1418">
                    <text>a dirty body morphology phenotype was also reported to be able to result from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1419">
                    <text>a marked increase in acetylhydrolase activity PAF has the ability to result from expression of cDNA isoform II DNA in COS7.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1420">
                    <text>a phenotype of dirty body morphology has the ability to probably result from reduced signaling by EGL-15.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1421">
                    <text>a phenotype of dirty body morphology has the ability to result from reduced signaling by EGL-15.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1422">
                    <text>a phenotype of scrawny morphology was able to result from Loading Signor of the EGL-15.</text>
                    <arg n="0">Loading Signor of the EGL-15</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1423">
                    <text>a phenotype of scrawny morphology was also reported to be able to result from reduced EGL-15 signal.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1424">
                    <text>a phenotype of scruwny body morphology was able to result from GL-15 Decrease Flag.</text>
                    <arg n="0">GL-15 Decrease Flag</arg>
                    <arg n="1">a phenotype of scruwny body morphology</arg>
                </example>
                <example src="REPLACE" no="1425">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF cells has the ability to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1426">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1427">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF is capable of result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1428">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF resulted in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1429">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1430">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF will finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1431">
                    <text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, as we have predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1432">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF can ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1433">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF cells has the ability to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1434">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF cells may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1435">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF has resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1436">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF may eventually result in a Clr phenotype</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1437">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF may have finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1438">
                    <text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF, as we have predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1439">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor is likely to resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1440">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1441">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor may eventually result in a Clr phenotype</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1442">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor may eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1443">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, as predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1444">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, as we have predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1445">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, as we have predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1446">
                    <text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, as we have predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1447">
                    <text>a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1448">
                    <text>a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive, as we have predicted, is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1449">
                    <text>a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive, as we have predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1450">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development can eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1451">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development can ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1452">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development cells can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1453">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development cells eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1454">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development is capable of result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1455">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development may have finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1456">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1457">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development resulted in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1458">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1459">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development, as we have predicted, may resulting in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1460">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1461">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1462">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive is capable of result rise to a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1463">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF cells may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1464">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1465">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF may eventually result in a Clr phenotype</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1466">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1467">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1468">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor cells has the ability to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1469">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor cells may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1470">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1471">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1472">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor may eventually result in a Clr phenotype</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1473">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor, as predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1474">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1475">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors cells may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1476">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1477">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors will finally result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1478">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors, as we have predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1479">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor cells can result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1480">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor may result in a Clr phenotype .</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1481">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor resulted in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1482">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor, as we have predicted, is able to result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1483">
                    <text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor, as we have predicted, may result in a Clr phenotype.</text>
                    <arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1484">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling cells eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1485">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling cells has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1486">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling cells has the ability to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1487">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling is shown to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1488">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1489">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1490">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, as predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1491">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, as predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1492">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling, as we have predicted, may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1493">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1494">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors is likely to resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1495">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors may eventually result in a Clr phenotype</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1496">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors may ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1497">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors, as we have result, is able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1498">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF cells has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1499">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF cells has the ability to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1500">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1501">
                    <text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, as predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1502">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling cells may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1503">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1504">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1505">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1506">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1507">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling will eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1508">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling will result in a Clr phenotype .</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1509">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling, as we have predicted, may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1510">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling, as we have predicted, will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1511">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling will result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1512">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling, as we have predicted, is able to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1513">
                    <text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling, as we have predicted, may resulting in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1514">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF can eventually result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1515">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1516">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1517">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF will result in a Clr phenotype .</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1518">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF, as predicted, can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1519">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF, as we have predicted, may result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1520">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF, as we have predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1521">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF cells has the ability to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1522">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF eventually resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1523">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1524">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1525">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF may have finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1526">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF, as predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1527">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF, as we have predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1528">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling cells can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1529">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling cells has resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1530">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling cells may have resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1531">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling has finally resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1532">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1533">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling is shown to ultimately result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1534">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling will finally result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1535">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling, as we have predicted, has the ability to result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1536">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling, as we have predicted, resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1537">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1538">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF may ultimately resulted in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1539">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF, as predicted, can result in a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1540">
                    <text>a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF, as we have result, is able to give rise to a Clr phenotype.</text>
                    <arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="REPLACE" no="1541">
                    <text>a superrepetitor has the ability to probably result from some alternative subdomains.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1542">
                    <text>a superrepetitor was able to result from mixed alternative subdomains.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1543">
                    <text>a superrepetitor was also reported to be able to result from some alternative subdomains.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1544">
                    <text>a variant has the ability to result from not to use the normal donor site of the intron 12 splice.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1545">
                    <text>a variant has the ability to result from the normal docking donor site of intron 12 could not be used.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1546">
                    <text>a variant was able to result from the normal site of the intron 12 fitting donor could not be used.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1547">
                    <text>a variant was also reported to be able to result from failure to use the normal donor site of splice of intron 12.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1548">
                    <text>a variant was also reported to be able to result from failure to use the normal site of the intron 12 splice donor.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1549">
                    <text>a variant was also reported to be able to result from the normal splice donor site of the 12th intron could not be used.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1550">
                    <text>alternative deflection of a single transcription has finally resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1551">
                    <text>alternative deflection of a single transcription, as we have predicted, is likely to resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1552">
                    <text>alternative deflection of a single transcription, as we have predicted, may resulting in difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative deflection of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1553">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may eventually result in mRNA species with different 5UTRs</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1554">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start will result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1555">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, as we have predicted, is likely to resulting in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1556">
                    <text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start, as we have predicted, will result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1557">
                    <text>alternative exon splicing 139 nt has the ability to result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1558">
                    <text>alternative exon splicing 139 nt is able to result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1559">
                    <text>alternative exon splicing 139 nt is capable of result rise to mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1560">
                    <text>alternative exon splicing 139 nt may result in mRNA species with 5 distinct UTRs .</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1561">
                    <text>alternative exon splicing 139 nt, as we have predicted, is able to result in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1562">
                    <text>alternative exon splicing 139 nt, as we have predicted, is likely to resulting in mRNA species with 5 distinct UTRs.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1563">
                    <text>alternative of a single transcription cut cells eventually resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1564">
                    <text>alternative of a single transcription cut cells has resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1565">
                    <text>alternative of a single transcription cut cells may have resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1566">
                    <text>alternative of a single transcription cut is shown to result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1567">
                    <text>alternative of a single transcription cut may eventually result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1568">
                    <text>alternative of a single transcription cut may result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut) .</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1569">
                    <text>alternative of a single transcription cut may result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1570">
                    <text>alternative of a single transcription cut will finally result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
                </example>
                <example src="REPLACE" no="1571">
                    <text>alternative of a single transcription cut will result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) .</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1572">
                    <text>alternative of a single transcription cut will result in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1573">
                    <text>alternative of a single transcription cut, as we have predicted, may have resulted in difference in C-terminal 28 amino acids between proteins beta(1) and beta(2).</text>
                    <arg n="0">alternative of a single transcription cut</arg>
                    <arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1574">
                    <text>alternative spacer of a single transcription cells eventually resulted in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1575">
                    <text>alternative spacer of a single transcription may result in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription) .</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1576">
                    <text>alternative spacer of a single transcription may ultimately result in difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription).</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1577">
                    <text>alternative splicing of a single transcription can eventually result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1578">
                    <text>alternative splicing of a single transcription eventually resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1579">
                    <text>alternative splicing of a single transcription finally resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1580">
                    <text>alternative splicing of a single transcription has the ability to eventually result in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1581">
                    <text>alternative splicing of a single transcription is likely to resulting in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1582">
                    <text>alternative splicing of a single transcription resulted in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1583">
                    <text>alternative splicing of a single transcription will result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1584">
                    <text>alternative splicing of a single transcription, as predicted, may have resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1585">
                    <text>alternative splicing of a single transcription, as predicted, resulted in the difference in the 28 C-terminal amino acids between beta(1) and beta(2).</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
                </example>
                <example src="REPLACE" no="1586">
                    <text>alternative splicing of a single transcription, as predicted, will result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1587">
                    <text>alternative splicing of a single transcription, as we have predicted, is able to result in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1588">
                    <text>alternative splicing of a single transcription, as we have predicted, may resulting in the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins.</text>
                    <arg n="0">alternative splicing of a single transcription</arg>
                    <arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
                </example>
                <example src="REPLACE" no="1589">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, cells eventually resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1590">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, cells has resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1591">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, has resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1592">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, may eventually result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1593">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, may result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1594">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, will eventually result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1595">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,, as predicted, resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1596">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,, as we have predicted, may result in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1597">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as we have predicted, may have resulted in mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1598">
                    <text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as we have result, is able to give rise to mRNA species with different 5UTRs.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1599">
                    <text>an electrophoretic subunit of fast-type LDH-B subunits was also reported to be able to result from liquid charge of the variant subunit.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1600">
                    <text>both 5 and 3 splice local mutations can eventually result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1601">
                    <text>both 5 and 3 splice local mutations can result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1602">
                    <text>both 5 and 3 splice local mutations cells is eventually able to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1603">
                    <text>both 5 and 3 splice local mutations finally resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1604">
                    <text>both 5 and 3 splice local mutations has finally resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1605">
                    <text>both 5 and 3 splice local mutations, as we have predicted, may have resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1606">
                    <text>both 5 and 3 splice local mutations, as we have predicted, will result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1607">
                    <text>both 5 and 3 splice mutations cells can result in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1608">
                    <text>both 5 and 3 splice mutations cells has resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1609">
                    <text>both 5 and 3 splice mutations cells may have resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1610">
                    <text>both 5 and 3 splice mutations is likely to resulting in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1611">
                    <text>both 5 and 3 splice mutations may result in high proportion of mature RNA containing introns .</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1612">
                    <text>both 5 and 3 splice mutations may ultimately resulted in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1613">
                    <text>both 5 and 3 splice mutations, as predicted, may have resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1614">
                    <text>both 5 and 3 splice mutations, as we have predicted, has the ability to result in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1615">
                    <text>both 5 and 3 splice mutations, as we have predicted, may resulting in high ratios of mature RNAm containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1616">
                    <text>both 5 and 3 splice mutations, as we have predicted, resulted in high proportion of mature RNA containing introns.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1617">
                    <text>both the mutations at the site of 5 and 3 splices can result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1618">
                    <text>both the mutations at the site of 5 and 3 splices can result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1619">
                    <text>both the mutations at the site of 5 and 3 splices cells eventually resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1620">
                    <text>both the mutations at the site of 5 and 3 splices cells has resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1621">
                    <text>both the mutations at the site of 5 and 3 splices cells is eventually able to result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1622">
                    <text>both the mutations at the site of 5 and 3 splices cells may have resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1623">
                    <text>both the mutations at the site of 5 and 3 splices cells may have resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1624">
                    <text>both the mutations at the site of 5 and 3 splices cells may have resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1625">
                    <text>both the mutations at the site of 5 and 3 splices eventually resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1626">
                    <text>both the mutations at the site of 5 and 3 splices eventually resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1627">
                    <text>both the mutations at the site of 5 and 3 splices has the ability to eventually result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1628">
                    <text>both the mutations at the site of 5 and 3 splices has the ability to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1629">
                    <text>both the mutations at the site of 5 and 3 splices is able to result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1630">
                    <text>both the mutations at the site of 5 and 3 splices is capable of result rise to high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1631">
                    <text>both the mutations at the site of 5 and 3 splices is shown to ultimately result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1632">
                    <text>both the mutations at the site of 5 and 3 splices may eventually result in of high proportion of mature mRNA containing introns</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1633">
                    <text>both the mutations at the site of 5 and 3 splices may ultimately result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1634">
                    <text>both the mutations at the site of 5 and 3 splices, as predicted, resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1635">
                    <text>both the mutations at the site of 5 and 3 splices, as predicted, will result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1636">
                    <text>both the mutations at the site of 5 and 3 splices, as we have predicted, is able to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1637">
                    <text>both the mutations at the site of 5 and 3 splices, as we have predicted, may result in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1638">
                    <text>both the mutations at the site of 5 and 3 splices, as we have predicted, may result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1639">
                    <text>both the mutations at the site of 5 and 3 splices, as we have predicted, resulted in high-proportion mature mRNA containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">high-proportion mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1640">
                    <text>both the mutations at the site of 5 and 3 splices, as we have predicted, resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1641">
                    <text>both the mutations at the site of 5 and 3 splices, as we have result, is able to give rise to of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1642">
                    <text>both the mutations of 5 and 3 splices cells eventually resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1643">
                    <text>both the mutations of 5 and 3 splices cells is eventually able to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1644">
                    <text>both the mutations of 5 and 3 splices cells is eventually able to result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1645">
                    <text>both the mutations of 5 and 3 splices eventually resulted in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1646">
                    <text>both the mutations of 5 and 3 splices has finally resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1647">
                    <text>both the mutations of 5 and 3 splices is capable of result rise to of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1648">
                    <text>both the mutations of 5 and 3 splices is likely to resulting in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1649">
                    <text>both the mutations of 5 and 3 splices may eventually result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1650">
                    <text>both the mutations of 5 and 3 splices may ultimately result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1651">
                    <text>both the mutations of 5 and 3 splices will eventually result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1652">
                    <text>both the mutations of 5 and 3 splices will finally result in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1653">
                    <text>both the mutations of 5 and 3 splices will result in of high proportion of mature mRNAs containing introns .</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1654">
                    <text>both the mutations of 5 and 3 splices, as predicted, resulted in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1655">
                    <text>both the mutations of 5 and 3 splices, as we have predicted, has the ability to result in of high proportion of mature mRNA containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1656">
                    <text>both the mutations of 5 and 3 splices, as we have predicted, is likely to resulting in of high proportion of mature mRNAs containing introns.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1657">
                    <text>cooperative binding of the repressor to its two sites is capable of result rise to repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1658">
                    <text>cooperative binding of the repressor to its two sites is shown to ultimately result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1659">
                    <text>cooperative binding of the repressor to its two sites may result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1660">
                    <text>cooperative binding of the repressor to its two sites resulted in repression .</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1661">
                    <text>cooperative binding of the repressor to its two sites, as we have predicted, may result in repression.</text>
                    <arg n="0">cooperative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1662">
                    <text>cooperative bonding of the repressor to its two sites can ultimately resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1663">
                    <text>cooperative bonding of the repressor to its two sites cells is eventually able to result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1664">
                    <text>cooperative bonding of the repressor to its two sites eventually resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1665">
                    <text>cooperative bonding of the repressor to its two sites has the ability to result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1666">
                    <text>cooperative bonding of the repressor to its two sites may eventually result in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1667">
                    <text>cooperative bonding of the repressor to its two sites resulted in repression .</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1668">
                    <text>cooperative bonding of the repressor to its two sites, as predicted, may have resulted in repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1669">
                    <text>cooperative bonding of the repressor to its two sites, as we have result, is able to give rise to repression.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1670">
                    <text>declining EGL-15 is likely to resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1671">
                    <text>declining EGL-15 may result in a phenotype of scrubbing body morphology .</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1672">
                    <text>declining EGL-15 may ultimately resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1673">
                    <text>declining EGL-15, as we have predicted, is able to result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1674">
                    <text>declining EGL-15, as we have predicted, may resulting in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">declining EGL-15</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1675">
                    <text>decreases the EGL-15 signaling can ultimately resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1676">
                    <text>decreases the EGL-15 signaling cells can result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1677">
                    <text>decreases the EGL-15 signaling may result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1678">
                    <text>decreases the EGL-15 signaling will result in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1679">
                    <text>decreases the EGL-15 signaling, as we have predicted, may have resulted in a phenotype of scrubbing body morphology.</text>
                    <arg n="0">decreases the EGL-15 signaling</arg>
                    <arg n="1">a phenotype of scrubbing body morphology</arg>
                </example>
                <example src="REPLACE" no="1680">
                    <text>decreasing EGL-15 sign cells may have resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1681">
                    <text>decreasing EGL-15 sign finally resulted in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1682">
                    <text>decreasing EGL-15 sign resulted in scrutinic body morphology phenotype .</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1683">
                    <text>decreasing EGL-15 sign, as predicted, can result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1684">
                    <text>decreasing EGL-15 sign, as we have predicted, has the ability to result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1685">
                    <text>decreasing EGL-15 sign, as we have predicted, may result in scrutinic body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1686">
                    <text>decreasing EGL-15 signal cells eventually resulted in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1687">
                    <text>decreasing EGL-15 signal is shown to ultimately result in scratched body morphology phenotype.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1688">
                    <text>difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription) was also reported to be able to result from alternative spacer of a single transcription.</text>
                    <arg n="0">alternative spacer of a single transcription</arg>
                    <arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
                </example>
                <example src="REPLACE" no="1689">
                    <text>differential encryption cells has resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1690">
                    <text>differential encryption is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1691">
                    <text>differential encryption is capable of result rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1692">
                    <text>differential encryption is likely to resulting in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1693">
                    <text>differential encryption may eventually result in existence of NF-YA isoforms</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1694">
                    <text>differential encryption may have resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1695">
                    <text>differential encryption will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1696">
                    <text>differential encryption, as predicted, resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1697">
                    <text>differential encryption, as we have predicted, is able to result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1698">
                    <text>differential splicing cells eventually resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1699">
                    <text>differential splicing has the ability to result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1700">
                    <text>differential splicing may eventually result in existence of NF-YA isoforms</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1701">
                    <text>differential splicing may eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1702">
                    <text>differential splicing may result in the existence of NF-YA isoforms .</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1703">
                    <text>differential splicing may ultimately result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1704">
                    <text>differential splicing may ultimately resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1705">
                    <text>differential splicing will eventually result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1706">
                    <text>differential splicing will eventually result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1707">
                    <text>differential splicing will result in existence of NF-YA isoforms .</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1708">
                    <text>differential splicing, as predicted, resulted in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1709">
                    <text>differential splicing, as predicted, resulted in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1710">
                    <text>differential splicing, as predicted, will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1711">
                    <text>differential splicing, as predicted, will result in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1712">
                    <text>differential splicing, as we have predicted, is likely to resulting in the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1713">
                    <text>differential splicing, as we have predicted, may have resulted in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1714">
                    <text>differential splicing, as we have predicted, may result in the existence of isoforms of NF-YA.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="REPLACE" no="1715">
                    <text>differential splicing, as we have predicted, will result in existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1716">
                    <text>differential splicing, as we have result, is able to give rise to existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1717">
                    <text>differential splicing, as we have result, is able to give rise to the existence of NF-YA isoforms.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1718">
                    <text>dirty body morphology phenotype was also reported to be able to result from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1719">
                    <text>existence of NF-YA isoforms has the ability to probably result from differential encryption.</text>
                    <arg n="0">differential encryption</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1720">
                    <text>existence of NF-YA isoforms was able to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1721">
                    <text>existence of NF-YA isoforms was also reported to be able to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">existence of NF-YA isoforms</arg>
                </example>
                <example src="REPLACE" no="1722">
                    <text>exon 13 skipping in animals s1031 can result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1723">
                    <text>exon 13 skipping in animals s1031 cells has the ability to ultimately result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1724">
                    <text>exon 13 skipping in animals s1031 eventually resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1725">
                    <text>exon 13 skipping in animals s1031 is shown to ultimately result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1726">
                    <text>exon 13 skipping in animals s1031 may eventually result in a 543 bp product</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1727">
                    <text>exon 13 skipping in animals s1031 may have resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1728">
                    <text>exon 13 skipping in animals s1031 may ultimately result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1729">
                    <text>exon 13 skipping in animals s1031 resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1730">
                    <text>exon 13 skipping in animals s1031, as predicted, can result in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1731">
                    <text>exon 13 skipping in animals s1031, as predicted, may have resulted in a 543 bp product.</text>
                    <arg n="0">exon 13 skipping in animals s1031</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="REPLACE" no="1732">
                    <text>expression of Nrf1 isoforms can result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1733">
                    <text>expression of Nrf1 isoforms cells eventually resulted in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1734">
                    <text>expression of Nrf1 isoforms, as we have predicted, has the ability to result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1735">
                    <text>expression of Nrf1 isoforms, as we have predicted, will result in this.</text>
                    <arg n="0">expression of Nrf1 isoforms</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1736">
                    <text>expression of cDNA isoform II DNA in COS7 cells has resulted in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1737">
                    <text>expression of cDNA isoform II DNA in COS7 has the ability to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1738">
                    <text>expression of cDNA isoform II DNA in COS7 is able to result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1739">
                    <text>expression of cDNA isoform II DNA in COS7 will result in a marked increase in acetylhydrolase activity PAF.</text>
                    <arg n="0">expression of cDNA isoform II DNA in COS7</arg>
                    <arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
                </example>
                <example src="REPLACE" no="1740">
                    <text>failure to use the normal donor site of splice of intron 12 is capable of result rise to a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1741">
                    <text>failure to use the normal donor site of splice of intron 12, as we have predicted, may resulting in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1742">
                    <text>failure to use the normal donor site of splice of intron 12, as we have predicted, resulted in a variant.</text>
                    <arg n="0">failure to use the normal donor site of splice of intron 12</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1743">
                    <text>failure to use the normal site of the intron 12 splice donor can result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1744">
                    <text>failure to use the normal site of the intron 12 splice donor cells can result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1745">
                    <text>failure to use the normal site of the intron 12 splice donor has resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1746">
                    <text>failure to use the normal site of the intron 12 splice donor is capable of result rise to a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1747">
                    <text>failure to use the normal site of the intron 12 splice donor, as predicted, will result in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1748">
                    <text>failure to use the normal site of the intron 12 splice donor, as we have predicted, resulted in a variant.</text>
                    <arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1749">
                    <text>growth in ras-dependent signaling can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1750">
                    <text>growth in ras-dependent signaling cells can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1751">
                    <text>growth in ras-dependent signaling may eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1752">
                    <text>growth in ras-dependent signaling may result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1753">
                    <text>growth in ras-dependent signaling will eventually result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1754">
                    <text>growth in ras-dependent signaling, as predicted, resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
                    <arg n="0">growth in ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
                </example>
                <example src="REPLACE" no="1755">
                    <text>high proportion of mature RNA containing introns was able to result from both 5 and 3 splice mutations.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high proportion of mature RNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1756">
                    <text>high ratios of mature RNAm containing introns has the ability to result from both 5 and 3 splice mutations.</text>
                    <arg n="0">both 5 and 3 splice mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1757">
                    <text>high ratios of mature RNAm containing introns was able to result from both 5 and 3 splice local mutations.</text>
                    <arg n="0">both 5 and 3 splice local mutations</arg>
                    <arg n="1">high ratios of mature RNAm containing introns</arg>
                </example>
                <example src="REPLACE" no="1758">
                    <text>liquid charge of the variant subunit is shown to result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1759">
                    <text>liquid charge of the variant subunit may eventually result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
                    <arg n="0">liquid charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1760">
                    <text>liquid charge of varying subunits can eventually result in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1761">
                    <text>liquid charge of varying subunits may ultimately resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1762">
                    <text>liquid charge of varying subunits resulted in an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1763">
                    <text>liquid charge of varying subunits, as we have result, is able to give rise to an electrophoretic subunit of fast LDH-B subunits.</text>
                    <arg n="0">liquid charge of varying subunits</arg>
                    <arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
                </example>
                <example src="REPLACE" no="1764">
                    <text>mRNA species with 5 distinct UTRs was able to result from alternative exon splicing 139 nt.</text>
                    <arg n="0">alternative exon splicing 139 nt</arg>
                    <arg n="1">mRNA species with 5 distinct UTRs</arg>
                </example>
                <example src="REPLACE" no="1765">
                    <text>mRNA species with different 5UTRs has the ability to result from alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation.</text>
                    <arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with different 5UTRs</arg>
                </example>
                <example src="REPLACE" no="1766">
                    <text>mixed alternative subdomains may ultimately result in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1767">
                    <text>mixed alternative subdomains, as we have predicted, resulted in a superrepetitor.</text>
                    <arg n="0">mixed alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1768">
                    <text>multiple alternative subdomains cells may have resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1769">
                    <text>multiple alternative subdomains has resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1770">
                    <text>multiple alternative subdomains is able to result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1771">
                    <text>multiple alternative subdomains may have finally resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1772">
                    <text>multiple alternative subdomains may have finally resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1773">
                    <text>multiple alternative subdomains may result in superrepetition .</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1774">
                    <text>multiple alternative subdomains may result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1775">
                    <text>multiple alternative subdomains may ultimately result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1776">
                    <text>multiple alternative subdomains may ultimately result in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1777">
                    <text>multiple alternative subdomains will eventually result in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1778">
                    <text>multiple alternative subdomains, as predicted, may have resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1779">
                    <text>multiple alternative subdomains, as we have predicted, is likely to resulting in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1780">
                    <text>multiple alternative subdomains, as we have predicted, may have resulted in a superrepetitor.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1781">
                    <text>multiple alternative subdomains, as we have predicted, resulted in superrepetition.</text>
                    <arg n="0">multiple alternative subdomains</arg>
                    <arg n="1">superrepetition</arg>
                </example>
                <example src="REPLACE" no="1782">
                    <text>negative effect of the mutation cpxA was able to result from reduced transcription of the csgA gene encoding for the clinic.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1783">
                    <text>negative mutation effect cpxA was able to result from reduced transcription of the csgA gene encoding for curline.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1784">
                    <text>non-functional truncated proteins was able to result from the other three alterations.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1785">
                    <text>non-functional truncated proteins was able to result from the other three mutations.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1786">
                    <text>non-functional truncated proteins was also reported to be able to result from the other three mutations.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1787">
                    <text>not to use the normal donor site of the intron 12 splice cells has the ability to ultimately result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1788">
                    <text>not to use the normal donor site of the intron 12 splice has finally resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1789">
                    <text>not to use the normal donor site of the intron 12 splice may have resulted in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1790">
                    <text>not to use the normal donor site of the intron 12 splice may result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1791">
                    <text>not to use the normal donor site of the intron 12 splice will result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1792">
                    <text>not to use the normal donor site of the intron 12 splice, as we have predicted, is able to result in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1793">
                    <text>not to use the normal donor site of the intron 12 splice, as we have predicted, is likely to resulting in a variant.</text>
                    <arg n="0">not to use the normal donor site of the intron 12 splice</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1794">
                    <text>of high proportion of mature mRNA containing introns has the ability to result from both the mutations at the site of 5 and 3 splices.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNA containing introns</arg>
                </example>
                <example src="REPLACE" no="1795">
                    <text>of high proportion of mature mRNAs containing introns has the ability to probably result from both the mutations at the site of 5 and 3 splices.</text>
                    <arg n="0">both the mutations at the site of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1796">
                    <text>of high proportion of mature mRNAs containing introns was also reported to be able to result from both the mutations of 5 and 3 splices.</text>
                    <arg n="0">both the mutations of 5 and 3 splices</arg>
                    <arg n="1">of high proportion of mature mRNAs containing introns</arg>
                </example>
                <example src="REPLACE" no="1797">
                    <text>reduced EGL-15 signal cells is eventually able to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1798">
                    <text>reduced EGL-15 signal will eventually result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1799">
                    <text>reduced EGL-15 signal will result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1800">
                    <text>reduced EGL-15 signal, as predicted, resulted in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1801">
                    <text>reduced EGL-15 signal, as we have predicted, has the ability to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1802">
                    <text>reduced EGL-15 signal, as we have predicted, is able to result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1803">
                    <text>reduced EGL-15 signal, as we have predicted, will result in a phenotype of scrawny morphology.</text>
                    <arg n="0">reduced EGL-15 signal</arg>
                    <arg n="1">a phenotype of scrawny morphology</arg>
                </example>
                <example src="REPLACE" no="1804">
                    <text>reduced EGL-15 signaling can eventually result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1805">
                    <text>reduced EGL-15 signaling can ultimately resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1806">
                    <text>reduced EGL-15 signaling cells eventually resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1807">
                    <text>reduced EGL-15 signaling eventually resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1808">
                    <text>reduced EGL-15 signaling is able to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1809">
                    <text>reduced EGL-15 signaling is capable of result rise to a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1810">
                    <text>reduced EGL-15 signaling will finally result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1811">
                    <text>reduced EGL-15 signaling, as we have predicted, may have resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced EGL-15 signaling</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1812">
                    <text>reduced signaling by EGL-15 can eventually result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1813">
                    <text>reduced signaling by EGL-15 cells eventually resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1814">
                    <text>reduced signaling by EGL-15 eventually resulted in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1815">
                    <text>reduced signaling by EGL-15 may eventually result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1816">
                    <text>reduced signaling by EGL-15 will result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1817">
                    <text>reduced signaling by EGL-15, as predicted, will result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1818">
                    <text>reduced signaling by EGL-15, as we have predicted, has the ability to result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1819">
                    <text>reduced signaling by EGL-15, as we have predicted, has the ability to result in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1820">
                    <text>reduced signaling by EGL-15, as we have predicted, is likely to resulting in pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1821">
                    <text>reduced signaling by EGL-15, as we have predicted, may have resulted in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1822">
                    <text>reduced signaling by EGL-15, as we have predicted, will result in a phenotype of dirty body morphology.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">a phenotype of dirty body morphology</arg>
                </example>
                <example src="REPLACE" no="1823">
                    <text>reduced signaling by EGL-15, as we have result, is able to give rise to pulled body morphology phenotype.</text>
                    <arg n="0">reduced signaling by EGL-15</arg>
                    <arg n="1">pulled body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1824">
                    <text>reduced transcription of the csgA curlin encoder gene can eventually result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1825">
                    <text>reduced transcription of the csgA curlin encoder gene cells eventually resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1826">
                    <text>reduced transcription of the csgA curlin encoder gene has the ability to eventually result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1827">
                    <text>reduced transcription of the csgA gene encoding for curline can eventually result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1828">
                    <text>reduced transcription of the csgA gene encoding for curline can ultimately resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1829">
                    <text>reduced transcription of the csgA gene encoding for curline finally resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1830">
                    <text>reduced transcription of the csgA gene encoding for curline is shown to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1831">
                    <text>reduced transcription of the csgA gene encoding for curline may eventually result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1832">
                    <text>reduced transcription of the csgA gene encoding for curline may result in negative mutation effect cpxA .</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1833">
                    <text>reduced transcription of the csgA gene encoding for curline, as predicted, may have resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1834">
                    <text>reduced transcription of the csgA gene encoding for curline, as we have predicted, resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1835">
                    <text>reduced transcription of the csgA gene encoding for the clinic cells can result in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1836">
                    <text>reduced transcription of the csgA gene encoding for the clinic cells can result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1837">
                    <text>reduced transcription of the csgA gene encoding for the clinic cells is eventually able to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1838">
                    <text>reduced transcription of the csgA gene encoding for the clinic finally resulted in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1839">
                    <text>reduced transcription of the csgA gene encoding for the clinic has finally resulted in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1840">
                    <text>reduced transcription of the csgA gene encoding for the clinic resulted in negative mutation effect cpxA .</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1841">
                    <text>reduced transcription of the csgA gene encoding for the clinic, as we have predicted, is able to result in negative mutation effect cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative mutation effect cpxA</arg>
                </example>
                <example src="REPLACE" no="1842">
                    <text>reduced transcription of the csgA gene encoding for the clinic, as we have predicted, may resulting in negative effect of the mutation cpxA.</text>
                    <arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
                    <arg n="1">negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1843">
                    <text>reduction of EGL-15 signaling cells can result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1844">
                    <text>reduction of EGL-15 signaling cells has resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1845">
                    <text>reduction of EGL-15 signaling cells has the ability to ultimately result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1846">
                    <text>reduction of EGL-15 signaling finally resulted in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1847">
                    <text>reduction of EGL-15 signaling may have finally resulted in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1848">
                    <text>reduction of EGL-15 signaling may result in a dirty body morphology phenotype .</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1849">
                    <text>reduction of EGL-15 signaling may result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1850">
                    <text>reduction of EGL-15 signaling may result in dirty body morphology phenotype .</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1851">
                    <text>reduction of EGL-15 signaling may ultimately result in dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1852">
                    <text>reduction of EGL-15 signaling resulted in a dirty body morphology phenotype .</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1853">
                    <text>reduction of EGL-15 signaling will result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1854">
                    <text>reduction of EGL-15 signaling, as predicted, resulted in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1855">
                    <text>reduction of EGL-15 signaling, as we have predicted, has the ability to result in a dirty body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">a dirty body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1856">
                    <text>reduction of EGL-15 signaling, as we have predicted, is able to result in scratched body morphology phenotype.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1857">
                    <text>reduction of csgA gene transcription csgA coding cells may have resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1858">
                    <text>reduction of csgA gene transcription csgA coding is shown to ultimately result in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1859">
                    <text>reduction of csgA gene transcription csgA coding may have finally resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1860">
                    <text>reduction of csgA gene transcription csgA coding may ultimately resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1861">
                    <text>reduction of csgA gene transcription csgA coding resulted in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1862">
                    <text>reduction of csgA gene transcription csgA coding, as we have predicted, is likely to resulting in negative effect of cpxA mutation.</text>
                    <arg n="0">reduction of csgA gene transcription csgA coding</arg>
                    <arg n="1">negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1863">
                    <text>reduction of the EGL-15 signaling cells can result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1864">
                    <text>reduction of the EGL-15 signaling cells has the ability to ultimately result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1865">
                    <text>reduction of the EGL-15 signaling eventually resulted in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1866">
                    <text>reduction of the EGL-15 signaling may have resulted in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1867">
                    <text>reduction of the EGL-15 signaling will result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1868">
                    <text>reduction of the EGL-15 signaling, as predicted, will result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1869">
                    <text>reduction of the EGL-15 signaling, as we have predicted, is likely to resulting in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1870">
                    <text>reduction of the EGL-15 signaling, as we have predicted, will result in bodys dirty morphology phenotype.</text>
                    <arg n="0">reduction of the EGL-15 signaling</arg>
                    <arg n="1">bodys dirty morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1871">
                    <text>repression was also reported to be able to result from cooperative bonding of the repressor to its two sites.</text>
                    <arg n="0">cooperative bonding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="REPLACE" no="1872">
                    <text>scratched body morphology phenotype has the ability to probably result from decreasing EGL-15 signal.</text>
                    <arg n="0">decreasing EGL-15 signal</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1873">
                    <text>scratched body morphology phenotype has the ability to probably result from reduction of EGL-15 signaling.</text>
                    <arg n="0">reduction of EGL-15 signaling</arg>
                    <arg n="1">scratched body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1874">
                    <text>scrutinic body morphology phenotype was able to result from decreasing EGL-15 sign.</text>
                    <arg n="0">decreasing EGL-15 sign</arg>
                    <arg n="1">scrutinic body morphology phenotype</arg>
                </example>
                <example src="REPLACE" no="1875">
                    <text>some alternative subdomains is shown to ultimately result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1876">
                    <text>some alternative subdomains, as we have predicted, may result in a superrepetitor.</text>
                    <arg n="0">some alternative subdomains</arg>
                    <arg n="1">a superrepetitor</arg>
                </example>
                <example src="REPLACE" no="1877">
                    <text>the donor place of normal helix of intron 12 could not be used can result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1878">
                    <text>the donor place of normal helix of intron 12 could not be used cells eventually resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1879">
                    <text>the donor place of normal helix of intron 12 could not be used cells is eventually able to result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1880">
                    <text>the donor place of normal helix of intron 12 could not be used eventually resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1881">
                    <text>the donor place of normal helix of intron 12 could not be used has resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1882">
                    <text>the donor place of normal helix of intron 12 could not be used is shown to result in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1883">
                    <text>the donor place of normal helix of intron 12 could not be used may have resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1884">
                    <text>the donor place of normal helix of intron 12 could not be used resulted in a variant .</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1885">
                    <text>the donor place of normal helix of intron 12 could not be used, as predicted, may have resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1886">
                    <text>the donor place of normal helix of intron 12 could not be used, as we have predicted, resulted in a variant.</text>
                    <arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1887">
                    <text>the donor site of the normal helix of intron 12 could not be used finally resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1888">
                    <text>the donor site of the normal helix of intron 12 could not be used has resulted in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1889">
                    <text>the donor site of the normal helix of intron 12 could not be used has the ability to eventually result in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1890">
                    <text>the donor site of the normal helix of intron 12 could not be used is shown to result in a variant.</text>
                    <arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1891">
                    <text>the expression of isoforms of Nrf1 cells may have resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1892">
                    <text>the expression of isoforms of Nrf1 is capable of result rise to this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1893">
                    <text>the expression of isoforms of Nrf1, as predicted, resulted in this.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="REPLACE" no="1894">
                    <text>the negative effect of cpxA mutation was able to result from a decrease in csgA gene transcription from csglin coding.</text>
                    <arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
                    <arg n="1">the negative effect of cpxA mutation</arg>
                </example>
                <example src="REPLACE" no="1895">
                    <text>the negative effect of the mutation cpxA has the ability to result from a decrease in transcription of the csgA gene from csglin encoding.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1896">
                    <text>the negative effect of the mutation cpxA was also reported to be able to result from a decrease in transcription of the csgA gene encoding csgA.</text>
                    <arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1897">
                    <text>the negative effect of the mutation cpxA was also reported to be able to result from a decrease in transcription of the csgA gene from csglin encoding.</text>
                    <arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
                    <arg n="1">the negative effect of the mutation cpxA</arg>
                </example>
                <example src="REPLACE" no="1898">
                    <text>the net charge of the variant subunit cells has resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1899">
                    <text>the net charge of the variant subunit cells may have resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1900">
                    <text>the net charge of the variant subunit has the ability to result in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1901">
                    <text>the net charge of the variant subunit, as predicted, may have resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1902">
                    <text>the net charge of the variant subunit, as we have predicted, may have resulted in a fast-type electrophoretic subunit LDH-B of variant.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
                </example>
                <example src="REPLACE" no="1903">
                    <text>the normal docking donor site of intron 12 could not be used can ultimately resulted in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1904">
                    <text>the normal docking donor site of intron 12 could not be used has the ability to result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1905">
                    <text>the normal docking donor site of intron 12 could not be used is able to result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1906">
                    <text>the normal docking donor site of intron 12 could not be used is shown to result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1907">
                    <text>the normal docking donor site of intron 12 could not be used resulted in a variant .</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1908">
                    <text>the normal docking donor site of intron 12 could not be used will finally result in a variant.</text>
                    <arg n="0">the normal docking donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1909">
                    <text>the normal donor site of intron 12 donation could not be used will result in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1910">
                    <text>the normal donor site of intron 12 donation could not be used, as predicted, may have resulted in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1911">
                    <text>the normal donor site of intron 12 donation could not be used, as we have predicted, may resulting in a variant.</text>
                    <arg n="0">the normal donor site of intron 12 donation could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1912">
                    <text>the normal site of the intron 12 fitting donor could not be used cells is eventually able to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1913">
                    <text>the normal site of the intron 12 fitting donor could not be used may result in a variant .</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1914">
                    <text>the normal site of the intron 12 fitting donor could not be used will eventually result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1915">
                    <text>the normal site of the intron 12 fitting donor could not be used, as predicted, can result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1916">
                    <text>the normal site of the intron 12 fitting donor could not be used, as we have predicted, is likely to resulting in a variant.</text>
                    <arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1917">
                    <text>the normal site of the intron 12 splice donor could not be used can result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1918">
                    <text>the normal site of the intron 12 splice donor could not be used cells may have resulted in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1919">
                    <text>the normal site of the intron 12 splice donor could not be used is able to result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1920">
                    <text>the normal site of the intron 12 splice donor could not be used is shown to ultimately result in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1921">
                    <text>the normal site of the intron 12 splice donor could not be used, as we have predicted, may resulting in a variant.</text>
                    <arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1922">
                    <text>the normal splice donor site of intron 12 could not be used cells eventually resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1923">
                    <text>the normal splice donor site of intron 12 could not be used, as we have predicted, may have resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1924">
                    <text>the normal splice donor site of the 12th intron could not be used cells has resulted in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1925">
                    <text>the normal splice donor site of the 12th intron could not be used has the ability to result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1926">
                    <text>the normal splice donor site of the 12th intron could not be used is able to result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1927">
                    <text>the normal splice donor site of the 12th intron could not be used may ultimately result in a variant.</text>
                    <arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1928">
                    <text>the other three alterations cells is eventually able to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1929">
                    <text>the other three alterations eventually resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1930">
                    <text>the other three alterations has finally resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1931">
                    <text>the other three alterations is likely to resulting in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1932">
                    <text>the other three alterations is shown to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1933">
                    <text>the other three alterations may have finally resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1934">
                    <text>the other three alterations may result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1935">
                    <text>the other three alterations, as predicted, may have resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1936">
                    <text>the other three alterations, as we have predicted, has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1937">
                    <text>the other three alterations, as we have predicted, is likely to resulting in non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1938">
                    <text>the other three alterations, as we have result, is able to give rise to non-functional truncated proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1939">
                    <text>the other three changes has the ability to result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1940">
                    <text>the other three changes may have resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1941">
                    <text>the other three changes will result in non-functional truncated proteins .</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1942">
                    <text>the other three changes, as predicted, can result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1943">
                    <text>the other three changes, as we have predicted, may result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1944">
                    <text>the other three changes, as we have predicted, will result in non-functional truncated proteins.</text>
                    <arg n="0">the other three changes</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1945">
                    <text>the other three mutations eventually resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1946">
                    <text>the other three mutations has the ability to eventually result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1947">
                    <text>the other three mutations may eventually result in non-functional truncated proteins</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1948">
                    <text>the other three mutations may eventually result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1949">
                    <text>the other three mutations resulted in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1950">
                    <text>the other three mutations, as predicted, will result in non-functional truncated proteins.</text>
                    <arg n="0">the other three mutations</arg>
                    <arg n="1">non-functional truncated proteins</arg>
                </example>
                <example src="REPLACE" no="1951">
                    <text>the place of normal splice donor of intron 12 could not be used is likely to resulting in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1952">
                    <text>the place of normal splice donor of intron 12 could not be used may have resulted in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1953">
                    <text>the place of normal splice donor of intron 12 could not be used will result in a variant .</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1954">
                    <text>the place of normal splice donor of intron 12 could not be used will result in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
                <example src="REPLACE" no="1955">
                    <text>the place of normal splice donor of intron 12 could not be used, as predicted, may have resulted in a variant.</text>
                    <arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
                    <arg n="1">a variant</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
